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Fibronectin is a multidomain, multifunctional, adhesion glycoprotein composed of
subunits ofmolecularweight around 250 kD. It exists as a two subunits, soluble, form in
tissue-culture media and plasma but can also exists as a multiple subunits, fibrillar,
insoluble, form in tissues or in cell cultures.
Fibronectin now seems to function principally as part of the system which anchors
cells in tissues. To understand this function, models of fibronectin shape and changes in
its conformation are widely used and referred to .
However, despite the fact that the physicochemical study of fibronectin was
started as early as 1955 , there is still little experimental data on this topic compared
with other aspects of fibronectin. Furthermoremany of the proposed models do not
match with the observations in the literature .
Chapter I presents a review of the current knowledge of fibronectin .
Chapter II describes the various physicochemical techniques applied to fibronectin
in this work.
In chapter III, the purification of the fibronectin molecule and of some of its
constituent domains are developed. This includes various improvements from the
classical purification method.
Chapter IV shows the construction of a model of the fibronectin molecule in solution
through the combination of original data and published work.
The rotational relaxation times, as measured by electric birefringence, are 0.8psec.
in 150 mM ionic strength and 0.2 and 12 psec. in 50 mM ionic strength. The radius of
gyration determined by neutron small angle scattering experiments is 7.3 nm.The limited
enzymatic disgestion performed in physiological conditions is found not to differ from
the usual patterns and helps to establish the existence of fibronectin in solution as a
compact succession of domains. The diffusion coefficient of the 145-155 kD central
P 16
domain, measured by photon correlation spectroscopy, is 3.1 10~7 cm2 sec."^ . Neutron
small angle scattering experiments on the 44 kD collagen binding domain suggest that its
shape is approximately spherical.
The proposed model for the conformation of the fibronectin molecule is a flat
structure with anti-parallel chain position roughly equivalent to an oblate elllipsoid
with a main axis of 10 nm and an extension of about 10.
In chapter V plasma fibronectin prepared from metastatic cancer patients studied by
light scattering techniques shows an abnormal aggregation property in vitro .
Unsuccesful attempts to relate this with various biochemical properties are also
described.
Chapter VI shows that the interaction between heparin and fibronectin do not result
in any large change in conformation as shown by light and neutron scattering experiments
. The published differences in physicochemical properties could rather be explained by
aggregation.
An appendix describes possible evidence that vitronectin, another plasma
cell-adhesion protein, could exist in two forms differing in their heparin binding
properties . This finding could lead to a new purification method for vitronectin .
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CHAPTER I:
STRUCTURAL AND BIOLOGICAL PROPERTIES OF FIBRONECTINS
T 1 INTRODUCTION
Fibronectin was first identified as "Cold insoluble globulin " in 1948 by Morisson ,
Edsall and Miller who described this protein as the major contaminant of fibrinogen
prepared by Cohn's cold ethanol fractionation technique .
Nearly thirty years later it was also found in material synthesized by cells in
culture and tissues and referred to as "Surface fibroblast antigen "Large external
transformation sensitive glycoprotein" and "Cell surface protein".
It is now defined as an extracellular , multidomain , adhesive glycoprotein . Its
main function seems to be as part of the system that anchors or moves cells in the tissues.
At themoment, despite a large number of studies, there is no clear position about
what fibronectin really does in this system . On the other hand the structural properties
are often well documented. The review presented below will reflect those facts.
I 2 PRIMARY STRUCTURE,
I 2 1 Determination of the primary structure :
The determination of the primary structure of fibronectin was not an easy task
considering the size of this protein which is of the order of half a million Daltons. The
sequencing was carried out by two different methods : either by the classical protein
sequencing by enzymatic and chemical degradation or by molecular biology techniques.
The first step in our knowledge of the primary structure was the determination of
the aminoacid composition of plasma fibronectin by Mosseson et al. in 1975. It is now not
really useful since the primary structure has been determined allowing a much more
precise knowledge of the composition .
The next problem was to determine the number of subunits in the plasma
fibronectin. This important point was clarified by Engvall et al. ( 1978 ) . They showed
that the plasma fibronectin molecule is a disulphide bonded dimer. In a more recent
work Skortengaard et al. ( 1986 ) suggested that the link between the two chains
maintains them in an anti-parallel configuration . This will be of some importance in the
construction of a model in chapter IV below. /
Bovine plasma fibronectin was sequenced by Petersen's team in Denmark and
human plasma fibronectin by Garcia Pardo's in U.S.A ( See :Petersen et al. 1983,
Skortengaard et al. 1982,1983 ,1986 and in Garcia-Pardo et al. 1983,1985 ). Both teams
1
used the fact that the fibronectin molecule is composed of a succession of protease
resistant functional domains. For this reason smaller fragments of the molecule can be
generated . Their size is more suited to protein sequencing than the very large integral
molecule.
Petersen et al. (1982), on a partial determination of the sequence , discovered a
striking feature of the primary structure of fibronectin. Three types of internal
homologies called type I, II and III were found within the molecule. Further work on
the sequence showed that the fibronectin molecules are made of the concatenation of
those three basic structures. Their positions are shown in Fig I 1 .
Both type I and type II homologies are made on the same frame of disulphide
bonded cysteine residues linked in a 1-3 , 2-4 pattern ; this pattern defines loops that
have also been called "Fingers". Their positions along the primary structure are shown
below in Table I 1.
One of the most striking features of fibronectin when compared to many other
proteins , is the linear arrangement in the primary structure of the sequences involved in
its properties. Not only can the sequence be cut into independent active domains but, (as
described below in Table 11 and paragraphs I 3 2 & 3 ), the segment of the molecule
responsible for a property can , in the cases of the collagen and cell binding properties ,
even be restricted to a linear sequence of the size of a small peptide .
Partial amino-acid sequences deduced from cDNA clones for chicken , calf , rat
and human have been described ( Fagan et al. 1979,Kohrnblitt et al. 1983,1984 and
Schwartzbauer et al. 1983 ) . Eventually KohrnbHtt et al. (1985 ) reported the
complete primary structure of human plasma fibronectin from cDNA. ( See Table II).
This work was followed by the total determination of the sequence from bovine plasma
fibronectin by classical protein sequencing techniques thus showing the position of post
transcriptional modifications such as phosphorylation or glycosylation (Skorskengaard
et al. 1986 ) .
I 2 2 Alternative splicing of fibronectin mRNA.
Multiple fibronectin mRNA's can exist ( Schwartzbauer et al. 1983 , Kohrnblitt
et al. 1984 ) and are a consequence of alternative splicing of the gene . This explains
how the primary structure can vary with the origin of the fibronectin. Presence or
absence of some domains defines the various forms of fibronectins . They are Plasma ,
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Monoclonal antibodies conjugated with affinity chromatography of limited
thermolysin digest have been the investigators' favourite tool for the investigation of
the expression of domains : All the alternatively spliced domains described as yet are
type III homologies.
From Nto C ends:
A) ED-A is the name of the first alternatively spliced domain . Its insertion point is
residue 1599 in the bovine plasma form . It is detected bymonoclonal antibodies 1ST 9
and FN 3 . There is no ED in human plasma fibronectin ; it is only present in a small
fraction of the cellular form produced by normal cells and a high fraction of cellular
form produced by transformed cells . ( Paul et al. 1986,Borsi et al, 1987).
B) The second one , is called ED-B and is expressed at high levels in fibronectin from
transformed cells but is absent in the plasma form (Zardi et al. 1987 ).
C) The third one called IIIcs (residues 1871 to 1990 in the bovine plasma form ), is also a
type III homology (Seikiguchi et al 1985,Matsuara et al 1985 ). Its presence defines
the difference between the two chains of plasma fibronectin ( Matsuara et al.
1985 ) .The subunit a has the IIIcs domain while the subunit (3 does not have it. The
quantitation of the subunit expression in fibronectin from various sources ( Castellani
et al. 1986) shows that IIIcs is only expressed on one chain in the plasma form and
that its presence is increased in normal cells fibronectin and is maximal in
transformed cells fibronectin where all molecules are a, a type .
I 2 3 Structural analogies with other proteins.
The three types of internal homologies of fibronectin have been reported as being
homologous to otherprotein sequences.
A) The type I homology has few known homologous proteins : Human alpha
factor Xlla and tissue type plasminogen activator (Skorkengaard et al. 1986) and
also Thrombospondin ( Lawler et al. 1986 ).
B)The type II homology of fibronectin , present in the fibronectin molecule only in the
collagen binding domain ( residues 314 to 370 and 374 to 430 in the bovine plasma
molecule ), is homologous to the " Kringle" structure , an autonomous structural and
folding domains . Kringle type structures are also present in prothrombin ,
plasminogen , urokinase , tissue type plasminogen activator , alpha chain of
haptoglobin , bovine seminal BSP-A3 and PDC 109 protein. Each type II homology is
coded by one exon and it is believed that those modules , all devoted to protein
5
binding, might have evolved from a common ancestor . (Patthy 1983& 1985 , Baker
et al. 1985 , Seidah et al. 1987 , Owens et al. 1986 ).
C) A particular type III segment of fibronectin including the peptide RGDS (See cell
binding in I 8 3) is also found in thrombospondin ( Lawler et al. 1986 ) and
vitronectin which are two other adhesion proteins of the extracellular matrix and
also in Von Willebrand Factor ( Tikani et al. 1986) and C3 complement factor
( Wright et al. 1987 )
Table I 1
Primary structure of the alpha chain of human plasma fibronectin ,( From Kohmblitt et
al 1985). Tine positions of the carbohydrate side-chains are indicated by arrows.
29 k D Heparin binding N terminal domain.
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Central DNA-Cell Heparin binding domain, the cell attachment site is underlined.
SGPVEVFITETPSQPNSHPIQSAPQPSHISKYILRWRPKNSVGRWKEATIPGHLNSYTI
KGLKPGWYEGQLISIQQYGHQEVTRFDFTTT ( III 1 )
S TSTPVTSNTV TGETTPFSPL VATSESVTEI TASSFVVSWV SASDTVSGFR
VEYELSEEGD EPQYLDLPST ATSVNIPDLL PGRKYIVNVY QISEDGEQSL ILSTSQTT
( III 2 ).
APDAPPDPTVDQVDDTSIWRWSRPQAPITGYRIVYSPSVEGSSTELNLPETANSVTL
SDLQPGVQYNITIYAVEENQESTPWIQQETT ( III 3 ).
T
GTPRSDTVPSPRDLQFVEVTDVKVTIMWTPPESAVTGYRVDVIPVNLPGEHGQRLPIS
RNTFAEVTGLSPGVTYYFKVFAVSHGRESKPLTAQQTT ( III 4 ).
4'
KLDAPTNLQFVNETDSTVLVRWTPPRAQITGYRLTVGLTRRGQPRQYNVGPSVSKYP
LRNLQPASEYTVSLVAIKGNQESPKATGVFTT ( III 5 ).
LQPGSSIPPYNTEVTETTIVITWTPAPRIGFKLGVRPSQGGEAPREVTSDSGSIWSGLTP
GVEYVYTIQVLRDGQERDAPIVNKWT ( III 6 ).
PLSPPTNLHLEANPDTGVLTVSWERSTTPDITGYRITTTPTNGQQGNSLEEWHADQS
SCTFDNLSPGLEYNVSVYTVKDDKESVPISDTIIP ( III 7 ).
t
AVPPPTDLRFTNIGPDTMRVTWAPPPSIDLTNFLVRYSPVKNEEDVAELSISPSDNAV
VLTNLLPGTEYWSVSSVYEQHESTPLRGRQKT ( III 8 ).
GLDSPTGIDFSDITANSFTVHWIAPRATITGYRIRHHPEHFSGRPREDRVPHSRNSITL





IEGLQPTVEYWSVYAQNPSGESQPLVQTAVT ( III 11).
Insertion position for the E D. domain, ( absent in plasma fibronectin ).
TAIPAPTDLKFTQVTPTSLSAQWTPPNVQLTGYRVRVTPKEKTGPMKEINLAPDSSSV
WSGLMVATKYEVSVYALKDTLTSRPAQGWTTLE ( III 12 ).
NVSPPRRARVTDATETTITISWRTKTETITGFQVDAVPANGQTPIQRTIKPDVRSYTIT
GLQPGTDYKIYLYTLNDNARSSPWIDAST (III 13 ).
AIDAPSNLRFLATTPNSLLVSWQPPRARITGYIIKYEKPGSPPREWPRPRPGVTEATIT
GLEPGTEYTIYVIALKNNQKSEPLIGRKKT( III 14 ).
DELPQLVTLPHPNLHGPEILDVPSTVQKTPFVTHPGYDTGNGIQLPGTSGQQPSVGQQ
MI FEEHGFRRTTPPTTATPIRHRPRPYPPNV ( IIICS ).
TT
GQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFRVPGTSTSATLTGLTRGATYNII
VEALKDQQRHK ( III 15 ).










I 3 1 Introduction.
As usual with glycoproteins and very unfortunately, the nature of the
glycosylation is one of the lesser known aspects of fibronectin. While the structural and
biological consequences of the variability in aminoacid sequences are well documented,
the structure and variations in glycosylation, ( as well as their consequences ), are
relatively neglected .
Fibronectin is mostly a N glycan glycoprotein ( Taksaski et al. 1979 ) thus
glycosylation can be inhibited by tunicamycin ( Duskin et al. 1976 ) and export from the
cells is unaffected by 1 Deoxynojirimycin (Parent et al. 1986 ).
I 3 2 Carbohydrates of plasma fibronectin.
This problem has not been solved in a satisfactory way since partial
determinations only exist and sometimes show variations among each other.
A) The composition in carbohydrates of human plasma fibronectin , from
Mosseson et al. (1975 ), in percentage of the total mass, is : sialic acid 1.2 % ,hexose
1.8 % ,hexosamine 2.1% . A possible pattern for human plasma fibronectin
glycosylation has been proposed (Wrann et al. 1978) .The structure of the sugar side
chains of bovine plasma is known ( Taksaki et al 1979).
B) An attempt to determine the position of the carbohydrate side-chains in human
plasma fibronectin was made by Hayashi et al. (1983 ). They found ten glycosidic
chains by plasma molecule ; three chains per collagen binding domain and two
chains per cell binding domain . But this does not match with the
determination in the bovine plasma form , where sugar sidechains number and
positions are shown below (Skorskergaard et al. 1986 ):
a) Collagen binding domain : asparagine residues position 399, 497,511.
p ) Between collagen and DNA binding domains position 846.
y) Position 976 in the DNA binding domain.
8 ) Between DNA end cell binding domains on residue 1213.
8 ) In the IIIcs domain on residues 1943-1944.
The carbohydrate sidechains are similar to those of other plasma glycoproteins .
The sequence Gaipi- 3 GlcNac, present in the bovine plasma molecule was also found in
milk oligosaccharides and in bovine prothrombin. ( Taksaki et al 1979 ). Analysis of the
porcine fibronectin carbohydrates shows that the sugar sidechains are the same as in
9
porcine plasma gelatin binding protein and are similar to those in human
plasma-Fibronectin except for fucose distribution. (Isemura et al. 1-984).
I 3 3 Carbohydrates of cellular or oncofetal fibronectins.
Oncofetal or cellular fibronectins have a different glycosylation pattern from
that of plasma fibronectins ( Wagner et al. 1981 ,Fukuda et al. 1982 ,Zhu et al. 1984).
A) The structure of carbohydrates from human amniotic fluid fibronectin has been
determined . It shows an increase of lactosamin sidechains during gestation ; this
increase in lactosamin content seems correlated with lower collagen affinity
(Yamaguchi at al. 1986, Zhu et al. 1987 ). Near term nearly 10 % of
the molecule mass is represented by carbohydrates .
B) Fibronectin produced by normal and transformed cells has, at least for a proportion of
the total synthesis , a modified glycosylation .
C) They showspecific Lentil lectin reactive sites in fibronectins produced by transformed
cell lines .
D ) They present specific binary sialosyl chain NeuAc a 2— 3 / or 6Gal (3 1— 4 GlcNac,
within the collagen binding domain for fibronectin produced by normal cells, at the
N terminal region of the central domain for fibronectin produced by transformed
cells. ( Nichols et al. 1986. )
I 3 4 Functions of glycosylation.
The functions of carbohydrate side-chains in fibronectins are still not very well
understood . Glycosylation effects on fibronectin properties were investigated in a
comparative study of cellular fibronectin produced in cell culture in presence or absence of
tunicamycine. ( Jones et al. 1986) . Cellular fibronectin produced in the presence of
tunicamycin ,free from post transcriptional modifications and therefore with no
carbohydrate side-chains shows:
A) A better cell attachment efficiency as shown by a cell attachment assay ;this is in
contradiction with the findings of Obara et al. 1987 who noticed that expression of
the cell binding domain in E.Coli, (therefore non glycosylated ), produced a 80 kD
cell attachment domain as efficient as the whole fibronectin molecule .
B) A better collagen binding efficiency. ( Urea concentration greaterr to 3 M is required
to elute nonglycosylated fibronectin from a collagen column as normal fibronectin is
eluted at lower urea concentrations ). In a similar way increased glycosylation as in
placental fibronectin decreases the affinity between fibronectin and collagen.
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( Yamaguchi et al. 1986 ). We must notice that this does not prove that the binding
itself is affected . It might well be that only the urea denaturation is made easier .
C) Some unaffected heparin binding properties .
It has been confirmed that the glycosylation has a protease degradation
protective effect particularly on the collagen binding domain .( Olden et al. 1979 ) .
I 4 PHOSPHORYLATION AND SUI.PHATION
Fibronectins from various sources are phosphorylated . The phosphorylation site
of bovine plasma fibronectins is on the serine residue in position 2263 , three residues
before the C End of the molecule , ( Skorskengaard et al. 1986 ). This position seems to
be the same in fibronectin from human adult normal fibroblasts in culture metabolically
labelled by ^P ( Ledger et al. 1981 ).
The culture of various transformed cell lines produced variable results , some
authors claiming that fibronectin produced by the transformed cell lines bear more
phosphate , ( Ali et al. 1981 ), other thinking they bear less phosphate , ( Teng et al.
1979 ).
There is one sulfatation site in fibronectin from normal cells culture, detected by
OC
metabolic labelling with sulphate, within type I homologies at the C terminus
17 kD domain . ( Liu et al. 1987 ).
I 5 FREE SULPHYDRYL GROUPS.
The existence of free sulphydryl groups on fibronectin is very important because
they might be involved in its polymerisation . ( See I 11 below ). There are two free
sulphydryl groups per fibronectin subunit ( residues 1201 and 2215 ) in the bovine
plasma molecule.
The free sulphydryl groups are not accessible to reagents in normal buffer
conditions needing a guanidinium chloride concentration of 3 M to be fully exposed .
( Williams et al. 1983 ). Surprisingly, despite this fact, CuSO^ induced polymerisation
( Vartio 1986 ) , which, according to this author, uses those free sulphydryl groups ,
occurs in physiological buffers with addition of milimolar amounts of CuSO^ but no
chaotropic agent .It must be noticed that the characterization of polymerisation
involved in this study is probably not perfect. This was shown by the fact that Vartio
claims that ZnC^ cannot induce the polymerisation of fibronectin, but with a ZnC^
concentration of 10 mM fibronectin prepared for this work could be rapidly polymerised
1 1
and formed visible precipitates.
I 6 SECONDARY STRUCTURE.
The secondary structure composition of plasma fibronectin , and of some of its
constituent domains , is known from circular dichroism studies ( Alexander 1978 ,
Kotelianski et al. 1981 , Odermatt et al. 1982 , Venyaminov et al. 1983, Welsh et al.
1983). The major conclusions are shown in Table I 2 below.
Table I 2: Secondary structure patterns of fibronectin and trypsin generated fibronectin
domains.fVenyaminov et al. 1983)
|3 Sheet Non organised a Helix
Fibronectin 35% 50% 0%
70 kD Gelatin binding domain . 28% 68% 0%
65-60 kD Heparin binding domain . 33% 69% 0%
60 kD Central domain. 37% 63% 0%
Results from various teams are similar . The most important conclusion is that
the molecule is made of structurally independent domains retaining their individual
conformation when they are isolated from the complete molecule. This is based on the
following facts :
A) The sum of the individual domains spectra yields the spectrum of the intact
molecule.
B) Although large transition in conformation is observed between pH 5 and 10.8 the C.D.
spectrum remains nearly unchanged, but clearly a large irreversible denaturation
occurs at pH superior to 10.8 ( Odermatt et al. 1982).
T 7 THRFH-DTMFNSTONAI. STRUCTURE.
17 1 Results from electron microscopy.
The results from electron microscopy studies show little agreement amongst
themselves. This problem will be discussed further in paragraph IV 10 1.
One proposed structure (Engel et al. 1981,Odermatt et al. 1982 ) ,is a V shaped
model with two equal-length arms of about 60 nm , the diameter being around 3 nm
relatively constant all over the molecule. Bends in the arms are preferentially located
at 20 and 40 nm from the intersection of the two arms . The angle between them being
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from 40 to 110 degrees with an average of 70 degrees . A shaped image has been
observed , total length being 120 to 160 nm (Erickson et al. 1981 ).
Other teams ( Koteliansky et al. 1981 , Tooney et al. 1983 ) report a "Patch" type
structure with average dimensions of 15.5 by 8.8 and 16 by 24 nm respectively.
Some of those structures are presented in Fig I 3 below.
I 7 2 Results from analytic centrifugation.
Numerous results are available and are summarised in Table I 3 below.
( From : Alexander et al. 1978 , Kotelianski et al. 1981 , Tooney et al. 1983 , , Lai et al.
1984 ).
Table I 3 : Results from analytical centrifugation studies
„ „ . . .. „ fS Values
Buffer composition (mM).Sample.
Complete Fibronectin.
50 kD coil-binding domain.
72kD N-Terminal domain.
120 kD C-Terminal domain.
170 kD C-Terminal domain.
170 kD C-Terminal domain.




TES 20, NaCl 150
Nad 750
1% AceticAcid
AceticAcid 20, NaCl 150
Nad 150, TES 20
TRIS 20
CAPS






































I 7 3 Results from disulphide bond investigation.
The fibronectin molecule in its plasma form possesses 29 intra chain and two
inter-chains disulphide bonds per 250 KD subunit
It is important to notice that the susceptibility to reducing agents of the inter and
intra chains bonds is relatively similar as shown in points A to C below . All these data
suggest that the links between the two chains are not very accessible to the solvent.
A) When 90 % of the inter-chains bonds are reduced, nearly 30 % of the intra-chain
bonds have also been reduced. ( Engel et al. 1985).
B ) Furthermore as reduction causes an unfolding of the molecule , which can be
monitored by dynamic light scattering , the gelatin binding property is lost before
any macromolecular conformational change is observed (Williams et al. 1983 ).
Appearance of a macromolecular change in conformation after reduction is also
relatively slow.
C ) An immunological study ( Vuento et al. 1980 ) has shown that the reactivity of
human plasma fibronectin and its fragments to rabbit anti fibronectin antibodies is
perturbed by alkylation or reduction resulting in high loss of antigenicity . A large
fragment of 180 to 200 kD lacking only the C-Terminal region ( which includes the
inter-chain disulphide bonds ) has the same immunological reactivity as the intact
fibronectin molecule.
I 7 4 Results from denataration.
Those results are very important because they confirmed the existence of the
multidomain structure of fibronectin as suspected from circular dichroism studies.
Thermal denaturation profiles show the denaturation of six to eight independent
domains and also that the thermotropic properties are unaltered between pH 7 to 10
( Koteliansky et al. 1981 , Franceschi et al. 1985 ). Thermal influence on intrinsic or label
fluorescence of fragments or complete fibronectin has been investigated (Ingham et al.
1984 ). The collagen binding domain ( Chymotryptic digest 42 K D ) retains its functional
activity even after heating at 85 C where its fluorescence parameters did not show any
transition. The N terminus 25 K D heparin binding domain also seems resistant to
temperatures up to 85 C . The central 140 kD domain lacking the type I or type II
homologies, is the least stable and shows a denaturation profile close to that of
complete fibronectin.
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I 7 5 Models of fibronectin conformation in solution.
As pointed out before there seems to be little interest in the study of the
three-dimensional structure of fibronectin. Not considering the very low resolution
sedimentation studies, five major works were devoted to this topic:
A) Williams et al. ( 1982 ) from fluorescence , intrinsic viscosity and dynamic light
scattering measurements has proposed a flexible elongated structure susceptible of
increase in flexibility and decrease on dimensions after binding of a cyanogen
bromide fragment of collagen ( a 1 ( I ) CB 7 ) .Their calculated axial ratio varies
from 8/1 to 22/1 . The translational diffusion coefficient ( Dt) value is 2.26 10"^ C&S-
in phosphate buffer at neutral pH ,2.15 10"^ and 1.55 10 at pH 9 and 11
respectively. Dt is insensitive to temperature in a 10 to 37 C range but decreases from
7 7
2.2 10 to 2.4 10 c.g.s. with addition of collagen fragments.
B) Rocco et al. (1983,1987 ), from solution light scattering measurements ( at pH = 8 ),
including a not-quite-satisfactory measurement of radius of gyration by light
scattering proposed a model based on the succession of rigid beads , each bead
representing an internal homology. Their values for the radii of gyration are 17.5 nm
in 1M NaCl buffer and 10.7 nm at physiological salt concentrations.
C) Homandberg ( 1986 ) based his model on a new and original approach studying
the interactions between purified domains , and between purified domains and
complete fibronectin . His main conclusion is that there are two main interactions :
C-Terminal part of the molecule with itself and with the N-Terminal end. In an
other paper (1987) he showed the inaccessibility of N terminal region to solvents .
D ) Hermann et al. ( 1986 ) used the same approach and analysed the distribution of
charged residues along the protein.
E ) Sjoberg et al. ( 1987 ) measured the radius of gyration by small angle x-Ray and
neutron scattering and analysed the intensity as a function of Q . The conclusions
from those authors are that fibronectin is a oblate ellipsoid particle of semi axis
1.44 and 13.8 nm with a volume of 1150 nm^They suggested to chose the the model of
Hormann with inter-chain interactions.
Some of the models derived from those studies are presented in Fig I 3 below.
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Fig I 3 .
Models of fibronectin three-dimmensional structure
Erickson et al 1981
Engel et aL 1981
L c
Rocco 1983 & 1986
Wiliams et al 1982.
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I 7 6 Transitions in conformation.
Three different ligands are reported to alter the conformation of fibronectin.
A ) Heparan sulphate : Osterlund et al. (1985 ) studied the circular dichroism spectra of
fibronectin in presence of cellular heparan sulphate and showed a change in the
spectra he attributed to a conformational change in the fibronectin molecule .
B) Heparin : Welsh et al. (1983 ) also detected changes in conformation of fibronectin
upon heparin addition bymeasurement of CD. properties. The conclusion from those
results was similar to those from A , unfortunately although the two ligand are
very similar, the effects on the spectra appears to be rather different. This will be
discussed in Section VI6 An electron spin resonance study by Ankel et al. (1986)
also reported a conformational change due to heparin binding but at least some of
those conclusions are probably incorrect as discussed ChapterVI, section 6 .
D) Williams et al ( 1982) showed that the diffusion coefficient of plasma fibronectin
varies with addition of cyanogen bromide fragment & of type I collagen from its
initial value of 2.4 10"'' to 1.19 lO"'7 and 2.08 10"'' upon addition of respectively 2 and
4 moles of collagen peptide permole fibronectin.
I 8 FUNCTTONAT. PROPERTIES.
V
I 8 1 Heparin binding
Heparin interactions with fibronectin have been widely studied .Heparin has
been shown to form cryoprecipitates with fibronectin (Stathakis et al. 1977, Jilek et al.
1979) . All those studies refer to heparin which is generally used as a model for cell
surface heparan sulphate, the carbohydrates type encountered by Fn in vivo, (Hedman
et al. 1982 ).
All fibronectin domains generated by thermolysin digest except the 40 kD gelatin
binding domain , the C terminal 30 kD fibrin binding domain and the 3 kD interchain
linking region bind to heparin . The fragments binding to heparin are shown in bold type
in diagram below which presents the position and molecular weight of thermolysin
generated domains:
asubunit: H2N 28 - 40 -14- 110 -38,-30 -3 COOH
p subunit: H2N 28 - 40 -14- 110 -.29-30 -3 COOH
17
The strong binding site ( underlined ), is insensitive to pH variations and calcium
ions and it is possible that some sites might be hidden in the native intact molecule (
Siri et al; 1986 ) .The weak binding sites which are inefficient at physiological salt
concentrations, might only be due to non specific ion-exchange type interactions.
The best investigation of the binding is a study by Bentley et al. (1985 ), of both
heparin binding and heparin-induced cryoprecipitation in solution by fluorescence
polarization. They found ,in physiological buffers ,two sites ( per subunit ) with
f\ ft
dissociation constants values of 10 and 3.5 10 M. They showed that despite the fact
that a significant amount of binding still occurs at 0.5 M ionic strength,
cryoprecipitation, for which optimum ionic strength is from 0.05 M to 0.1 M , is fully
abolished at ionic strength superior to 0.3 M .They also reported that binding was
quicker and required lower fibronectin concentrations to occur than cryoprecipitation .
Cryoprecipitation also seems to reduce the flexibility of the molecule.
According to a study on immobilised heparin, the binding with intact fibronectin
seems inhibited by physiological concentrations of calcium ( Siri et al. 1986 ). This is
surprising considering the position of fibronectin in the extracellular matrix . But Richter
et al. (1985), reported that precipitation by heparin is inhibited by calcium ions .
Welsh et al. ( 1983 ), Osterlund et al. ( 1985 ) Ankel et al. ( 1986 ) reported a
conformational change due to heparin or heparan binding , this has been described
above in I 7 8.
Precipitation of radio-labeled fibronectin occurs slightly even at 37 degrees and
electron microscopy study of the precipitate reveals fibrils leading to the hypothesis
that heparin binding could uncover the polymerisation sites of fibronectin .
Cryoprecipitation is a heparin concentration dependent phenomenon and is saturable .
(Richter et al. 1985 ) .
Ogamo et al. (1985) described the interaction of fibronectin with various classes
of heparin .
Heparin binding has also been shown to enhance the binding of fibronectin to
collagens of various types ( See I 8 2 below).
T 8 2 Gelatin-Collagen binding.
The binding between fibronectin and collagen-type proteins or their denaturation
products was reported by Engvall et al. (1978 ). It has provided a very easy purification
method of fibronectin based on affinity chromatography on immobilised gelatin.
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The binding site of collagen on the fibronectin molecule has been characterized
first as a domain ( Balian et al. 1978 ) then sequenced on the bovine plasma molecule
(Skorstengaard et al. 1983 ) and finally by expression in E-coli ( Owens et al. 1986 )
revealed as a linear 14 residues sequence after the second type II homology , ( Starting
residue 434 ). This sequence is:
434
Ala-Ala-His-Glu-Glu-Ile-Cys-Thr-Thr-Asn-Glu-Gly-Val-Met.
The nature of the binding with collagen is unclear . It clearly is resistant to as
high salt concentrations as 2 M Na CI ,( Forastieri et al. 1985 and personal data
presented in the section of this thesis on preparation of the fibronectin molecule ).
Chemical modification of arginine residues , ( Vuento et al. 1983 ), destroys this
interaction but this is now thought to be be due to a loss of structure involving
modification of all the molecule rather than an arginine residue being really involved
in the interaction since no Arg is present in the binding sequence. On the other hand
fibronectin can be eluted from gelatin columns by elution in the presence of 1 M Arg.
Fluorescence polarization experiments , ( Forastieri et al. 1983 and 1985 ), were
carried out on two different systems :
A) Complete fibronectin- [ gelatin-fragments ] system
B) [ 42 kD gelatin binding domain of fibronectin ]- gelatin system.
The results show that there is positive cooperativity in the case of system A with
two dissociation constants of approximately 10"^ and 10"^ M : The second set of
experiments (B) gave values for dissociation constants in solution ranging from 310"^
M in 10 mM phosphate pH 7.3 to 6110"^ M in tris 100 mM NaCl 150 mM .
Various parameters can modulate this binding.
A )The interaction is stronger in the presence of Heparin ( Jilek et al. 1979 ).
B ) The presence of carbohydrates on the molecule seems to weaken the interaction; the
effect of glycosylation on fibronectin properties has been studied by Jones et al.
(1986) in a comparative study of cellular fibronectin produced in cell culture in
presence or absence of tunicamycine. Cellular fibronectin produced in the presence of
tunicamycin and therefore with no carbohydrate side-chains shows an increase in
cell attachment as shown by a cell attachment assay and collagen binding
efficiency. ( Urea concentration superior to 3 M is required to elute nonglycosylated
fibronectin from a collagen column while normal fibronectin is eluted at lower urea
19
concentrations ). In a similar way increased glycosylation as in placental fibronectin
decreases the affinity between fibronectin and collagen. ( Yamaguchi et al. 1986 ).
C ) The binding depends on the size of the fibronectin fragment: It is stronger with a
small 40 Kfc chymotryptic collagen binding domain than with a slightly bigger 60 kD
collagen binding domain. ( Griffin et al. 1986 ). We must note that those two latter
findings do not prove that the binding itself is affected and it might well be that
only the urea denaturation is made easier.
The binding of fibronectin on collagen varies with various collagen types:
A ) The binding is possible with many types of collagen at least types I, II, III, IV .
They show the same affinity in a denatured form but native type III is more active than
native type I or II. ( Engvall et al. 1978 ).
B ) With type I collagen , it occurs on CB 7 fragment, precisely on residues 757 to 791
(Kleinmann et al. 1978 ,Dessau et al. 1977 ). Gross unfolding of the molecule is not
required (Ingham et al. 1985 ) but a study with immobilised collagen binding domain
shows that the binding with native type I occurs at 37 C but not at 4 C ( Engvall et
al. 1981 ) suggesting the necessity of a slight unfolding of the collagen molecule .
C ) On type IV collagen of the basement membrane the binding occurs as shown by
immuno-electron microscopy at the free end of the long arm(Aumalley et al. 1986).
D ) Binding with fibronectin seems to delay the rates of self assembly of collagen type
III and accelerate the rate of type I.
E ) The collagen-like tail of Acetylcholine esterase and of complement factor Clq can
also bind fibronectin ( Grassi et al. 1983 ).
I 8 3 The main cell binding site on the fibronectin molecule.
The major cell attachment site on the fibronectin molecule has been characterised
as a single tetrapeptide Arg-Gly-Asp-Ser "RGDS" ( Ruoslahiti at al. 1984 ).The
sequence RGDS and its reverse sequence SDGR bind to cells in suspension and inhibit
BHK cell adhesion ( Akiyama Et al. 1985a ). This sequence is also the one recognized by
the vitronectin and thrombospondin receptor.
A 80 k D cell binding domain synthesized by expression in E.Coli of its cDNA has
been shown to be as active , for cell attachment, as complete fibronectin . Then post
translation modifications like glycosylation or phosphorylation are not required for full
cell adhesion property . But a 30 kD fragment was 50 times less active than the whole
molecule showing the necessity of the environment of the peptide for full function. (
Obara et al. 1987). Furthermore a 75 kl)tryptic fragment containing this sequence is able
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to promote both cell spreading and motility but when restricted to a Ilk fragment still
containing RGDS the motility promotion is lost. (McCarthy et al. 1985 ).
The dissociation constant for the fibronectin-receptor interaction ,with cells in
suspension , has been determined by two teams as 1.710"^ with 280,000 receptors per cell
and 3.6 10"^ with 128,000 receptors per cell ( respectively Johansson 1985 and
McKeownlongo et al. 1983 ) .It seems (Chernoussof et al. 1985 & Pesciotta et al. 1987 )
that cell layers in culture, have saturated fibronectin binding sites as shown by the very
small incorporation of exogenous labelled fibronectin or fibronectin fragments.
Cell binding can be modulated by collagen ( Nagata et al. 1985 ) but type I
collagen cellular receptor recognizes the RGDS peptide therefore the real influence of
fibronectin and collagen in this modulation might be difficult to define . ( Dedhar at al.
1987 ).
Recent studies suggest that the mechanism chosen by certain infectious agents also
rely on an RGDS - Cell interaction ; infection by trypanosome uses a peptide modelled on
RGDS ( Ouaissi et al. 1984 & 1985 ).
It is important to notice that many of the studies involving cell binding function
use a cell attachment assay where fibronectin or its fragments are adsorbed on the
surface of a culture dish . The question is whether fibronectin distribution is even on
them. A recent study with scanning electron microscopy determination of the adsorbed
material,shows that, in the conditions used by those authors, fibronectin distribution is
even in certain places and forms a network in other parts . Therefore some results might
be affected by this problem. ( Murthy 1987 ). Furthermore the general images of
fibronectin adsorbed on electron microscope grid are very different from the structure
suggested by studies of fibronectin in solution raising further doubts on the retention of
conformation after adsorption on cell culture dishes.
The cellular receptor to fibronectin will be described below in section 114 2.
18 4 Alternative cell binding sites on the fibronectin molecule.
A possible other binding site has been identified at the mid-third of the molecule
( Donaldson et al. 1985 ) ;possibly as 70 kD N terminal fragment promoting a cell-binding
insensitive to RGDS , collagen or heparin ( Mc Keownlongoet al 1985). This could be
confirmed since the assembly in matrix requires both the 30K N-terminus end and the 110
K cell binding domain (McDonald et al. 1987 ) . And also the effects of cell binding
domain and heparin binding domain are cooperative and resemble those of the whole
molecule. ( Beyth et al. 1984 ).
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An alternative spliced site moduling cell type specificity has been reported ,
apparently by one team only, ( Humphfries et al. 1986 ) .
T 9 VARIOUS OTHER BINDINGS.
19 1 DNA binding properties of fibronectin .
DNA binding of fibronectin and its fragments was studied by Sin et al. (1986 ). It
is sensitive to calcium ions and pH variations , it may occur with all thermolysin
generated fragments except the 40 kD collagen binding and the 20 and 3 kD last C
terminal domains . Despite the fact that Zardi et al. ( 1979 ) found some reactivity to
anti-fibronectin antibodies in intranuclear material, the DNA binding of fibronectin
seems to rely on simple ion exchange mechanism with the polyanion created by DNA
molecule at near neutral pH and has little chance of having any physiological
significance anyway since fibronectins are extracellular proteins.
19 2 Fibrin binding of fibronectin .
Binding between fibronectin and fibrin was shown by Stathakis in 1978 . The
complexes between fibrinogen and fibronectin are cryo-insoluble . There are two binding
sites : one is the N-Terminal 28 kD domain, the other the C-Terminal 31 KD domain ;
the 31 kD domain requires 2mM Ca2+ and 0.15 M NaCl for binding but raising the
temperature to 25 C seems to disrupt this interaction ( Garcia-Pardo 1985 ).
1 9 3 Various other bindings.
In addition to the major binding properties reviewed above and presented in Fig. I
1, fibronectin can also bind to various other biological material ,like :
A) Thrombospondin (Homandberg 1987b),
B ) Bacterium and viruses including a transforming virus : RD114 ,p30 ( Salonen et al.
1984)
C ) Plasminogen activator ( Salonen et al. 1985 , this might be important in cancer
related degradation processes, see below in I 18)
D ) C reactive protein (Salonen et all984 ).
D ) Gangliosides , through fibronectin 31 k D N-terminus end with a Kd of 1.4 10"^ M
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I 10 POLYMERISATION
110 1 Polymerisation in vitro.
Two ways to induce fibronectin polymerisation in vitro are known, they both rely on
disulphide bonding.
A ) Williams et al. (1983 ) used guanidinium chloride ; exposure to at least 1 M
guanidinium chloride ,( Optimum at 3 M ), resulted in exposure of 1.5 to 1.9 cryptic
free SH groups and polymerisation. Blocking the free SH groups by
N-Ethylmaleimide inhibits this polymerisation. Heparin,fibrin,hyaluronic acid
deoxycholate , methylamine , EDTA or calcium ions have no effects on the
polymerisation , ( The authors omitted that in those conditions ,with a
guanidinium-chloride concentration higher than 1 M, binding to collagen or heparin
was impossible ).
B ) Vartio ( 1986) used various metal salts at a milimolar range from pH 7 to 9 and
noticed two different types of polymerisation ,both accelarated by an increase of
temperature .
a) CuSO^ induced polymerisation , according to this author, is dependent on the
free SH groups and occurs only within a 140 kD C terminal fragment where the free
SH are. It is inhibited by blocking the free SH by N-Ethylmaleimide .
(3 ) FeClg induced polymerisation is possible by disulphide exchange in the type
I or type II homologies as shown by the possible polymerisation of 30 kD N-terminal
domain 40 kD collagen binding domain and the 120-140kD C terminal domain.
Furthermore this FeClg induced polymerisation is possible even after exposure of
fibronectin to N-Ethylmaleimide .
I 10 2 Polymerisation by cellular systems.
Experiments of binding of labelled fibronectin to cells in culture, ( McKeownlongo
et al. 1983 & Fellin et al. 1988 ), shows two different steps in fibronectin incorporation
into matrix : First binding to cells in a deoxycholate sensitive mode (this corresponds to
the binding of fibronectin to the cellular receptor ), and then formation of deoxycholate
insoluble fibrils by polymerisation of fibronectin.
Exchange in the N terminal region seems to explain this because iodoacetamide
treated ( free SH blocked ) fibronectin is still incorporated normally in the matrix and
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cathepsin G generated N-terminal 28 K D domains can be aggregated as large multimers
in cell culture. ( McKeownlongo Et al. 1985 ). This is confirmed in a recent study where
the site responsible for polymerisation by cells is located in the 28 kD N- terminal
domain ( Mc Donald et al. 1987).
I 11 CROSST.TNKTNGnFFTRRnNEr.TTN
Fibronectin can be cross linked with collagen by factor Villa (Mosher et al. 1979).
Two sites have been shown to accept the factor Villa induced crosslink : the residue
number 3 ( Mosher et al. 1979 &McDonagh et al. 1981) and a site in the heparin binding
domain ( Fetsus et al. 1985 ). The crosslink with collagen has been proved on collagens
type I ( precisely on fragments CB7 and CB 8 of al( I) collagen ), Type II, Type III and
Type V. Crosslink with collagen type IV has not been proven in the same study (Mosher
1984).
Crosslink to adsorbed fibronectin on glass plates is also possible with a 47 Kd
intracellular protein ( Aplin et al. 1981 ).
I 12 VARIOUS OTHER PROPERTIES.
As an enormous amount of work is devoted to fibronectin ( over 400 published
papers a year), various odd functions and properties have been described . Amongst the
most significant were:
A ) A possible proteolytic activity as S protease , coupled with self inhibition ,of
fibronectin has been shown by Veil-Douhala et al. ( 1986 ) by study of fibronectin self
degradation and demonstration of homology between the sequence of a type III
homology of fibronectin and the sequence of SH protease inhibitors.
B )Fibronectin fragments can increase the DNA synthesis by cells in culture (Humpfries
et al. 1983 ).
T 13 FUNCTTONAT. ANAT.OGIJES.
Other , often multidomain-multifunctionnal, proteins involved in cell anchoring are
known such as:
A )Laminin present in basement membranes.
B ) CAM: Cell adhesion molecules ( Review by Edelman 1983 ).
C) Thrombospondin from platelets and tissues or cells in culture .
D ) Vitronectin also called spreading factor ( Review by Ruoslahiti et al. 1987) present
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in plasma,cell culture or tissues.
Some extracellular collagen-gelatin binding proteins have also been described
with molecular weight of 56,62 and 47 kD ;the latter one is called Colligin and is the
only one to bind to native type IV collagen (Kurkinen et al. 1984).More recently a 21 kD
protein was discovered (Keski-Oja et al. 1986).
I 14 FTBRONEGTTNS IN CELL ANCHORING PROCESS.
I 14 1 Cellular receptors to fibronectin.
Many fibronectin receptors in various cell lines have been described:
A) A 48 K receptor stabilized by Calcium but not Magnesium (Oppenheimer-Marks et al.
1984 a).
B ) Two receptors 140 Kd and 45 Kd immunologically different (Urushihara et al. 1985).
C) Adhesion of cells mediated by a 145 kD or 140 kD plasma membrane receptor
( Giancotti et al. 1985 , Akiyama et al. 1986 b ).
D ) The fibronectin receptor on platelets was described as: lib .Ilia platelet membrane
receptor complex common to fibronectin ,Von Willebrand factor and vitronectin
(Pyteia et al. 1985 a) .
E ) Virtanen et al. ( 1987 a ) report three receptors 45, 140,170 kD the 140 kD being lost
after transformation. But Pyteia et al. (1985 b ) observed the 140 kD receptor in
osteosarcoma cells in culture.
F ) Receptors in rat hepatocytes and fibroblasts have been prepared by affinity
chromatography on immobilised fibronectin ( receptor remaining bound under 1 M
NaCl but released by 1.5 mM RGDS. ) they appeared as 155 and 105 kD under non
reducing changing to 145 k +20 k and 130 k respectively after reduction .
I 14 2 Description of the "140 Kd " cellular receptor of fibronectin.
Better biochemical characterization and cDNA cloning of the a subunit of the
" 140 kD " receptor ( Pyteia et al. 1985 a & b 1986 , Argraves et al. 1986), define the
receptor as noncovalent complexes of a and (3 subunits.
The a subunit being composed of two disulphide bonded chains of Mr 20 to 30 kD
and 140 to 120 kD, the p subunit being composed of one chain of 90 to 140 kD . This receptor
shows important primary structure similarities with the vitronectin receptor .
The light a chain should be the anchoring point of the receptor in the membrane
25
because it contains at its C end approximately twenty hydrophobic aminoacid residues.
Reaction with antibodies raised against the beta subunit of rat fibroblast receptor
suggests that the cell line specificity is in the alpha subunit.
Inhibition by monoclonal antibodies against this receptor shows that only a
small fraction of the existing 140 k D receptors is required for adhesion (Brown et al
1987). A possible consequence is that receptors might exist both on the surface and
internally to form a pool of spare receptors, as suggested by Molnar et al. (1987).
The fibronectin receptor is a real membrane protein : Horwitz et al. (1986 )
described a continuity between fibronectin , its receptor and an intracellular protein ,
talin .This has been suspected since a long time as Ali et al. in 1977, showed that
fibronectin could be released from cell surfaces after cytochalasin treatment. The shape
of transformed cells can be normalized by addition of exogenous fibronectin or RGDS
peptide! Chen et al. 1986 ) . Continuity between the receptor and the cytoskeleton js
also shown by colocalisation of fibronectin-140kD receptor and microfilaments bundles
(Duband et al. 1985).
The 140 k receptor distribution on the cell is changed by transformation (not only
infection by transforming virus as shown by temperature sensitive mutants ) ,
Transformation of chick embryo fibroblasts by SV 40 virus is also associated with
phosphorylation of the receptor . After transformation despite the fact that the
receptors are still expressed ; the continuity:
[ extracellular -fibronectin]-[ receptor ]-[microfilaments ]
is lost, the receptors do not bind fibronectin anymore, and show only little adherence to
vitronectin ( Chen et al. 1986 ). Actin is then localised more at the periphery of the
cells and this is coupled with a loss of cell-attached fibronectin (DiRenzo et al. 1985 ).
Investigation of the number of receptors during development in rats shows a strong
decrease just before birth and keeping to a low level after. ( Kawasaki et al. 1986 ). In a
possibly similar way artificially induced lung injury is followed by an increase of the
number of receptors at the surface of macrophages (Kradin et al. 1986).
I 15 T.OCAT.TZATTON OF FTBRONFCTINS.
Historically the fibronectin molecule was discovered as a cold insoluble globulin
from plasma by Morisson et al. ( 1948 ). In fact those authors purified the complex
between fibrinogen and fibronectin which is cold-insoluble. Fibronectin alone is perfectly
soluble at near zero temperatures.
Fibronectins are present as the plasma type at a mean concentration of 300 mg/1,
with apparently wide differences between individuals. Cellular type fibronectins are
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one of the major components of the extracellular matrix of cells in culture with the
heparan sulphate proteoglycan and type I collagen ( Hayman et al. 1982, Woods et al
1984 ). Fibronectins seems to be present in all tissues (Steneman et al. 1978 ). More
detailed studies have shown various type of associations such as: association with type
IV collagen and heparan sulphate proteoglycan in the basement membranes ( Laurie et
al. 1982 & 1983), with type II collagen in cartilage ( Giant et al. 1985 ).
I 16 POSITION OF FIBRONECTTNS IN THE CEI.L-MATRIX INTERACTION.
Fibronectin and its receptor are one of the links between the extracellularmatrix,
( particularly collagen and heparan sulphate proteoglycans ) and the intracellular
cytoskeleton. Those links have been described with the cellular receptor to fibronectin in
I 14.
I 17 FTBRONFCTTN.S TNVDT.VFMFNT IN BIOLOGICAL PROCESSES.
I 17 1 Development.
Fibronectin has been shown to be associated with moving cells in embryos
( Sternberg et al 1986 ). Antibodies against fibronectin receptor have also been shown to
strongly perturbate normal embryo development ( Bonner-Fraser et al. 1986 ). From those
two examples , ( amongst many other similar studies ), it is clear that fibronectin plays
an important role in cell motion and development processes but its exact function is at
present still undetermined. It is also interesting to note that the amount of cell surface
fibronectin is reduced during the mitotic events , ( Steneman et al. 1977 ), possibly
correlated to the need of looser cell support connection to allow cell division.
I 17 2 Wound healing.
Fibronectin is involved in cell motion and therefore plays a role in wound
healing. This topic has been investigated particularly in the field of ophatalmologic
lesions . The work of T. Nishida in Japan and M.Berman in the U.S.A. seems the most
important contribution but will not be reviewed here.
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I 18 FTBRONECTIN INVOLVEMENT TN CANCER PROCESSES
I 18 1 Modifications at the molecular level.
The differences between fibronectins produced by normal and transformed cells
have been described in paragraphs 12,1 3 & 14 . Briefly fibronectin from
transformed cells have different primary structures , glycosylation phosphorylation .
I 18 2 Modification of synthesis and localisation.
Although the plasma levels of fibronectin are unchanged in patients with cancer
diseases ( Kawamura et al. 1983 ) , the synthesis of fibronectin by cell in culture is
modified by transformation.
The first work relating fibronectin to transformation problems showed that
addition of anti-fibronectin antibodies to the media of normal fibroblastic cells in
culture, resulted in the loss of the normal morphology and appearance of transformed
like rounded cells ( Yamada et al. 1978). Reduction of synthesis in the matrix was
reported by Smith et al. (1978 ) . Addition of transforming growth factor P to cell in
culture results in an increase in fibronectin mRNA synthesis ( Ignotz et al. 1986 ).
Transformation of chick embryo fibroblasts by Rous sarcoma vims results in an increase of
fibronectin synthesis but a decrease of incorporation in the matrix ( Wen-Tien et al.
1984); this is coupled with a lack of extracellular heparan sulphate ( Hayman et al.
1982 ). Di Renzo et al ( 1985 ) showed that non metastatic lines of transformed cells
retained fibronectin better than the metastatic ones.
Although fibronectin involvement in the modification of the matrix and of cell
shape ,( possibly due to action of the matrix on cytoskeleton through transmembranne
links like the fibronectin-receptor ), induced by transformation is clear, studies trying to
correlate tumoregenicity and fibronectin incorporation in cell matrix have failed. This is
no surprise considering the number of possible factors involved:
A) Changes in the fibronectin rates of synthesis and degradation .
B ) Changes in fibronectin receptor number and affinity.
C) Changes in the system responsible for fibronectin incorporation into the matrix.
D) Changes in the extracellular matrix molecules that can bind to fibronectin.
E) Changes involving other adhesion molecules such as Laminin and thrombospondin.
A better understanding of all those factors will be required to explain the role of
fibronectin , at cellular and tissue level, in cancer processes .
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I 18 3 Degradation,
If there is no agreement on the modifications of synthesis of fibronectin after
transformation, there is aggipement on the fact that fibronectin ( as well as the other
molecules from the extracellular matrix , see review by Tryggvason et al 1987 ) ,
undergoes substantial degradation by tumour cells:
A ) Release of small ( Mw less than 30 kD ) peptides fragments from fibronectin
covalently bound to collagen layers is increased 3 fold in transformed cells
(Wen-Tien et al. 1984 ); this degradation process is sensitive to 1-10 phenantrolene.
B ) The work of Vartio (1980) shown how a matrix of fibronectin could be degraded by a
metal activated proteinase.
C ) A guanidinobenzoatase has been described as associated with tumours in vivo and
used for histological determination of tumours by Steven et al. (1985 )
I 18 4 Transforming enhancement properties.
The collagen binding domain from fibronectin purified from metastatic cancer
patients or produced by tumour cells in vitro was shown to possess transforming
enhancement properties on cultured normal fibroblasts. ( DePetro et al. 1983)
I 19 CONCLUSION OF CHAPTER T.
From this review it can be seen that despite the fact that fibronectin has been very
much under study , its physicochemistry is still poorly understood . In subsequent
chapters various physicochemical techniques , such as light scattering , neutron





II1 PHOTON CORRELATION SPECTROSCOPY.
II I I iritrpcjygtiQn.
This technique, first described by Pecora (1964 ), allows direct determination of
the translational diffusion coefficient D^. It has several advantages :
a ) The error is limited to a few percent. In some conditions used in this work it even
seemed to be less than 1 %, see IV 3 below.
b) 15minutes only are required to do a measurement.
c) It is an absolute technique requiring no calibration.
d ) A ligand can be added or the buffer conditions can be altered in the same sample,
e ) The temperature can be adjusted over a wide range.
f) 500 pi of sample only are required. Just before this work was completed a way was
found allowing measurements with a sample volume of less than 100 pi .(see II1 11
below).
g) To some extent an estimation of Djs possible even with polydisperse samples.
II 1 2 Principle pf photon gorrelgtjon gpeqtroscopy: Relation between the cprreigtipn
fyiPbtipn and the trans'atiprigi diffu?ion coefficient .
This technique has been reviewed by Berne and Pecora (1974 ). The light
scattered by a very small volume of the sample is detected by a photomultiplier. The
intensity of scattered light is proportional to the concentration of the scattering
particles . In a very small volume because of the Brownian motion of the particles the
concentration fluctuates . Those fluctuations are linked to the ability of the particles to
diffuse in the solvent and therefore to the diffusion coefficient. Pecora ( 1964 ) showed
that the first order normalized correlation function was linked toDj-:
g1 (x) = exp(icoQt) exp(-Tx) (1111)
Where: g-j (t) is the value of the normalized first order autocorrelation function for
delay time x .
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C0q is the frequency of the incident light.
T is a constant equal to with K = 4 n (n /^}sin (9 / 2 ) (9 is the angle of
scattering, n the refractive index of the sample ).
As described below, in photon correlation spectroscopy an actual measure of the
second order correlation function ( g2(t) ), is obtained. Since g2(t) is related to first
order correlation function ( g^ (x )), g2(x) may readily be used to yield a value for Dj..
II 1 3 Description of the spectrometer and raw signal acquisition.
All light scattering work in this thesis has been carried out with a 4700C system
built by Malvern instruments ( Malvern U. K.).The spectrometer can be seen on Fig. II1
and Fig. II 2. It comprises the following :
1) A cell holder allowing the cell containing the sample to be in a thermostated ,
index matching waterbath .Temperature was adjusted to a selected value above
room temperature by a heating resistor controlled by a thermostat. Generally a
temperature of 25 °C was used , slightly over the ambient temperature of 23 to
24°CWhen lower temperatures were required , ice cold water was circulated in a
heat exchange coil until the appropriate temperature was reached . Temperature
was then constant, to less than +-1 ° C ,in the small time period required to perform
a measurement .The water of the index matching bath could be filtered by
recirculation with a peristaltic pump through a 0.22 (im filter ( Millipore France )
to remove any dust which would create a high background.The pump was
systematically run for 15 minutes prior to anymeasurement session.
2) A stepper motor driven turntable : This device allowed a photomultiplier angular
positioning with a precision better than 0.1 degree. The angular position ( 9 ) of the
photomultiplier was directly controlled through the user computer.
3) A photomultiplier equipped with a special optical device ,( see fig II 3 ):
a) A focusing lens.
b ) One vertical slit and a rotatable turret presenting micron range aperture pinholes
to restrict the measuring field,
c ) An interference filter to limit the detection to the proper scattering wavelength.
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Fig III :
Side view of the Malvern 4700 c spectrometer.
Laser source Steppermotor controled turntable. Sample cell Water bath.
Fig 112 :
Top view of the Malvern 4700 c spectrometer.
Laser source. Steppermotor controled turntable. Sample cell. Water bath.
iTemp, controlm
,™^:TT?£?$$$$*£$?!User computer data:
I:processing and storage. i|?||
.?Correlator?
I ;.xN i N i?&iy iy
Pump Filter
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These elements allow restriction of the measurement of the scattered light to a
very small volume . It is important to notice that what is in fact really measured in the
4700c Malvern system is not the light fluctuations , directly due to the particle
concentration fluctuation but the light fluctuations due to interference created by the
scattering of coherent light by particles in motion .This is referred to as fluctuation
spectroscopy as opposed to concentration spectroscopy.The main advantage of fluctuation
spectroscopy over concentration spectroscopy is that it can be done with much larger
measuring volumes , thus the optical requirements are much more easy to achieve . For
those practical reasons fluctuation spectroscopy is widely used.
An analogue to digital converter is included in the photomultiplier so its output
is pulsed. The pulse frequency is directly proportional to the intensity of scattered light
in the measured volume.
Fig II 3 below shows the disposition of those elements as well as the viewfinder
which helps during the optical alignment procedure of the system.
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II 1 4 The observed second order correlation function.
In this paragraph it will be shown how the signal from the spectrometer can be
processed to yield a correlation function.
The correlation function of the time dependent signal and a delayed version of
itself also called autocorrelation is defined as :
C(t)-limb><0 1/ T V(t)V(t + x)dt (II1 2 )
Where:
T is the period of the function.
V represents the signal.
T is the time offset of the signal.
This relation is valid for an analogue function . The construction of a digital correlator
requires for technical reasons the treatment of a digital signal.
The definition of the first order digital field autocorrelation is :
G1(t,t + x)= < E(t). E(t + x)> (II1 3 )
But in fact what is measured is the second order correlation (intensity) function :
G2( t ,t +X ) = <I(t). I (t + X ) > (III 4)
We must notice that over long periods of time the value of the second order
correlation function is the square of the mean intensity:
G2(t,t + X) = <I>2 (II 1 5)
This property is used for the estimation of the "in range index" ( See II 1 5 ). Both G-j
and G2 can be normalized by division respectively by < I > and < I > creating gl and
g2-
Fig. II 4 describes the "architecture" of the correlator. The processing of the
photomultiplier ( P.M. ) , data , leading to the second order correlation function
construction is outlined below through the steps A to G.
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Fig IT—4u
Malvern K 7032 Correlator, auto-correlation set-up.
( From Malvern Instruments manual, with permission )
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A ) The raw signal from the photomultiplier is a random pulse train which arrives from
the P.M as described in II 1 3. Pulses are synchronized to 10 MHz clock . The
total pulses are integrated over the experiment duration by the total sample
counts monitor.
B )Counts are accumulated in the " clipper accumulator " over a period of time (T): the
sample time. A sample time clock controls this duration . T depends on the particle
ability to diffuse and therefore is linked to its Stokes radius. T is chosen
either by the experimenter or automatically by the software, to avoid situations
where :
a ) T is too short. A loss of information occurs resulting from analysis of only a part
of the correlation function.
P ) T is too long. There is a loss of the correlation when V (t) = V (t + xT).
C) The number of counts accumulated over T is transformed to 8 bit code information
(Value from 0 to 255) .If the number of pulses (n ) on a sample time is superior to 255,
the prescale system divides this value to avoid clipping if n > 255 .The prescaled
number of counts is integrated all over the experiment at this level by a prescale
monitor.
D) After one period T the contents of the " clipper accumulator" are moved to the first
position of the delay register. As "old " samples advance in the register as every
new one arrives one can say that each delay register represents a delayed version of
the signal.
E) For each correlation channel every time a pulse arrives at the correlator input the
content of each delay register is added to the sum of its corresponding accumulator.
So the sum of over k samples in each register represents the correlation
coefficient corresponding to its position , that is to its shift delay.
F) A user controllable experiment duration clock defines the total duration of the
experiment.
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G) Serial and parallel processing : ( See Fig II 5 & 6 ) . This is a special feature of the
Malvern correlator. It allows creation of the correlation function on a linear or a log
time scale by the use of serial, or parallel processing.
If the correlator is used in a "Serial " mode all the information stored in
correlator channels is linearly spaced in time : V (t - n T) with n from 1 to 64.
But if the correlator is used in " parallel " mode , channels are divided into
four subcorrelator blocks . Instead of being composed of decay registers linearly
scaled in time , the decay registers are divided into four groups each having its own
correlation time, the relation between the four correlation times being
exponential. This mode allows a much longer time decay range to be analysed thus
giving a much larger sample size range . It is called the variable time expansion .
II I 5 Determination of the diffusion coefficient from the observed second order
correlation function.
As shown in II 1 4 above, the value of registers represents the correlation
coefficients for various multiples of the sample time delay: this is a measure of the
second order correlation function g2 (x). The relation between first order g^ ( t ), and
second order g2 (x ) .normalized correlation functions has been shown by Cummins (1973)
to be:
g2(t,t+T)=l + [g1(t,t + x)]2 (II 16)
As seen in II 1 2 the exponential decay shown by the correlation function is linked to
the translational diffusion coefficient by :
g! (x ) = exp (i C00 x) exp (- r x ) (II1 1 )
Where :
coq is the frequency of the incident light.
F = D K2 with K = 4 IT / A. n sin ( 0 / 2 ), 0 is the angle of scattering , n the
refractive index of the sample .
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So a plot of:
Ln ( g2 (t) -1 ) versus x (II 1 7 )
will have a slope of 2 T. As T = D with K = 4n/Xnsin(0/2) , the calculation of
the observed diffusion coefficient DQ^S is then straightforward.
The machine calculates D
w , extrapolation to 20 0 C in water , using the
classical formula :
D20,w = Dobs ft sol /ti20w)(293 /Tso1)(II18).
Where :
D0bs is rneasured diffusion coefficient in the experimental conditions of
viscosity and temperature.
T| soj is the solvent dynamic viscosity.
^20w is c^yr,arnic viscosity of water at 20 ° C
T SQ| is the absolute temperature of experiment.
So the only requested parameters for a measurement of D 2q w by photon
correlation spectroscopy are :The scattering angle 0, the measured temperature T so|,
the viscosity of the solvent at this temperature t| SQ| .
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Fig IT 5;
Malvern K 7032 Correlator: serial configuration.
















Malvern K 7032 Correlator: parallel configuration.
( From Malvern Instruments manual , with permission )
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II 1 6 Problems created by large out of scale objects: "In Range index".
Any particle clearly too big for the selected sample time (T) will not be included
in the diffusion coefficient distribution but will add some slower decay component
background over all channels. A way of estimating this contribution is to divide the
value of mean intensity < I > obtained by extrapolating the experimental correlation
g2(x) to high T by the average of counts of the last channels. If there is no contribution of
out of range particles this ratio will be 100 % but if there is any out of range contribution
in the signal the average counts on the last channels will be slightly higher than the
extrapolated value of < I > ,thus the ratio will be less than 100 %.We usually had 99 %
in range signal, the out-of-range contribution being probably rather due to aggregation or
bubbles than dust. The presence of dust particles is easily noticed because they give rise
to violent scatter bursts that can actually be seen in the solution ; this was not observed
in our samples.
II 1 7 Problems created bv the polvdispersitv of solutions : "Polvdispersitv index"
We must take into account the problem created by the non monodispersity of the
sample . If the sample is perfectly monadisperse we have shown above how the
correlation function could be simply described by an exponential . Pusey et al ( 1974 )
have shown how this model could be transformed leading to the definition of a
polydispersity index and two compound analyses.
The presence of several particle size classes will show up as a sum of exponentials
and can be transformed into:
iY>' -
Ln( I gl(x)l ) = 2 Km(r)(-x)m / m! ( II 1 9)
m=l
Practically, m is limited to m = 2 so :
Ln( I gl(x)l ) = -ri + n2/(r2/2)(IIl 10).
This expression is fitted to the observed curve :
Ln ( g2 (x ) -1 ) versus x (II 1 7 ).
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2|i2 / is defined as the polydispersity index and is equal to zero only if there is
no polydispersity and . It is systematically calculated . Under 10% a "monodisperse"
single exponential fitting is used. If this index is over 10% the software has a specific
feature to estimate the distribution. The software possesses in memory the shape of
correlation functions for a large number of diffusion coefficients; it then calculates a
multi-exponential curve and fits it with the observed one. We must notice that no
assumption on the distribution (like two compounds distribution as above) is made.
So each analysis provides the following parameters :
An average D20( w .
A distribution of D2q w as a function of signal intensity.
A polydispersity index.
An "in range index" testing the presence of large objects out of scale.
II 1 8 Limitations of the technique.
In all those calculations no account is taken of a so called shape factor whose
contribution is zero only if particle size is reasonably small, compared to wavelength of
the light used or at zero angle for large particles .
Furthermore as the intensity of scattering is proportional to the square of the
mass of the scattering particle, it is then proportional to the sixth power of their size .
This means that the contribution of larger particles easily overwhelms that from
smaller particles . This is a special concern in the presence of aggregates .
II 1 2 Experimental parameters,
A) The laser source : an Argon - Ion laser ( Innova 4 U.S.A ) was set at 514.5 nm with a
power range from 100 to 250 m W approximately. A light control mode allowing
control of the laser power directly by a photoelectric cell feed back limited the
source intensity fluctuations to approximately 1 or 2 %.
B) The buffer viscosity, because of its low salt and very low protein concentration , was
taken as water viscosity . The software automatically corrected for temperature
induced variations.
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C) The refractive index was measured and found to be 1.335 for our standard buffer.
D) Experimental time for measurements on the fibronectin molecule was set between 5
and 15 sec. with very little difference in observed results.
F) The sample fundamental time was set to a time placing diffusion coefficient of the
investigated particle in the middle of a hundred fold scale. In practise the
approximate Stokes radius (Rs ) for the investigated particles was entered in the
computer. The Stokes radius was then transformed into the corresponding diffusion
coefficient by direct transformation from Rs to the diffusion coefficient D by the
classical Einstein relation : (where T| is the solvent viscosity ):
D=*%/ 6tc ti Rs (II1 11)
Then D was related to the decay of the observed function and sample fundamental
time was calculated.
G) Each measure was made up of several runs , ( typically 20 to 50 ); the software
calculated the mean value of the integration of counts for each run, and rejected any
run with a significant difference in integration .
II 1 ID Sample handling and preparation.
To remove any possible dust or contaminant from the 1 cm diameter quartz cells
(ALV Lasers F.R.G.), they , as well as their teflon caps , were stored in pure sulphuric
acid . Prior to use they were washed twenty times with double distilled water to remove
any acid traces and three times with filtered sample buffer to make sure the buffer
composition of the sample would not be altered by some remaining water.
The buffers as well as the sample were filtered on "Nucleopore" filters (U.S.A.).
They are well known for their very constant pore size as well as low sample retention
because of their design as flat surfaces as opposed to ordinary filters which have mesh
like surfaces .Filtration was preferred to centrifugation because it is a quicker process
and also the size control was easier.
When filtering the samples care was taken to :
A) Reject the first two drops corresponding to the filter "dead volume ".
B) Transfer the drops on the side of the cell to the main body of the solution, allowing
them to slide gently down , thus avoiding reformation of aggregates after filtration.
This technique also avoided the use of metal needles which leads to metal
contamination triggering fibronectin polymerisation as well as creating high speed flows
leading to aggregation.
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II 1 11 Photon correlation spectroscopy of very small volume samples.
A way was found, unfortunately too late to be applied to this work, that allows
the measurement of samples with a volume smaller than 100 jil. The sample cell was a
micro-fluorescence cell of internal dimensions of 2cm high by 1 cm long by 02 cm wide .
The laser beam goes through the 1cm path allowing the cell liquid interface to be far
enoughfrom the measured volumeAs the cell does not need to be full for a measurement,
samples with a volume as small as 50 p.1 can be used. The limitation on the sample
volume is due more then to the problems created by the filtration or centrifugation of
such small volumes. The setback of this technique is that measurements can only be
performed at angles between 50 and 130 degrees.
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II2 MGT.HCUIARWEIGHT MEASUREMENTS BY LIGHT SCATTERING
II 2 1 Introduction.
There are many techniques allowing molecular weight determination in
solutions; among them light scattering has several disadvantages as discussed below .
However it was helpful in our work because it could be carried out conveniently in the
Biochemistry department, in the same conditions , using the same samples for photon
correlation spectroscopy . This provided a good complement to photon correlation
spectroscopy by determining quickly if changes in the diffusion coefficient were due to
changes in conformation only, or to changes in molecular weigh also . So it was used as
a comparative technique more than for absolute Mrmeasurements.
II 2 2 MblbCblar wgight determinations,
Rayleigh ( 1871 ) studied light scattering from a dilute gas. Developments by
Schmoluchowsky ( 1908 ) ,Einstein ( 1910 ) and Debye ( 1947 ) allow treatment of
scattering from large molecules in solutions . They show that vertically polarized light,
scattered by a dilute solution of macromolecules is described by:
Kc / Re = 1 / Mr [ 1+ (16n2 n2 / 3 A.2) Rg2 sin2 (0/2) ] + 2a2c + 3 a3c +....
(II 21 )
Where :
9 9 9 A
K is an optical constant: 2 II n (dn/dc) / H ^; dn /dc represents the
refractive index increment with concentration , n is the refractive index of the
solvent, X the incident light wavelength and ?{ is Avogadro's number.
cis the concentration of the studied molecule in g /ml.
Rq is the Rayleigh ratio of the molecule ( Iq / Ig ) ( r2 / 1+cos2 9 )with r as the
sample to detector distance .
Mr is the molecular weight of the studied molecule .
Rg is the radius of gyration of the studied molecule .
Iq / Ig the ratio of scattering intensity over incident beam intensity.
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9 is the scattering angle .
a2 ,ag represents Virial coefficients .
It is important to notice that:
A) At concentration c = 0 the expression becomes :
K 0 / Rq = 1 /Mr [1 +(16n2n2/3 X2 ) Rg2 sin2 (0/2) ]. (II 2 2 )
B) At concentration c = 0 and angle 0 = 0:
K0/Ro=l/Mr. (II 2 3 )
*
9
C) If molecules are small compared to X (practically Rg <X / 20 ) the factor (1611
n^ /3 X2 ) Rg^ sin^ (0/2) tends towards zero so that the angular dependence of K /
Rg is very small and in practise only measurements at one angle with a range of
concentrations are required for a simple zero concentration extrapolation.
Zimm (1948 ) presented a representation now called Zimm Plot or extrapolation
technique which allows the determination of both Mr and Rg in the general case of
molecules with a radius of gyration non negligible compared to X .By plotting: K c / Rg as
a function of sin^ (0/2) + Z c (Zis a constant arbitrarily chosen to spread the data on
the graph), an array of points is created allowing the extrapolation of a line towards
c=o, and a line towards angle 0=0. Those two lines have the same intercept on the y
axis which is the value of K
Q / RQat c = 0 and 0 = 0 that is 1 / Mr. (II 2 3 ) .The slope of
the zero concentration extrapolation is (1611^ n^ /3 X2 ) Rg^ sin^ (0/2) (from equation II 2
1 ). From the measured slope the radius of gyration Rg is easily calculated.
Practically the Rayleigh ratio is very difficult to measure because of the
requirement of the determination of absolute light intensities . This problem is solved by
the use of a standard scatterer. We chose toluene . Let us define :
Rg as the specimen Rayleigh ratio
Rg t the toluene Rayleigh ratio
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Ig the scattering intensity of the sample at angle 9
lQtthe scattering intensity of toluene at angle 0
Ig the incident beam intensity.
1 1
Kc/ Rg = [ Kc /Rq ( Rg t)] ( Rg t) ~l becomes, if we replace all the Rayleigh ratios in
brackets by their values,:
V Rg =( Kc / [ (I9 / Iq) ( r2 / 1+cos2 0 )-l][( I0 / Iet) ( r2 / 1+cos2 6 )])
(Retri-fKc/t Iq / I9t) ]( Re t)1 (II 2 4 )
So that only Ig and Igt have to be measured since a reference value of (Rg t) is
given by the instrument maker and used as a standard .
Practically Ig must represent the scattering from the salute only . The intensity
scattered by a buffer cell Ig^ is subtracted from the measured solution scattering .
Furthermore every photomultiplier generates a " dark current ", i.e. an electronic
background current generated in absence of light. It is measured by putting a lid on the
photomultiplier optics and it is subtracted systematically from every measured
intensity.
II 2 3 Experimental set up and techniques .
The PCS 100 spectrometer was the same as for the photon correlation studies and
is described in II 1 2 . To minimize possible experimental errors due to the source or
detection the specific following precautions were taken for molecular weight
measurements:
A) The laser was set in light regulation mode where a small portion of the beam is
directed on a photoelectric cell controlling the tube current by a feed back
mechanism.
B) The laser cooling system temperature might also affects the laser output; we checked
that the fluctuations were limited within a 2 ° C range and that no long term drift
occurred in the laser cooling water temperature .
C) When a small power laser output was required the laser current was kept fairly high
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( over 20 A ) but the laser aperture was closed . This allows the laser to work with a
fairly high current where its output is steadier.
D) To avoid any drift in the photomultiplier sensitivity, room temperature had to
remain constant during the experiments . This was checked and we verified that the
temperature fluctuations were kept within the range of + - 1 ° C.
E) To avoid saturation of the photomultiplier, the maximal count rate at lower
angle and higher concentration was set at about 200,000 counts per sec. giving a
reference intensity of around 50,000 counts/sec and a buffer background of around 5000
counts per sec.
F) All buffers have been degassed .
G) The software has a specific feature to limit the effect of possible dust or bubble
contamination . All measurements are split into a number of shorter runs, the mean
value and standard deviation of intensity is calculated, allowing the rejection of any
run with a significantly different value from the average.
H) Before each measurement the optical alignment of the cell was checked by observing
the position of the transmitted beam on a distant wall without and with the cell in
position.
II 2 4 Experimental parameters and sample handling.
These were the same as those used for correlation spectroscopy; the specific
parameters for Mr determination were :
A) The use of spectroscopic analytical grade toluene ( Aldrich Co U.S.A.) as a standard
(L
of refractive index 1.494 and Rayleigh ratio 18.3 10 cgs .
- In the absence of a published value of dn/dc for fibronectin at 514.5 nm a standard value
of 0.19 was chosen only slightly different from the published value for fibronectin at 633
nm of 0.174ml/g .
II 2 5 Limitations of this technique.
This technique ( Mr measurements by light scattering ) has several limitations :
A ) It requires calibration against a known scatterer.
B ) A refractive index increment with concentration increase must be measured with high
accuracy, which was not possible in ourwork.
C) It is very sensitive to dust and aggregates . The intensity of scattering is proportional
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to the square of the mass of the scatterer and therefore to the sixth power of its size .
D ) Source and detector fluctuations might be difficult to control over a long period of
time.
E ) As sample preparation might alter the initial sample concentration , its
concentration is measured on the last dilution by spectrophotometric determination
of absorbance at 280 nm . Obviously any error will be amplified by a 2.5 factor when , as
is generally the case, this optical density reading was carried out on the 4/10
dilution .However the worst remaining error comes from the index increment
determination, but this was not a problem in this work because it only generated a
constant error and thus did not interfere with comparative Mr determinations.
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II 3 SMALL ANGLE NEUTRON SCATTERING
II 3 1 Introduction.
This technique has benefited from the availability of high flux reactors coupled
with better neutron detection. Neutrons are scattered by nuclei and unlike X-radiation do
not show any systematic variation of scattering length with Z , allowing , despite a
lower flux by cross-section , smaller sample concentration than required for X-Ray small
angle scattering. The reason for this is that scattering is proportional to the fourth
power of the wavelength and longer wavelength can be obtained with neutrons .
Furthermore with neutrons the samples can be larger samples than for X-radiation .See
reviews of the technique by Jacrot (1976), Stuhrmann and Miller (1978), Perkins (1988).
Its main advantage as opposed to X-Ray solution scattering is the absence of
radiation-induced damage to the sample.
II 3 2 Theory of small angle scattering.
This has been developed by Guinier and Foumet (1955).It is valid for neutron and
also for X-Ray scattering. Let us first consider the set up :Fig II 7
Fig II 7
Detector
A thin sample is hit by a monochromatic radiation beam .The scattered radiation
has the shape of spherical waves. If the detector intercept is a very small solid angle
this spherical portion can be considered plane.Guinier showed that the relation between
the scattered radiation intensity and the scattering angle is :
Log I = Log Nb2 - 4 IT2 / 3 X2 0.4343 Rg2 Q2 (II3 1 )
Where :
I is the scattered radiation intensity .
Nb is related to the number of particles scattering radiation.This factor is
related to the molecular weight Mr ( see II 3 5 below).
X is the radiation wavelength.
R„ is the radius of gyration of the particle.
©
Q is related to the scattering angle 29 and the wavelength X by
Q = 4II sin 0 ( X )-1*
The graph of Log I versus Q gives : Log I (Q) = B - a (Q r B is the value of Log I when Q
= o, value which is related to on the other hand, the radius of gyration Rg of the
particle can be evaluated from the slope of the line Log I =B-a(Q) : ( See II 3 1 )
Rg = 0.416 A,(a)1/f2 (II 3 2).
II 3 3 Experimental set up.
All neutron scattering experiments in this work have been carried out at the Institut
Laue Langevin in Grenoble (France).The instrument called "D 11" has been described by
Ibel (1976). It is described in Fig. II 8 below . Very small alterations have been made
since then : samples are now in a free environment at atmospheric pressure ( Fig II 9
below ), the position of the detector ,the beam stopper and the sample cell are now
remote-controlled through the machine computer by steppermotors.
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Fig II 8















View of the sample holder of the
D 11 neutron small angle scattering camera.
1) Neutron guide.
2) Sample cells.
3) D 11 camera.
4) Sample changer system.
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Briefly a beam of cold neutrons with wavelength from 0.4 to 1.8 nm leaves the
reactor via a cold neutron guide . A velocity selector , composed of helical slots is
positioned 40m from the reactor core. This selector allows only neutrons within a 10 %
range of a defined velocity to be transmitted. This allows the selection of neutrons
within a 10 % range of the desired wavelength. After collimation , neutrons hit the
sample over an area of approximately 1 cm .
The samples are enclosed in quartz cells ( Hellma FRG) with a thickness of 0.1 cm
and 0.2 cm respectively for H2O and D2O solutions. This way of handling the sample is
very convenient because optical density readings are easily done on the sample itself
allowing a precise concentration determination . Furthermore the sample has little risks
of aggregation or polymerisation induced by handling as it goes directly out of the
filtration filter into the measurement cell with very little disturbance.! see IV 3 below).
The detector is made from 4064 1 cm BF3 filled cells arranged in a square array
of 64 x 64 cells. The detector and its associated Cd beam-stopper are positionable under
vacuum by remote control.
Run duration is determined by setting a value of neutron counts for the integration
of a small fraction of the incident beam. This ensures that two runs with the same time
integration effectively have the same number of incident neutrons . Because of small
source fluctuations a time based integration would not be as precise. For each run the
counts on each cell are integratedThose counts constitute the raw data which come out of
the detector.
II 3 4 Application to our measurements: data processing and determination of the
radius of gyration Rg.
The raw data (i.e. integrated counts for each cell for a certain number of incident
neutrons ) are processed as follows.
A ) First all equivalent runs are added : all water runs, all sample x runs and so on .This
creates a set of raw data output from the 4096 cells of the detector.
B ) This raw data is then reduced by circularly averaging and transformation into a
one dimension data I(Q)-f ( Q ). All those transformations are carried out by a
computer programme at I.LL called " RNIL".
C ) Afterwards another programme called " SPOLLY " performs subtraction of
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intensities for each Q value, creating two spectra :
1) Water final spectrum =
{[ (water-filled cell spectra ) minus (detector response spectra) ] minus
A-j [ (empty cell spectra) minus (detector response spectra) ]).
A.j represents the water transmission factor which is used to attenuate the empty
cell scattering to the level it really has in the water spectrum.
2)Sample final spectrum =
{[(Sample-filled cell spectra) minus (detector response spectra)] minus
A2 x [(Buffer-filled cell spectra) minus (detector response spectra)]).
A2 is a correction factor equal to the ratio of sample to buffer transmissions and is
very close to 1 because the solutions are very dilute (0.05 to 0.15 %).
For each value of Q the intensity of the water final spectrum is subtracted from
sample final spectra , creating for each sample a file of
I( Q) / iinc (Q) =f(Q).
Where I ( Q ) is the intensity of radiation scattered by the sample and I jnc ( Q ) is
the incoherent scatter from pure water.
D ) The curves are smoothed and "RGUIM " programme produces the classical Guinier
representation by fitting the experimental points to a line in a preset range of Q ,
calculating Rg and extrapolating the value of I ( 0 ) / I jnc ( 0 ) at Q = 0,( origin of
the curve ).
II 3 5 Principle of the determination of Mr by small angle neutron scattering.
In solutions neutrons are scattered by nuclei producing both coherent and
incoherent scattering. Only coherent scattering can be used to derive some structure
information. At zero scattering angle the intensity of coherent scattering 1(0) depends
only on the size and number of nuclei present and not on their arrangement .Furthermore
the incoherent scattering by the solute in 0.05 to 1% wt/vol concentration range of
biological studies is negligible compared to incoherent scattering due to the solvent.
This allows Mr determination by extrapolation of 1(0) intensity to zero scattering
angle . The technique of Mr determination from this work has been described by Jacrot
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and Zaccai ( 1981 ) and will be briefly reviewed below. ( The various parameters
required for calculations are also from this work.)
The relation between the zero angle scattering intensity and the number of
particles in solution, valid for any radiation providing the proper contrast term
(Xb - psV )2, is chosen, is given by :
I ( 0) = Nb ( Zh - Ps V) 2 A (II 3 3 )
Where: 1(0) is the coherent scattering intensity at zero scattering angle.
C is the concentration in g / cm
Xb is the sum of coherent scattering length for the considered molecule.
ps is the solvent scattering density ,( scattering length per unit volume of the
solvent).
V is the dry volume of the particle.
Nb is the number of particles diffracting.
Nb = C 7{ts 1/Mr (113 4)
With :
Mr is the molecular weight to be determined.
Cis the concentration of solute g/ml.
t is the sample cell thickness.
s is the intercept of the neutron beam with the cell.
is Avogadro's number.
A is a factor depending on the geometry of the system and the incident beam I Q as
defined below:
A = Ts , I o Q (II3 5 )
With:
Tg is the sample transmission : the ratio of the intensity transmitted by the
sample cell and the intensity of the incident beam. Tg is easily measured.
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IQ is the incident beam intensity in neutrons per second. It is important not to
confuse it with I (0) solution forward scattering at angle zero.
Q is the solid angle of the scattered beam intercepted by the detector.
As the number of particles diffracting at a given concentration Nb is
proportional to the invert of the molcular weight Mr and - pgV is proportional to
Mr, the expression II 3 3 can be seen as : 1(0) / C = Constant X Mr .
II 3 6 Estimation of the incoherent scatter from water as an absolute scale for
molecularweight determination by neutron small angle scattering.
In order to determine Mr ,at first, an estimation of A , ( Tg times Io Q ) ,is
required:
A) Tg is the sample transmission : the ratio of the intensity transmitted by the sample
cell and the intensity of the incident beam. Tg is easily measured as follows : an
attenuator is inserted in the incoming neutron beam to bring down its intensity then
the beam backstop is removed . The ratio of the integration of the counts
measured for a given period by the cells at the centre of the detector with the
sample over the integration of the counts measured by the same cells for the same
period with no sample is the sample transmission Ts.
B ) The product Io Q I0 : the incident beam intensity in neutrons per second. ( It
is important not to confuse it with I (0) solution forward scattering at angle zero.) ,
and Q.: the solid angle of the beam intercepted by the detector.
An absolute measurement of IQ is difficult but this problem is avoided by
measuring both scattering and transmission from a pure water filled cell. The
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estimation of I0 is based on the fact that ,at the 10 A neutron wavelength used for
our experiments, incoherent scattering from water is strong and has very little
angular dependence. Let us first consider the experimental set up and define the




Q is the incident beam we intend to measure.
I jnc corresponds to the incoherent scatter of water.
I pj2o's t^ie beam transmitted by the water filled cell.
S is the cross-section of the beam.
As IQ = Ijnc + lH20 an<^ ^H20 = ^H20 ^o ,we can define the transmission
factor for water : Tj_j2o
TH20 = I H2G / IQ (II36)-
The incoherent scattering from water at a solid angle of 4 n is : Ijnc = (1 - Tj_j20 ) ^o ^
for the solid angle Q defined by the intercept of the scattered beam by the detector
is:
Iinc = n-TH20)Io(4ir^ (113 7).
So the measured I jnc incoherent scatter from water over an angle Q is linked to the
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incident beam IQ. (For neutron wavelength less than 0.1 nm a correction factor arises
from the fact that the incoherent scattering of water becomes non isotropic . See
Jacrot (1976). This was not required in the measurements performed in this work
where the wavelength was 1 nm)
In practise 1(0) mc can be measured from the intensity of incoherent scattering from
water at Q = 0. A water spectrum for all Q range ismeasured; a spectrum of an empty
cell is subtracted to suppress the contribution of quartz scattering . Because the
measurements from water and specimens are all performed with the same sample
and detector position , Q. is constant and can be ignored in the ratio : I ( 0 )sampie
over 1(0) inc So:
A = TsI(0)inc4n/l-TH2O (H3 8).
( TH20 is equal to I H20 / Io as defined over in equation II 3 6).
The expression II 3 3 can now be written as
1(0) = CJ{ t Mr Ts I ( 0 )inc 411 / 1-Th2q [ 1 / Mr ( 2^-pgV)]2
Then can be rearranged in :
Mr =1(0) [Ctft Tgp1 [411 / 1-TH20 r1 [ 1 / Mr ( 2^ - p V)] ~2
I (0 )inc
(113 9)
The various parameters are determined as follow:
A )A value for 1(0) / I (0 )inc is calculated for each sample as described in II3 4 C
B) C is the solute concentration in g /ml. As the experiments are performed in quartz
cells this concentration can easily be determined , providing the extinction
coefficient is known, by a measure of the absorbance at 280 nm.
C) t is the sample thickness in cm
D ) 4 II / 1 - Tj_j2q 0311 be measured an equals 0.072
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E ) The only remaining factor to estimate is : [ 1 / Mr ( Z^ - pg V )] 2 , the contrast
term . Because its estimation requires some calculations it will be described in a
special paragraph : II 3 7 below.
II 2 Z Determination of the contrast factors for fibronectin and the 44 k D gelatin
binding domain of fibronectin.
The contrast factor is composed of two terms both dependent upon the D2O content
of the solvent.
The proportion of D2O in the buffer % D2O must be measured for each sample
containing D2O from transmission experiment in the following way:
The transmission of a 100 % water buffer and a 100 % (In practise > 99 %)D20 buffer are
measured. With those two points, drawing a line of transmission as a function of D2O
concentration, allows determination of the D2O content of an unknown sample buffer by
simplymeasuring its transmission. ( As the samples are dilute solutions the absorbance
due to the solute or the buffer salts are neglected). This is important because the samples
are equilibrated by dialysis and therefore the D2O concentration must be measured
A) The first term of the factor is Z^ ( 1 / Mr ) , the sum of scattering length of the
constituents of the molecule permass unit , values of Z ^ in H2O and Z ^ in D2O are
tabulated. The knowledge of the D2O percentage in the solution allows
determination of the share of respective scattering lengths in H2O and D2O as follows:
2^ (1/ Mr ) = E b H2O + % D2O (E D20 - £ H20 ) U/ Mr) (II3 10 ).
As the amino-acid residues composition is known both for fibronectin and the
domains we studied we can calculate the scattering length Z^ (1 / Mr ) for both of
them, see Tables II 1 to 4 below.
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B) The second term ps V (1 / Mr ) is the product of the solvent scattering length per
volume unit ps by the dry volume of the particle V divided by Mr, both V and Mr
can be calculated from the molecule composition.
For a mixture of H2O and a certain percentage of D2O called % D2O as a solvent
ps = (- 0.0056 + 0.0697% D2Q ) 10 A2 cmi#f||
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Table II 1 .














ZbH2Q 10~12 cm ).
Mass ( D).
Mass x number ( D).
Number . ZbH2Q / Mr (1CT12 cm / D).
Number .ZhE^O-Zh^O/Mr (10 ^2cm / D)
1 2 3 4 5 6 7 8 9
Gly 358 1.728 2.769 1.041 57 20406.000 1.300e-3 7.728e-4
Ala 175 1.645 2.686 1.041 71 12425.000 5.970e-4 3.778e-4
Val 358 1.479 2.52 1.041 99 35442.000 1.100e-3 7.728e-4
Leu 226 1.396 2.437 1.041 113 25538.000 6.543e-4 4.877e-4
lie 202 1.396 2437 1.041 113 22826.000 5.848e-4 4.361 e-4
Phe 95 4.139 5.180 1.041 147 13965.000 8.154e-4 2.051 e-4
Tyr 0000s—1 4.719 6.802 2.083 163 30644.000 1.800e-3 8.119e-4
TrP 76 6.035 8.118 2.083 186 14136.000 9.512e-4 3.283e-4
Asp 213 3.845 4.886 1.041 114 24282.000 1.700e-3 4.597e-4
Glu 254 3.762 4.803 1.041 128 32512.000 2.000e-3 5.483e-4
Ser 351 2225 4.308 2.083 87 30537.000 1.600e-3 1.516e-3
Thr 483 2142 4.224 2.082 101 48783.000 2.100e-3 2.085e-3
Asn 189 3.456 6.58 3.124 114 21546.000 1.400e-3 1.224e-3
Gin 239 3.373 6.497 3.124 128 30592.000 1.700e-3 1.548e-3
Lys 147 1.586 5.752 4.166 129 18963.000 4.835e-4 1.270e-3
Arg 229 3.466 9.714 6.248 157 35953.000 1.600e-3 2.967e-3
His 87 4.959 6.521 1.562 136.5 11875.500 8.947e-4 2.818e-4
Met 49 1.764 2.805 1.041 131 6419.000 1.793e-4 1.058e-4
Cys 124 1.93 4.013 2.083 103.1 12784.400 4.963e-4 5.358e-4
Pro 336 2227 2.227 0.000 97 32592.000 1.600e-3 0.000
Total 4379 482220.900 0.024 0.0167
63
Table II 1 2
Calculation ofV/Mr for the complete plasma fibronectin molecule.
q q
Amino.Acid. Number of residues. Volume (A). Volume x number of residues (A)
Gly 358 66.4 23771.200
Ala 175 91.5 16012.500
Val 358 141.7 50728.600
Leu 226 167.9 37945.400
lie 202 168.8 34097.600
Phe 95 203.4 19323.000
Tyr 188 203.6 38276.800
Tip 76 237.6 18057.600
Asp 213 113.6 24196.800
Gu 254 140.6 35712.400
Ser 351 99.1 34784.100
Thr 483 122.1 58974.300
Asn 189 135.2 25552.800
Qn 239 161.1 38502.900
Lys 147 176.2 25901.400
Arg 229 180.8 41403.200
His 87 167.3 14555.100
Met 49 170.8 8369.200
Cys 124 105.6 13094.400
Pro 336 129.3 43444.800
Total 4379 602704.10
Mr (482,220 D ),has been calculated in Table II 1 above, then V/Mr = 125 D/A^
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Table II 1 3.
Calculation of Zb/Mr for the gelatin binding domain of the plasma fibronectin molecule.




EhE^O- LbH2a 10"12 cm ).
Mass ( D).
Mass x number ( D).
Number . £bH20 /Mr (10"12 cm / D).
Number.EbD2O-£bH2O/Mr(10"^2cm / D)
1 2 3 4 5 6 7 8 9
Gly 41 1.728 2.769 1.041 57 2337.000 1.608 e-3 9.686e-4
Ala 9 1.645 2.686 1.041 71 639.000 3.360e-4 2.126e-4
Val 21 1.479 2.52 1.041 99 2079.000 7.048e-4 4.961 e-4
Leu 14 1.396 2.437 1.041 113 1582.000 4.435e-4 3.307e-4
lie 10 1.396 2.437 1.041 113 1130.000 3.168e-4 2.362e-4
Phe 12 4.139 5.180 1.041 147 1764.000 1.127e-3 2.835e-4
Tyr 20 4719 6.802 2.083 163 3260.000 2.142e-3 9.454e-4
Trp 11 6.035 8.118 2.083 186 2046.000 1.507e-3 5.200e-4
Asp 21 3.845 4.886 1.041 114 2394.000 1.832e-3 4.961 e-4
Glu 18 3.762 4.803 1.041 128 2304.000 1.537e-3 4.252e-4
Ser 23 2225 4.308 2.083 87 2001.000 1.161 e-3 1.087e-3
Thr 36 2142 4.224 2.082 101 3636.000 1.750e-3 1.701 e-3
Asn 23 3.456 6.58 3.124 114 2622.000 1.804e-3 1.631 e-3
Gin 31 3.373 6.497 3.124 128 3968.000 2.273e-3 2.198e-3
Lys 12 1.586 5.752 4.166 129 1548.000 4.319e-4 1.135e-3
Arg 17 3.466 9.714 6.248 157 2669.000 1.337e-3 2.41Oe-3
His 16 4959 6.521 1.562 136.5 2184.000 1.801 e-3 5.672e-4
Met 9 1.764 2.805 1.041 131 1179.000 3.603e-4 2.126e-4
Cys 27 1.93 4.013 2.083 103.1 2783.700 1.183e-3 1.276e-3
Pro 20 2227 2.227 0.000 97 1940.000 1.011e-3 0.000
Total 391 44065.700 0.025 0.017
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Table II 1 4.
Calculation ofV/ Mr for the gelatin binding domain of the plasma fibronectin molecule.
Amino.Acid. Number of residues. Volume (A^). Volume x;
Gly 41 66.4 2722.400
Ala 9 91.5 823.500
Val 21 141.7 2975.700
Leu 14 167.9 2350.600
lie 10 168.8 1688.000
Phe 12 203.4 2440.800
Tyr 20 203.6 4072.000
Trp 11 237.6 2613.600
Asp 21 113.6 2385.600
Glu 18 140.6 2530.800
Ser 23 99.1 2279.300
Thr 36 122.1 4395.600
Asn 23 135.2 3109.600
Gin 31 161.1 4994.100
Lys 12 176.2 2114.400
Arg 17 180.8 3073.600
His 16 167.3 2676.800
Met 9 170.8 1537.200
Cys 27 105.6 2851.200
Pro 20 129.3 2586.000
Total 391 54220.800
Mr (44,066 D ), has been calculated in Table II3 above, then V/Mr = 1.23 D /A^
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U 2 8 Formulae for the determination of the molecular weight of complete
fibronectin and the 44 k D gelatin binding domain of fibronectin..
Using (II3 4) and the proper contrast term calculated from
Table II1 to 4 over.we have :
A) For Fibronectin:
Mr = 0.072 ( 1(0) / I(O)inc) ( C Ts e )4 (31 - 70.4 % D2Q) ~2 109
(II 3 11)
Where :
% £)20 is t^,e proportion of D2O in the solution.
Ts is the sample transmission,
e thickness of the cell in cm.
B ) For the 44 kD gelatin binding domain.
Mr = 0.072 ( 1(0) / I ( 0 ) inc) ( C Ts e )4 (31.9 - 70.5 % D20 )'2 10 9
(II 3 12)
II 3 9 The problem of the carbohydrate content of those proteins.
The complete fibronectin molecule and the 44 kD gelatin binding domain are both
glycosylated. As the amount of carbohydrates is in the range of 5 % of the mass and
considering that the precisian of the measurement of Mr in solution is only of the order of
10 %, it seems reasonable not to consider this problem.
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II 4 POLYACRYIAMIDE GEL ELECTROPHORESIS
II 4 1 E;<p<?rimeptal conditions,
The technique of Laemlli (1970 )was used . Gels were cast in 16 x 14 x 0.15 cm
dimensions between two glass plates with the gel and buffers composition given by this
author. Gradient gels were cast with the help of a two channel peristaltic pump at a
flow of 200ml/h. Solutions of acrylamide or buffers were not degassed prior to use.
For a separation range from approximately 800 kD to 50 kD Mr , 200 kD to 40 kD Mr or
100 kD to 15 kD Mr , 3.5 % - 5 % , 3.5 % - 6 % or 4.5 % - 10 or 12 % acrylamide gels were
respectively chosen.
The 3.5 % acrylamide top gel created much finer bands with the high molecular
weight material than the ordinary 4.5 % concentration generally used . On the other
hand gels were then difficult to handle .
Various grades of acrylamide from B.D.H. ( U.K). gave no apparent differences
in results. The Acrylamide - Bis Acrylamide mixture was stored in the dark at 4 ° C . Bio
- Rad ( USA) Type AG 501 X 8 ion exchange beads were added in this stock solution to
remove any acrylic acid formed by acrylamide degradation in solution.
The gels were run at a constant current of 50 to 55mA per gel (this corresponds to a
power of 30 W at most in each gel ). The gel running kits were equipped with a water
cooling device. To ensure proper cooling, the lower buffer solution was stirred
continuously. The duration of the run was determined by the time required for the dye
front to reach a position a few millimetres over the end of the gel plate. This was
dependent on the amount of salts in the sample but generally in the order of 150 minutes.
Fixation and staining were carried out :
Either :
A) through normal Coomassie - R staining procedure ( from Fairbanks et al. 1971 ):
Fixation for 1 h in 40 % Ethanol, 10 % Ethanoic Acid ,50 % water.
Overnight staining in 0.125 % Coomassie R 250 in 40 % Ethanol, 10 % Ethanoic
Acid ,50 % water.
Destaining by several changes of destaining solution : 15 % Ethanol ,10 % Ethanoic
acid in water.
Or:
B) by a quick stainingmethod derived from Versterberg et al. (1977) allowing
visualization of the bands in less than one hour, as well as a much better background
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after destaining which increases the quality of the photography of gels.
Fixation for 30 min in 40 % Ethanol, 10 % Ethanoic Acid ,50 % water, warming at
60 °C.
Staining 45 min at 60 ° C in a stain prepared in the following way : 0.125 %
Coomassie G 250 is dissolved in approximately 200 ml of water with vigorous
stirring ; 8.5 ml of perchloric acid are added slowly . This allows the stain to form
large micelles with colour turning from blue to brown . Water is then slowly added ,
up to 250 ml . Stirring is carried on for one hour and followed by filtration on
Whatman 1 paper.
The bands are immediately visible and destaining is done by several changes of
destaining solution : 15 % Ethanol ,10 % Ethanoic acid in water removes the slight
remaining background.
Photographs of all gels were taken on Polaroid 667 film ( Positive + negative )
allowing permanent record with no risks of band fading. When required, gels in the wet
state were scanned on a Joyce Loebl scanner with digital analysis.
II 4 2 Analysis.
The gels were analysed by the classical technique of Weber et al. ( 1969 ), by a
representation of Log ( Mw) as a function of Rf. Rf for a specific band is the distance from
the top of the separating gel to the specific protein band divided by the distance from
the top of the separating gel to the front as defined by the bromophenol dye line.
This plot when applied to the molecular weight standards yielded a straight




II 5 1 Introduction.
The most frequent application of electric fields to macromolecules is
electrophoresis where macromolecules are moved across a gel by an electric field.
Electrophoresis is present in nearly all biochemical research as an analytical technique
and is sometimes also used in a preparative way.
But an electric field can also orientate molecules (if they have a permanent or
field induced electric moment ). An orientation induced birefringence can be detected
if the molecules possess an optical anisotropy. This effect has been described by Kerr as
early as 1875,( Kerr 1875 & 1880). When applied to large biomolecules, this effect can
help to investigate not only some of the hydrodynamic properties but also some of the
properties of the molecules' structure such as their flexibility. As opposed to
electrophoresis this technique is extremely rarely applied in biochemical studies.. Just
a few teams in the world currently publish experiments carried out by this technique in
the field of biochemistry .
.II 5 2 Theoretical background of the electric birefringence effect.
As the electric birefringence effect has been fully described by Fredericq and
Houssier (1973), a short description will be presented below.
A medium is said to be birefringent if the velocity of light propagating through it
is dependent upon the plane of polarisation of the incident beam. For one direction of
propagation of the light beam, the solution possesses two refractive indexes : n= and n
j_ . The parallel and perpendicular compounds of the polarized light therefore travel at
two different speeds in the medium .When the beam comes out of the birefringent
medium, the two compounds are out of phase by an angle (j).
The birefringence of the medium , ( A n ), is defined as the difference in refractive
index (n ) between two orthogonally polarized beams :
AiWn=ynx(II 5 1).
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The birefringence ,A n is related to the shift in phase, p by the relation :
A n= <)> A, / 2 7t 1 (II 5 2).
Where 1 is the length of the path in the birefringent media. After passing through the
analyser, the intensity of the beam I is related to the initial intensity Io by the
relation:
I=Io sin 2 <(> (II 5 3 ).
In the absence of an electric field an homogeneous solution is optically isotropic
therefore as the analyser is oriented in order to stop the beam no signal is detected. In
the presence of an electric field the molecules undergo orientation . As the solution
becomes anisotropic n= , the refractive index in a direction parallel to the electric
field, and n_j., the refractive index in a direction perpendicular to the field became
different. The parallel and perpendicular compounds of the polarized light therefore
travel at a different speeds in the cell, and as a birefringence occurs a signal can now be
detected after the analyser.
In practice , in order to obtain the sign of A n as well as a higher sensitivity , a
quarter-wave plate is inserted before the analyser . The latter is rotated at an angle a
from the crossed position. ( See Fig II 11 ). The field-off intensity is then different from
zero and defined as Ia Therefore the measurement of Ij. intensity at time = t will be
linked to A n. and not An2. This configuration changes the relationship between 11 and <}>
which becomes :
<1 (t)" la >/!« - sin2 (« + <t> (t)/2 ) < sin 2 -1)"1 < n 5 4 )
Which can be rearranged as :
<t> (t) = 2 { sin [ (I (t)- Ia )/ Ia +1 )1/2 sin a ] - a } (II 5 5).
<[> ^ can be related to the time-dependent birefringence A n (by the relation II
5 6 below:
A n (= X <f> (t) / 360 1 (II 5 6 ).
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Fig II 11
Electric birefringence optical set-up with quarterwave plate.
( Size reduced along optical axis,expanded along the electric field axis )
Kerr cell. Quarter-wave plate. Analyser with rotation mounting





Optical axis and laser beam.
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It must be noticed that the variations in the intensity of the transmitted beam:
( I Ia ) that are in fact detected are not strictly related to A n (t). . But in the
conditions where : ( I (max)- Ia ) / I ot <0.1 with I(max) being the field on steady state
birefringence it must be noticed that n ^ - n ^ max ^ /n ^ max) does not differ ofmore
than 1 % from ( I I(max )) / I (max) * ^'s t^en Possible to treat the variations of
intensity as a good indication of the variations of the birefringence.
II 5 3 Experimental set up.
All the birefringence experiments from this work were performed by the author in
The " Laboratoire de Biologie Physicochimique " in the Universite GBernard in Lyon
( France ) with the supervision of Professor Bernard Roux . The electric birefringence
equipment was "custom made" for this laboratory by Dr GBernengo. It is shown in Fig
II 12 below.
The sample is carefully transferred into a Kerr type cell made of two parallel
electrodes and two transparent windows mounted on a teflon base (see Fig II 13). A high
voltage source can create fields up to 10 kV/cm through the electrodes. The operator
triggers both the high voltage source and the oscilloscope sweep by a single switch. The
oscilloscope is equipped with a memory device allowing a trace recording. AID mW
laser is used as a monochromatic polarized light source . It is important to notice that
the laser source is oriented in order that the plane of polarisation forms an angle of 45
degrees with the electric field. The beam travels through the Kerr cell, a quarter-wave
retarder, an analyser which is oriented to stop the incident beam and finally is detected
by a photomultiplier directly connected to the oscilloscope.
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Fig IT 12 : Electric birefringence set up.
High voltage source
High voltage and oscilloscope trigger
Oscilloscope
* E
Laser Source. Kerr Cell. 1 / 1 wavelength Analyser,
plate.
Photomultiplier.
High voltage circuit Light path.






II—5—i General interpretation of a birefringence measurements.
Fig II 14 shows the data obtained for a 11 mg/ml solution of fibronectin in 100
mM NaCl,l mM EDTA, 50mM Tris , pH 7.4. The spikes indicated with arrows are
artefacts created in the electronics when the field is created or suppressed. The curve can














A) The rise of the birefringence: this step corresponds to the time during which the
molecules orientate within the solution. The speed of the appearance of
birefringence is linked to the ability of the molecule to orientate and depends both
on its electrical and hydrodynamic properties.
B) The steady state birefringence is shown by the flat part of the curve. The amplitude
of the steady state birefringence is linked to the optical and electrical properties of
the molecules, the electric field properties and the concentration of the
macromolecules.
C) The decay of birefringence. This corresponds to the time immediately following the
interruption of the field. Therefore the molecules lose their orientation and the
birefringence disappears. As at the start of this phase the electric field is
suppressed and the decay rate is only related to the hydrodynamic properties of the
molecules in solution.
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D) A fourth section can exist when the measurements are performed in a buffer where
the conductance is very high for this technique . This happens over 50 mM ionic
strength . In this case an oscillation of the signal might be observed in the final
section of the decay. It is due to perturbations created in the solution and must be
ignored. Fortunately it appears when the birefringence is only a small portion of its
maximal amplitude.
The points enclosed in boxes are artefactual. They are the consequence of electric
interferences when the field is created or interrupted . They are in fact quite useful
because they show the exact position on the curve of those two events.
II 5 5 Molecular interpretation of the measurements of the sign of the birefringence .
The birefringence can be positive or negative and this provides information about
the orientation of the molecule's electric dipole. In the cylindrical model of Benoit (
1951), the birefringence is positive and the electric dipole is aligned with the main axis
of the molecule.
II 5 6 Hvdrodynamic interpretation of the decay of the birefringence.
Because of the involvement of the optical, electrical and hydrodynamic
properties of the molecule , the interpretation of the rise and the steady- state
birefringence is an extremely complex problem which has not yet been solved in a
satisfactory way . Since the decay of the birefringence occurs only when the field is
interrupted , the decay is not linked to the electrical properties of the system but only
to the optical and hydrodynamic parameters of the molecules.
Various authors have worked on this problem . The interpretation is the most
simple in the case of models assuming the molecule shape as long cylindrical rods. In the
cylindrical model of decay of Benoit (1951 a & b ), the birefringence decay is given by:
An(t)/Aneq=e('t/T> (II 5 7).
Where:
A n ^ is the birefringence at time t after interruption of the field.
A n is the steady state birefringence ( generally just before the field
interruption).
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X is the orientation relaxation time .
In this cylindrical model x is related to 0: rotational diffusion coeffcient by the relation :
x = l/ 60( 115 8 ).
this relation allows a direct calculation of 9 rotational diffusion coefficient from the
normalized decay rate : x.
In a more recent work Wegener and his co-authors (1979), have worked out the
general expression of the decay. They show that in a general case the expression of the
decay was a multiexponential function involving five decay rates. Considering the
limits of the resolution on the measurement , such functions cannot be analysed.
Fortunately, in some cases the general expression shows that only one or two decay rates
are involved (this is due to symmetry relationships within the molecule). In those cases
the experimental curve should be single or bi-exponential . These authors show that
this could exist when the molecules could be approximated by long rods (as in the Benoit
model), but this is of little interest for the fibronectin molecule , as various other
hydrodynamic measurements allow us to rule out this model ( See chapter IV paragraph
3 & 4 ). They confirmed that ( as pointed out by Tao in 1969 in a study of fluorescence
depolarisation ) to a good approximation , for oblate ellipsoids as defined by Perrin
which are a shape more likely to fit with fibronectin , the five relaxation times ( x ) are
equal and were also given by the relation II 5 8 above .
IT 5 7 Practical data processing for the birefringence measurements.
The raw data was transferred from the memory of the oscilloscope to an Apple
lie computer where it was processed by a locally written programme in the following
way:
A) First the portion of the curve of interest was selected, in this precise case the decay
of the signal was analysed. ( The rise of birefringence can also be analysed which
yields informations on the electrical properties of the molecules in the cylindrical
model from Benoit).
B) The curve was transformed in semi-log coordinates and analysed for a single
exponential decay by a classical least square fitting of the points corresponding to
the longer times after field suppression.
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C) If the line created above was not crossing the origin, the values obtained for this
function were subtracted from each point leading to the calculation of a second
exponential decay function corresponding to a shorter relaxation time.
D) In this latter case the two functions were combined and plotted on the same graph as
the experimental data allowing an appreciation of the fitting of the model to the
experimental points. Fig IV 1 and 2 (in chapter IV ), shows that in the
application to the fibronectin molecule , the two situations occurred depending
on the buffer conditions.
II 5 8 Practical and theoretical limitations of the birefringence measurements.
The electric birefringence technique presents a number of specific experimental
and theoretical problems.
A) The main experimental limitation is that the creation of an electric field within a
solution can create a current and thus generate heat. The current is obviously linked
to the conductivity of the solution ( i.e. its ionic strength ). Ionic strength of
approximately 150 mM seems to be currently an upper limit. The type of buffers that
can be chosen for those experiments is therefore limited . No information can be
obtained for high ionic strength buffers.
B) In order to avoid any excessive heating of the solution the field is maintained only
for a fraction of a millisecond (generally 20 ps for the experiments presented in this
work). Unfortunately triggering the high voltage source for such a short period
appeared to be rather temperamental with the rather old generator used in this
work. This generator also had a tendency to sometimes keep the field for a much
longer time than requested , resulting in the loss of the sample. A new generator is
expected soon on this apparatus that should solve this problem.
D) An other problem is the synchronization between the field pulse and the oscilloscope
sweep. As the times involved are of the order of the ji second this is not always
satisfactory. A proper generatorwould be a considerable help here as well.
E) Fairly high concentrations had to be reached before any decent signal could be
recorded. This does not create good conditions for the study of fibronectin.
F) Nevertheless the main concern is not experimental but is due to the difficult
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interpretation of those measurements because of the complexity of the problem from
the theoretical point of view. Fortunately the fibronectin specimens did not present
any multi-exponential decay curves with more than two decay rates. This permitted




III 1 ONE STEP FIBRONECTIN PURIFICATION FROM PLASMA .
Ill 1 1 Introduction.
The plasma fibronectin purification technique in this work was derived from two
papers : Vuento et al. ( 1979) and Ruoslahiti et al. ( 1982 ). They both rely on affinity
chromatography as described by Cuatrecasas et al. ( 1968) but neither mentions any
precautions against clotting of blood during preparation.
The purification method is based on the high affinity of fibronectin to collagen
(or its denaturation product, gelatin) . As this property is shared by very few plasma
proteins, separation based on this property immediately results in a dramatic
purification from complete plasma to fibronectin in one step.
Ill 1 2 Plasma preparation.
The two types of starting material were :
A) Citrate treated frozen human plasma was supplied by the Scottish National Blood
Transfusion Service.
125 ml of plasma were made ImM in PMSF 5 mM in EDTA NaNg 100mg/l
It was then spun for 2h at 25 OC at a 10,000 g field and then for 10 minutes
at very low speed at 10 0C to solidify the lipidic top layer formed by centrifugation.
Human plasma is associated with three problems:
1) Possible contamination by human virus . This plasma was screened by the
S.N.B.T.S. and was transfusible , nevertheless, the contamination risks are not
totally suppressed.
2 ) Human plasma as opposed to bovine plasma may contain a noticeable amount of
lipids which tend to deposit on the glassware or the columns.
3 ) Proteolytic degradation might occur during the plasma collection and storage
times which are much longer than those for bovine plasma.
On the other hand most of the literature is devoted to the human plasma molecule
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therefore it is helpful to work with it.
B) Bovine blood anticlotted by 1 to 5 vol A.C.D. spun 3000 rpm for 5 minutes to remove
blood cells, was pelleted and then processed exactly as human plasma except for the
centrifugation step where the absence of a significant amount of lipoproteins s
EflT'V*»Sfcffig; .will
allowed reduction of the centrifugation time to 15 min.
Ill 1 3 Flow rates in column chromatography.
During all this work the usual flow rates depended on the column diameter and
are presented below:
Column diameter. (cm) Flow: Affinity chrom.(ml/h) Flow: Gel filtration (ml/h)
2.5 20 to 25 10 to 15
1.6 10 to 12 5
1 8 to 10 .
III 1 4 Affinity chromatography of plasma.
Plasma was applied to a 5cm^ by 5 cm column of commercial gelatin-sepharose .
Prior to plasma application the column was equilibrated by 100 ml of pH 7.35
phosphate buffer, P.B.S. (150mM ionic strength ), containing 5 mM EDTA . During all
gelatin affinity work the flow was kept at 25 ml/h . It was then rinsed by the following
buffers:
A) 100ml of the equilibration buffer to elute all unbound material.
B) 75 ml of 50 mM Tris 2 M NaCl pH 7.4 PMSF ImM, 5 mM EDTA. This step allowed
elution of all the contaminants either binding to gelatin or to the sepahrose-beads'
carbohydrates .
C) 100 ml of PBS buffer to lower the salt concentration if immobilized Lysin or heparin
affinity chromatography was to be performed later .
D) For the elution, various buffers have been tested with success
1)Urea 4 M tris 50 mM pH 7.5
2)Urea 2M 1 M NaCl 50 mM tris pH 7.5
3)Citrate 50 mM NaCl 100 mM pH 5.2
4)Lysinel M Tris 50 mM pH 7.4
5) Lysinr2 M Tris 50 mM pH 7.4
Fig III 1 shows the absorbance profile at 280 nm of the preparation.
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Before any salt or Tris addition , all urea solutions were deionized by passing
them through a 8 ml column of ion-exchange beads ( Bio Rad AG 501 X 8 ) to remove
urea degradation products. The conductivity of urea solutions was then smaller than
that of double distilled water.
Buffers 1-3 ( urea or citrate ) allow elution as a sharp peak. Buffer 1 was
abandoned as its very high urea concentration could give rise to
irreversible denaturation of fibronectin. Apparently the use of citrate in buffer 3
causes irreversible denaturation of the affinity media. Lysin elution (buffer 4 ) has
the disadvantage of resulting in a very broad elution peak and also the buffer shows
some absorbance at 280 nm perturbing the protein detection. On the other hand,
buffer 4 represented the mildest possible elution conditions. A good alternative was
developed in this work by the use of 2 M Lysinf( Buffer 5 ). The fibronectin was
eluted as a sharp peak and this avoided the use of urea . Buffer 5 is then a
good solution to the problem of the elution buffer.
Dialysis from high concentration solution to Tris 50 mM ,NaCl 100 mM ,EDTA
ImM, PMSF 50 jiM pH 7.4 was performed in three steps :
A) 4h dialysis which removes most of the passingmaterial as shown by some refractive
index measurements of a 4 M urea solution in our experimental conditions. See Fig III
2 below.







p I asma I 2M NaCI Elut c>n
i i i i i , i a , , brf em-i-




Dialysis of urea elution buffer.
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III 1 5 The problem of proteolytic degradation.
In this preparation, as often in protein purification , enzymatic proteolytic
degradation occurs and is the main problem in this preparation. Two protease inhibitors
were systematically added:
A )Phenyl-methyl -sulphonate-fluoride ( PMSF ), described by Farney et al. (1963 ) was
added to irreversibly inhibit serine activated-proteases present during preparation
by sulfonation of the serine residue of the active site . The concentration range was
from 0.5 to 0.05 mM. The main experimental problems with this inhibitor are :
a) Its poor solubility in water solutions ( approximately ImM ). The use of a
isopropanol stock solution is then required. This results in two problems :
Isopropanol contamination of the solutions if a rather dilute stock solution is
used,
or inhibitor precipitation in the case of a very concentrate stock solution which
tends not to mix quickly enough with the buffers.
(3) A poor stability : The half life of PMSF is , at 25 C and physiological pFl, is of
the order of 1 to 2h only .
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Y) A slow reactivity with its substrate at low temperatures (i.e. 4 C ).
B ) Ethylene-diamine-tetracetate , (EDTA), was added to reduce metal ions activity,
thus inhibiting metal activated proteases as well as inhibiting calcium dependent
clotting in plasma . It also prevents metal ions triggering fibronectin polymerisation
as shown by Vartio (1986 ).
No inhibitor for Thiol-activated proteases was added as fibronectin presents
two free SH groups which might have important physiological applications (see
chapter I ). As all preparations were usually conducted at physiological pH no acid
protease inhibitors ,such as pepstatin, were added.
The most immediate effect of degradation was to cut the molecule near the
C-Terminus end generating two slightly different subunits :
i) one with the double disulphide inter-chain bonds and a small part of the other chain.
ii) the other one missing the C end .
It must be pointed out that in physiological conditions, those fragments remained
associated by non covalent interactions. This degradation process is easily shown on a
non-reducing PAGE (Fig III 3 below). It must be noticed that most of the literature present
reducing gels where no estimation of the degradation can be done because after reduction
the bands of native fibronectin and of the main degradation products are at the same
place .
Ill 1 6 Results.
Yields have not been calculated for all the preparations carried out (over 50 ).
For example on 13 preparations an average of 17 mg of fibronectin per run has been
prepared. This represents a yield of 56 % with a theoretical plasma fibronectin
concentration of 300 mg/1. Large variations in the yields of the preparations were
observed , they seemed to reflect the normal variations of fibronectin concentrations of





Lane 1 Plasma, total protein loaded , aprox. 200 pg.
Lane 2 Plasma, total protein loaded , aprox. 40 pg.
Lane 3 Purified fibronectin, aprox. 30 p g.
Lane 3 Purified fibronectin, aprox. 10 p g.
As the gel was realized in non-reducing conditions,
the following bands can be seen:
A :Traces of multimers formed during boiling.
B: Native fibronectin made of two chains.
C: Isolated chains formed by degradation:
the two type of chains one missing the C
terminal domain, the other with two C
terminal domains are visible on lane 4.
D: Large degradation products of fibronectin.
Ill 2 FURTHER PURIFICATION STEPS .
IE 2 1 Introduction.
Further purification has sometimes proved to be necessary , mainly because of
degradation of fibronectin . This degradation probably occurred when the plasma was
collected because its extent was very variable with human material although the
purification procedure remained constant. With bovine plasma the degradation seemed
more limited possibly because of quicker collection and processing of the plasma. The
three techniques tested for the re-purification of fibronectin are described below :
III 2 2 Heparin affinity chromatography:
This method is based on the affinity of fibronectin to heparin; this was a
convenient way of obtaining higher concentration fractions without requiring the use of
an ultrafiltration concentrator leading to high gas solubilisation in the buffers . This is a
problem in light scattering experiments. Large fibronectin fragments containing both the
gelatin-binding domain and the strong heparin-binding domain were not separated from
the complete molecule .
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Ill 2 3 Lvsin affinity chromatography:
This technique (from Vuento et al .1979 ), was proven to be good but resulted in
poor yields probably due to poor binding to the column.
Fibronectin previously dialysed against 50mM NaCl, 25 mM Tris, 1 mM EDTA,
pH 7.4 was loaded on a 5 cm by 2.5 cm diameter column of commercial poly-L-Lysin
sepharose equilibrated with the same buffer . It was then rinsed by 100 ml of the same
buffer. The elution was carried out by 1 M NaCl 50 mM Tris, 1 mM EDTA, pH 7.4 buffer.
Ill 2 4 Gel filtration:
Gel filtration ( Technique described by Porath et al. 1959), on sephacryl S 500
was applied to the re-purification of fibronectin in this work. It had the disadvantage
of diluting the fractions and was also rather slow . Nevertheless gel filtration in 1M
NaCl 1 M urea 50 mM Tris pH 7.4 was the only technique that could separate intact
fibronectin molecules from the non covalent associations of hydrolysed subunits as
described above.
Ill 2 5 Problems associated with fibronectin solutions.
Fibronectin has a strong tendency to form large visible aggregates upon stirring ,
shaking , freezing and thawing or fast changes of ionic strength. This was particularly
marked in low ionic strength solutions in presence of urea. Proteolytic decomposition of
purified material did not seem to represent a problem.
Ill 3 PREPARATION OF SOME FIBRONECTIN DOMAINS.
Ill 3 1 Thermolvsin limited digestion.
The thermolysin ( E. C. 3.4.24.4. ) digest technique is from Seikiguchi et al
(1983).
Fibronectin was dialysed against 50 mM NaCl, 25 mM Tris, 0.5 mM EDTA pH 7.6, just
before enzyme addition CaCl2 was added to a final concentration of 2 .5 mM . Enzyme
concentration was 5 micrograms thermolysin per mg fibronectin . There was no attempt
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to quantify the yields of the digestion methods. The use of EDTA and excess Calcium ions
during the reaction seems strange il but it is based on the fact that EDTA - Metal
dissociation constant is several orders of magnitude smaller for calcium than for metals
susceptible to inhibit thermolysin action . Therefore addition of EDTA chelates all
disponible metal contaminants assuring a reproducible enzyme action over different
batches. The reaction was stopped by the addition of EDTA at a 5 to 10 mM
concentration. The various domains are recovered by affinity and gel-filtration
chromatography as follows.
Ill 3 2 Preparation of the gelatin binding domain.
The gelatin binding domain was prepared by loading the digest on a
gelatin-sepharose column equilibrated with digestion buffer, containing no calcium but
10 mM EDTA, rinsing the non-binding material with the same buffer and eluting the
bound material with 4 M Urea 50 mMtris 5mM EDTA pH 7.4 .
Ill 3 3 Preparation of the larger heparin binding domains.
The heparin binding domains were prepared by loading the digested sample on a
Heparin-sepharose column equilibrated with digestion buffer containing no calcium but
5 mM EDTA , rinsing with the same buffer and eluting by a gradient from 25 mM Tris
50mM NaCl to 25 mM Tris 0.5 or 1 M NaCl. The peak fractions were analysed on SDS
PAGE and the high molecular weight high affinity material 145-155k D was purified
by sephacryl S 200 gel filtration chromatography resulting in homogeneous material as
shown by SDS PAGE .
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CHAPTER IV
MODELS OF FIBRONECTIN IN SOLUTION
IV 1 INTRODUCTION.
Understanding the contacts between cells and the extracellular matrix requires
an accurate description of the three-dimensional structure of the elements that create
those connections . Thus the need for reliable models of all the molecules involved in
this anchoring system is clear. The involvement of fibronectins in the cell anchoring and
matrix organisation has been described in I 4 above and this seems to be the main
function of those molecules. Therefore good models of fibronectin might help to
understand fibronectin function and also how the cell-tissue interaction is created.
Crystallographic techniques allowing high resolution structure determination
to be carried out have not been applied to fibronectin yet. Crystallisation attempts were
performed by various teams and also on fibronectin prepared for this work with no
success yet. The fibronectin molecule tends to polymerise easily and therefore crystal
production does seem easily possible . One of the leading teams working on fibronectin
(Ruoslahiti in the U.S.A ), seems even now to have given-up the idea of crystallising
fibronectin and is at present trying to obtain crystals from vitronectin which also
possesses the sequence responsible for cell attachment: RGDS.
This lack of high resolution data for fibronectin is a real concern because, despite
a relatively large number of studies on this molecule , the tertiary structure of the
fibronectin molecule is still very poorly understood. Fortunately fibronectin does not
self-aggregate in solution.This is very important because studies in solution are therefore
possible with fibronectin . Laminin , for instance , has such strong self-aggregation
properties that it has been impossible yet, with this molecule , to perform many types
of studies in solution like light scattering .
TV 2 RESULTS FROM HT.Er.TRTC BIREFRINGENCE EXPERIMENTS.
IV 2 1 Introduction,
The electric birefringence data acquisition , processing and analysis has been
described insection II 5 . The original data as recorded by the oscilloscope and the
representations of the decay of the birefringence as a function of time are presented in Fig
IV 1 to IV 4 below.
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IV 2 2 Samples.
The fibronectin samples were prepared as described in chapter III. In order to
quickly reach the high concentration required for this study reverse dialysis against
high molecular weight Polyethylene glycol was performed . This allowed the
concentration to be raised quickly up to 11 mg /ml in 150 mM ionic strengthbuffer. The
reverse dialysis is preferred to the use of ultrafiltration . The contact of the protein with
the ultrafiltration membrane has been shown to lead to some denaturation effects on
some proteins . It has been shown , for instance, that the sign of the electric birefringence
induced in an F1 ATPase solution was reversed , therefore indicating an important
modification in the protein structure, when the protein solution had been concentrated
in an ultrafiltration cell , ( from a personal communication of B. Roux 1988). The
requirement to high protein concentrations is always a concern but this permitted the
electric birefringence measurements to be performed in physiological ionic strength
conditions.
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Electric birefringence measurement: Raw data.
[ Fn ] 11 mg/ml Buffer lOOmM NaCl ,50mM Tris pH 7.4
Fig IV 2:
Electric birefringence measurement: Raw data.




[ Fn ] 11 mg/ml Buffer lOOmM NaCl ,50mM Tris pH 7.4.





[ Fn ] 5.5mg/ml Buffer 50mM NaCl, 25 mM Tris pH 7.4
representation of Ln Dn (t)/ Dn (eq) as a function of time
time,p. sec
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IV 2 4 Analysis of the decay of the birefringence.
Table IV 1 :Results from electric birefringence measurements: Relaxation times x .
Buffer [Frilmg/ml Field kV/c;m % of signal. I^US. % of signal
lOOmM NaQ 11 10 0.8 100
50mM Tris pH 7.4
50mM Na CI 5.5 10 1.2 94 0.2 6
25mM Tris pH 7.4
With the restrictions mentioned in paragraph II 5 above, equation II 5 8 can be
applied and allows deduction of the rotational diffusion coefficient ( 9) from the
measured relaxation time (x) from the relation :
e = (6t)-1-
Table IV 2 : Correspondence between the relaxation tine x and the rotational diffusion
coefficient 9 , ( assuming the relation 9 = 1/ 6 x ).
x ( p.sec.) 0.2 0.8 1.2
9 (103 sec"1.) 833 208 139
IV 2 5 Remarks on the electric birefringence data.
In order to achieve a correct signal to noise ratio, both fibronectin concentrations
and the electric field had to be much higher than generally required for similar
studies of proteins of the same size (Roux 1988 ). This could be explained if the sum of
the field induced and permanent electricmomentum of fibronectin was clearly smaller
than the average for proteins . This hypothesis might be backed up by the extremely
asymmetrical profile of the birefringence recording showing that disorientation is much
faster than orientation. This could be explained if the fibronectin molecule , which is
made of two nearly similar chains , was symmetric and will be an important point in
section IV10 2&3 below.
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IV 3 LIGHT SCATTERING EXPERIMENTS ON THE COMPLETE MOT.FGI JI.F
The determination of the translational diffusion coefficient of fibronectin by
dynamic light scattering was first reported by Williams et al. in 1982.
In this work, with better equipment, those results were confirmed as a part of the
controls for experiments described in chapter V and VI below. The diffusion coefficient
of bovine plasma fibronectin at 40 degree angle as being 233 (+- 0.014 ) 10"7 c.g.s in 50 mM
Tris-HCl, 100 mM NaCl 1 mM E.D.T.A., pH 7.4 at 25 0 C For human plasma , in the
same conditions, the mean value was 2.2c.g.s. This value seemed not to depend of the
angle ofmeasurement as expected for a particle that is at least 25 times smaller than the
wavelength.
IV 4 SMALL ANGLE NEUTRON SCATTERING OFWHOLE FTBRONECTIN.
IV 4 1 Irifrpdugtipn,
Neutron scatteringmeasurements were performed at Station "D 11 " at the I.LL
(Grenoble France ) in June 87 for the work on the complete molecule and March 88 for the
domains. Unfortunately similar experiments on the complete molecule appeared in the
literature immediately after our own experiments. (Sjoberg et al. 1987). The technique
has been described in section II 3 above.
It has been possible to perform some measurements allowing only a few percent
error on the line fitting for the Guinier representations with a relatively low protein
concentration of approximately 1.5 mg/ml. Neutron scattering studies requires lower
concentrations than X-Ray scattering studies (the fibronectin concentrations were in the
order of 1 to 2mg/ml) therefore , not only the chances ofmultiple scattering are reduced
but the sample preparation and handling techniques are better:
A ) It has been possible to obtain the samples without further concentration of the
samples. This allowed avoiding the use of ultrafiltration devices which migth
lead to the denaturation of the protein due to the interaction of the protein and the
ultrafiltration membrane.
B ) Because of the low protein concentration , aggregation which is always a possible
consequence of working with high concentrations were reduced.
C ) An important condition to guarantee the validity of those measurements is that
samples for neutron small angle scattering experiments are enclosed in quartz cells.
As opposed to this , in X-Ray small angle scattering experiments the samples are
generally in capillaries (i.e. Sjoberg et al. 1987) or special cells . The handling of
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the sensitive fibronectin solution in quartz cells is much more gentle, and corresponds
to conditions where it could be checked by light scattering that no aggregation or
polymerisation occured.
Pavlov and Feodorov (1986) showed that the scattering curves for neutron
scattering of protein solutions ( as apposed to nucleic-acid solutions ), in D2O buffers do
not significantly differ from those obtained with X-Ray scattering inh^O buffers.
Therefore the data obtained in D2O buffers can be considered as fully valid for the
construction of models of the fibronectin molecule. This is confirmed by the small
differences shown between the measure of the radius of gyration in D2O and H2O in this
work . Those minor differences can probably be explained by the better signal /noise
ratio in D2O rather by a real change in the conformation of the molecule.
IV 4 2 Samples.
The samples for neutron small angle scattering were prepared by immobilized
gelatin followed by immobilized heparin affinity chromatography as described in
chapter III. The samples were checked by PAGE and photon correlation .The samples
were studied in light water buffer by dynamic light scattering :
n
The diffusion coefficient measured at 90 degrees and 25 "C was: 12710 cgs .
The polydispersity index, as defined in II1 7 above , was only 6 % .
The "in range " index, as defined in II1 6 above , was 99.5 %.
All those figures are a good indication that those samples were monodisperse and
free of aggregation in the conditions used for neutron small angle scattering experiments.
The fibronectin sample was also checked by 5 % acrylamide concentration
S.D.S.P.AG.E. A scan of this gel is shown in fig IV 5 below. The amount of
contamination by degradation fragments made of only one chain was found, as
determined by the ratio of their respective peaks areas in the gel,to be less than 10 % of
the total sample mass.
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Fig IV 5
Scan of S.D.S.P.A.G.E.: 10 |ig Fibronectin sample for neutron small angle scattering.
Absorbance
500 k D 250 k D Mw (k D )
IV 4 3 Results.
Data collection and analysis has been described in section II 3 above. They are
presented in Table IV 3 and Fig IV 6 to IV 8 below.All measurements were performed in
at 25 °C in 50 mM Tris, 100 mM NaCl, 1 mM EDTA pH 7.4 ,PMSF 50 pM.
Table IV 3 : Determination of the radius of gyration of fibronectin from neutron small
angle scattering experiments
Solvent. Q.Rg min. Q.Rg max Rg (i A ) Error % Mw k D.
h2o 0.5 1.95 71 0 2.3 505 kD
H2° 0.53 1.71 75 3 520 kD
d2° 0.5 1.65 73 0.9 510kD
d2o 0.5 1.40 74 1.4 505 kD
d2o 0.5 1.91 70 0.7 525 kD
It can be shown from those results that an average value of 73 A is a
approximation to Rg . The experimental molecular weight determined by the
techniques described above in section II 3 5 to 8 (The concentrations were determined by
the measure of the optical density at 280 nm using an extinction coefficient of 12.8 ), is
in good agreement with the theoretical value of approximately 500 k D obtained form
the composition of this molecule.
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Fig IV 6:









































IV 5 RESULTS FROM ENZYMATIC. LIMITED DIGESTION
Limited proteolysis is a cheap and easy to perform technique that allows
investigation of the tertiary structure of proteins. It has been extremely important for
fibronectin as shown in chapter I.
The structure of fibronectin as a concatenation of protease resistant domains
linked by protease sensitive segments is well known . The sequences that could
theoretically be cut are regularly distributed in the primary structure.Therefore , the
resistance to proteolysis of some large parts of the molecule as well as the high
sensitivity of some fragments! which remain more or less the same whatever enzyme is
used ) ,are a good indication of the existence in the fibronectin molecule of a succession of
compact domains connected bymore extended segments.
It must be noticed that this point does not rule out the possible existence of a
compact structure for the complete fibronectin : the domains might well be strongly
associated together creating a compact structure with the connecting segments away from
their surface as shown in diagrams below.
AlCompgct. rigid strqcthre;
Free access for the proteolytic enzyme.
V
Extended segment Compact domains.
B ) Extended . floppy structure:
Compact domain Extended segment Compact domain
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The published procedures include digestion conditions performed at non
physiological ionic strength or pH. ( i.e. : Thermolysin : Seikiguchi et all986 : 50 mM
Tris pH 7.6 ;). As apparently , there were no attempts to repeat a limited digest
experiment in physiological conditions, it seemed important to confirm that the
multi-domain model was still valid in a buffer of ionic strength of approximately 150
mM and pH 7.4
Limited digestion with thermolysin has been performed at 25° C in 50 mM
Tris,100 mM NaCl , 0.5 mM EDTA,2.5 mM CaC^ ■ pH 7.4, stopped after 1, 10, 30 or 60
minutes by addition of E.D.T.A up to 10 mM, and analysed by a 5-15 % gradient
S.D.S.P.A.G.E gel which is shown in fig IV 9 below.
Fig IV 9 :
S.D.S. PAGE , Reducing conditions,
of thermolysin digestion in physiological ionic strength:
l! 2 3 4 5 6
Lane 1 : Molecular weight standards 14,19.6, 30 ,44 ,69, 96 k D.
Lane 2:1 minute thermolysin digest.
Lane 3:10 minutes thermolysin digest.
Lane 4 : 30 minutes thermolysin digest.
Lane 5 : 60 minutes thermolysin digest.
Lane 6: control, undigested fibronectin.
After 60 minutes limited thermolysin digestion in 100 mM NaCl, 50 mM Tris ,2
mMCaCl2 ,05 mM EDTA (lane 5), fibronectin fragments were at positions corresponding
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to Mr of : 160 ,140 , 130 ,110 , 63 , 44 , 30, 27 k D . This is very similar to the pattern
reported in the literature in in 50 mM Tris pH 7.6 ( Seikiguchi et al. 1983 ), and our own
data obtained in 50mM Tris,25 mM NaCl pH 7.4.
IV 6 RESULTS FROM LIGHT SCATTERING ON PURIFTED 145-155 K D CENTRA!.
.HEPARIN AND CELT. BINDING DOMAIN.
Although the 145-155 k D thermolysin fragment represents a large portion of the
molecule ,because of problems in its preparation (it is not easy to generate this fragment
with high yields because it is easily cleaved ) . Gel filtration on sepahacryl S 200 of a
purified 145-155k D central heparin-cell binding domain showed that this domain was
excluded from S200 media which has an exclusion limit of 200 kD for spherical proteins.
This was the first indication of the fact that the shape of this fragment was non
spherical. Unfortunately the attempts to determine the radius of gyration of the
145-155k D central heparin-cell binding domain both by small angle neutron at the I.LL
and X-ray scattering at the Daresbury laboratories were failures because of a too weak
signal/noise ratio.
The diffusion coefficient has a value of 3.1 10 (+- 0.8 10"^) cmVl for this
fragment. The in range index, as defined in III 6 , was approximately 98 % . This
showed that only a small contribution to the signal was due to particles out of the
measuring range defined by the fundamental time. The fundamental time was set to scan
a range of particles sizes corresponding to Stokes radius of 2 to 200 nm . The Stokes
radius of this domain is can be calculated from the classic relation between the Stokes
radius and the diffusion coefficient. Its value is 7.8 nm ( assuming a viscosity of 0.009
c.g.s.), as the Stokes radius of a spherical particle of Mr 150 k D should be only 4 nm
approximately , we can conclude that this domain has a fairly extended structure .
TV 7 ESTIMATION OF THE ST7F AND SHAPE OF THE GOTTAGEN RINDING
DOMAIN,
IV 7 1 Introduction.
Gel filtration on sepahacryl S 200 of a 44k collagen binding domain preparation
allowed a rough estimation of its shape. The determination of Kav (As described by
Porath et al. 1959) was compatible with a globular shape when compared with a
standard calibration curve from the gel manufacturer.
The determination of the diffusion coefficient of the gelatin binding domain by
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light scattering techniques was impossible because of noticeable self aggregation
property . Fig IV 10 shows the scattering intensity as a function of the diffusion
coefficient. It clearly shows that most of the scattering intensity is due to aggregates
with a very low diffusion coefficient. Because the signal corresponding to isolated 44 kD
7 9 1
particles (i.e. with a diffusion coefficient around 410 cm s is too weak , deduction of
the diffusion coefficient of the 44kD gelatin binding domain from this data is
impossible. Results from the work of Homandberg et al ( 1986 ) confirmed that a weak
self interaction is observed for this domain .
Fig. IV 10:
Scattering intensity as a function of the diffusion coefficient,
44 kD Gelatin binding domain.
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IV 7 2 Small angle neutron scattering results.
The reasons for being able to limit the problems created by aggregation in
neutron small angle scattering studies were discussed chapter II section 2.
Fig. IV 11 below shows the Guinier representation of small angle neutron scattering
profile from the 44KD gelatin binding domain of fibronectin .
Fig. IV 11:
Guinier plot of scattering intensity for 44k collagen binding domain.
0**2 I0-3
The radius of gyration with a Guinier range of 0.7 to 1.47 for the product Rg.Q was
approximately 2 nm . Aggregation is still present but the approximation shown on the fig
ure IV 11 above seems realistic because the molecular weight determined by
calculations from the extrapolated intensity at zero angle as determined in chapter II, is
approximately 49 k D . This is compatible with the value determined by S.D.S.P.A.G.E
for this domain of 44k D.
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IV Z 2 Hvdrodynamic interpretation.
Because of the presence of aggregation in the solution , the determination of the
radius of gyration of the 44 k d gelatin binding domain is not very accurate. The
measured Rg is approximately 2 nm. The radius R, of a spherical protein of 44 k D Mr
,with 30 % hydration» approximately2.6 nm . The corresponding Rg is (3/5)"^^ R
that is : 2 nm . It is reasonable therefore to conclude that this domain is roughly
spherical.
IV 8 GENERAL REMARKS ABOUT A MODEL CONSTRUCTION.
IV 8 1 Introduction.
A realistic model of fibronectin in solution must try to integrate not only results
from this work but also results from the literature . It must be pointed out that some
authors do not follow this rule and seem to ignore all results which do not fit with their
models (i.e.: From the interaction between the N terminal part of the two chains Wolff
et al. 1988 describe fibronectin as spherical ignoring all previous hydrodynamic work .
Roco et al. 1983,1987 build string like models, made of very small size bead type subunits,
ignoring the limited enzyme digestion and denaturation results clearly indicating the
presence of large ordered domains).
Because of the multidomain multifunctional structure of fibronectin the models
can be defined for convenience at three different levels:
A) The hydrodynamic model. In this model the shape of the molecule is restricted to an
ellipsoid of revolution. The dimensions of the ellipsoid are estimated by
calculations from the measure of hydrodynamic parameters. This model does not
describe the shape of the molecule with high accuracy. Because ellipsoids of
revolution are amongst the few structures whose hydrodynamic properties can be
described by exact formulae ( Perrin 1934 ), the model accuracy is theroretically
limited only by the accuracy of the measure of hydrodynamic parameters and does
not requires any other data.
B ) The next degree of resolution are models that can define not only the general shape
of the molecule but also the relative position of the two chains. At this level, no
attempts can be made to define the size and precise position of the various
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domains. Those models will integrate hydrodynamic determinations of previous
section as well as results from fluorescence or even enzymatic limited digestion
studies performed on the complete fibronectin molecule. Often no perturbation (i.e.
labelling), is required. This allows study of the molecule in the state closest to
native . Thus the low resolution models bring a limited amount of information but
are not subject to errors induced by fragmentation (i.e. a possible rearrangement of
the domains after fragmentation ).
C) In the case of a multi domain molecule such as fibronectin, a higher resolution model
can also be proposed because spectroscopic evidence shows that fibronectin domains
retain their conformation even after isolation from the native molecule:
a ) The circular dichroism spectrum of the intact fibronectin molecule can be derived
from the combination of the spectra of the various domains (i.e
Odermatt et al. 1982 ).
P ) Works by Ingham et al 1984 and Franchesi et al 1985 show that thermal
denaturation properties,(as well as ,again, circular dichroism spectra ), are not
affected by a change in pH or by ligand addition. As the diffusion coefficient is
affected by a pH change ( Williams 1982 ) it is possible to conclude that
fibronectin is made of independent domains. A possible three domain structure
(Wallace et al. 1981) has been proposed from thermographic studies,
y) By expression in E.Coli of fragments of fibronectin of various sizes ( Obara et al.
1987),it has been shown that a 70 kD fragment containing the cell attachment
peptide RGDS has the same cell attachement efficiency as the complete
fibronectin molecule. This also is an indication that this molecule is made of
independent domains,( providing the cell attachement assay technique does not
result in a destruction of the tertiary structure of the fibronectin molecule).
Those facts , showing with a reasonable confidence that the structure of the
domains is not altered by their isolation from the intact molecule , allow the
proposal of models derived from informations on the intact molecule as well as from
the purified domains.
TV 8 2 The problem of modelling non rigid structures by hvdrodynamic techniques.
A number of recent advances in hydrodynamic studies are due to De La Torre and
his co workers ( see De La Torre et al 1977 a,b,c; De La Torre et al 1978 ,Bemal et al
1980,1981,). Those authors used spheres of various volumes and arrangements for the
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modelling of large macromolecules in solutions. All those studies refer to models where
the spheres are disposed in rigid associations. In a more recent work ( De La Torre et al.
1985), the case of two spheres connected by a flexible link has been studied. From this
work it can be concluded that the modelling, from hydrodynamic data, of a molecule
made ofmany subunits connected by flexible connections is not yet possible.
Some electron microscopic studies ( Engel et al.1981, Odermatt et al. 1982 ,
Erickson et al. 1981), seem to support the flexible model but as pointed out before those
pictures are definitely not compatible with the hydrodynamic behaviour of the
fibronectin molecule.
Fortunately there is little evidence that the fibronectin structure in solution is
non rigid. Some electron-spin-resonance data (Lai et al. 1984 & 1983 ,claim non rigidity
but those results are not satisfactory because of possible non rigid label-protein
association as discussed in chapter VI below. More serious is the data from fluorescence
polarization of Wiliams et al (1982 ) showing some flexibility of the N terminus end of
fibronectin labeled with fluorescein. The label is attached near to the N-terminal part
of the protein (position n° 3). Once again it is difficult to assume that the motion of the
label is due to large flexible domain of the protein rather than to motions restricted to
the molecule's N-terminal section. As discussed above in section 5 of this chapter ,the
existence of structurally independent domains is not at all compatible with a compact
structure . The work of Homandberg, (1986), even showed that non covalent interactions
occur between the various domains of fibronectin.
In conclusion although one cannot be fully positive about the existence of the
fibronectin molecule in solution as a rigid structure, this hypothesis can be made with a
reasonable degree of confidence.
IV 9 An hydrodynamic ellipsoid model for the fibronectin molecule in solution.
IV 9 1 Introduction.
The basic idea of this model is to determine the type and the semi-axis a & b of
an ellipsoid of revolution having the same hydrodynamic properties as the molecule .
Two types of ellipsoids can be defined : prolate or oblate , see Fig. IV 12 . They are
respectively called "ellipsoide allonge" or "ellipsoide aplati" in the work of Perrin
(1934 ) , which is the reference for all the hydrodynamic work with ellipsoid models
because it presents the relations between a and b and the diffusion coefficients .
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Fig. IV 12 :
Ellipsoids of revolution.
Prolate ellipsoid : a > b .
Oblate ellipsoid : a < b .
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Various techniques allow the estimation of a and b :
A ) The classical way is based on the fact that the following hydrodynamic
parameters are a function of a and b:
The radius of gyration : Rg.
The translational diffusion coefficient Dt
The rotational diffusion coefficient 0 .
a and b can be deduced from the comparison between the experimental
measurement of one of those parameters and its estimation calculated from the
volume of a spherical protein with the same degree of hydratation . Obviously the
results will be much influenced by the degree of hydration which is arbitrarily
chosen.The viscosity of the solvent must be known accurately and that is
generally not true. Furthermore the measure of 9 or Dt is based on a generally
complex interpretation of the measured experimental parameters which also can be
a source of errors.
B ) An alternative method is to measure the neutron or X-ray scattering intensity profile
of a solution of the molecule over a large range of scattering angle Q . The
fitting between the experimental curve and theoretical curves obtained with
ellipsoids with various sizes and shapes ( i.e. different a & b ) is then examined.
This allows a choice of the model corresponding to the best fit between the
experimentally determined curve and these obtained theoretically from a
hydrodynamic model. This technique was applied to fibronectin by
Sjoberg et al. 1987. The major problems associated with it are:
a ) That, as pointed out by Guinier (1955 ), two very different objects can have very
similar scattering curves.
(3 ) The optical parameters of the X ray or Neutron scattering camera , for
technical reasons (i.e. finite size of the beam , plane detector ), are far from being
perfect and can lead to serious distortions in the scattering profile curve. (This can
be shown by the differences between the radius of gyration of the
fibronectin molecule in published data and in the results from this
work . Those optical defects requires processing the data through desmearing and
deconvolution steps to try to minimise the effects of those problems.
C) It is also theoretically possible to calculate the ellipsoid dimensions : a and b , if at
least two of Dt, Rg or 8 are known . This last method of determination is not
frequently used by experimentors.. From the measure of the rotational diffusion
coefficient 0, and the translational diffusion coefficient Dt respectively by electric
birefringence and photon correlation experiments ( See for example Bernengo et al.
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1981 ) a and b were determined in various molecules. The problem in those
determinations are:
a ) That the rotational diffusion coefficient^. is often obtained from electric
birefringence experiments .Although 0 is a very sensitive function of the a and b,
the theory relating 0 to the decay of the birefringence is not always
satisfactory . This can cause serious errors in the calculation of 0
from electric birefringence experiments as discussed in paragraph II 8 .
Fortunately if 0 is not easy to determine . Decay rates for various ellipsoids
models have been related to the theoretical decays of a spherical molecule of the
same molecular weight. (See Tao 1969 and paragraph II 5 6 ).
(3 ) That for certain extensions p can vary substancially without creating much
change in the relations between the hydrodynamic parameters.
Technique B .despite the recording of a full scattering curve ( Fig IV 8 ) could ,
unfortunately, not been applied here .
IV 9 2 Determination of the type of ellipsoid by interpretation of the results from
the electric birefringence measurements .
The theoretical background for the electric birefringence measurements and
analysis was described in chapter II, paragraph 5 .6 above . The interpretation of the
results was developed by Tao in 1969 from the decay of fluorescence polarization but
expanded later to birefringence by Wengener et al.( 1979 ). We shall see how the type of
decay of the birefringence ( multi or single exponential), as well as the relaxation times
can yield information on the molecular structure. The principle is to compare the
observed birefringence relaxation time , xpn / to the relaxation time , x^, of a spherical
protein of the same molecular weight.
The ratio of the relaxation times xn for various ellipsoid shapes to the
relaxation time x^ of a sphere of same mass has been calculated ( Tao 1969 ) and
represented in Fig IV 13 & 14 below. From the curves of Fig IV 13 & 14 , it can be
immediately deduced , for any value of the relaxation time of an equivalent sphere,
that the prolate ellipsoid model of fibronectin has multi-eponential birefringence
decay curve and that for an oblate ellipsoid a single-exponential decay is a very good
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approximation .As pointed out above in IV 2, fibronectin in 150 mM ionic strength buffer
shows a birefringence decay that can be described by a single exponential decay of field
induced birefrinegence. The first conclusion of this measurement is that , if fibronectin is
a structure with an extension p, of less than 0.2 or more than 5 approximately ,the
ellipsoid model for fibronectin should be an oblate type.
The fact that the signal , obtained at high field , can be described by a single
exponential decay is also a proof that no molecular flexibilty can be detected by this
technique.
IV 9 3 Determination of the dimensions of the ellipsoid by the use of the
birefringence relaxation time and the radius of gyration .
As the molecular weight of fibronectin is known , it is possible to calculate the
extension of the ellipsoid model if some hypothesis is made on the degree of
hydratation of the molecule . This is shown below:
It is possible to calculate the theoretical relaxation time , of a spherical
protein of molecular weight Mr with a percentage of hydratation 8 ( g water/ g dry
protein ), from equations IV 1 to 5 below . For a sphere the birefringence relaxation
time is related to the rotational diffusion coefficient 0 , by:
xd = i/6 e-^iv i).
For a sphere of radius r , with T| as the solvent viscosity, 0 is given by:
0 = kT ( 8II T) r3)"1 (IV 2 ).
The relation between the radius ,r , of a protein and its molecular weight Mr ,partial
specific volume vo and degree of 1 hydration S 7 is :
r3 = 3/4HMr (vo + 8) / iV (IV3).
By combining IV 1, IV 2 and IV 3 :
Td(nsec) =109Ti(iVkT )" 1 Mr (vo + 5) (IV 4).
With: TJ = 0.009 c.g.s. and k T = 41.110"^3 c.g.s. at 25 « q
xd(nsec) =36410-6Mr(vo + 5)(IV5).
The theoretical relaxation time, xj t of a spherical protein of Mr equals to 500 k D ,
as fibronectin and the ratio of the observed relaxation time to the calculated one are
_
represented below in Table IV 4 for various degrees of hydration .
1 1 1
Table IV 4 : Determination of the ratio of the observed relaxation times, x 0bs,to the
theoretical ones ,x^ .








From the curve of Fig IV 14 the corespondence can be found between x0bs / x^
and p the ellipsoid extension. If we add some information like the measured Rg , the
dimensions can then be estimated. This allows calculation of the model volume . The
ratio of this calculated volume to the dry volume should correspond to the degree of
hydratation chosen as hypothesis. This is shown in table IV 5 below .
Table IV 5 : Calculation of the volume of an ellipsoid model and its degree of
hydratation from the measure of Rg and xpn.
xpn/^d P Rg 8 a b vol0
8 of model (:%).
6.1 13.5 7.3 0 0.85 11.5 470 <0
5.7 13 7.3 5 0.88 11.5 490 <0
5.4 11.5 7.3 10 1 11.5 554 <0
4.8 10.5 7.3 20 1.1 11.5 610 <0
4.3 9.5 7.3 30 1.21 11.5 670 5
3.9 8.5 7.3 40 1.35 11.5 750 20
3.6 7.5 7.3 50 1.53 11.2 850 35
4.8 10.5 8.9 20 1.34 14 1100 75
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Fig IV 13:
. -V'-r " V-":-* .. •
Ratio of the relaxation times of a prolate ellipsoid to a sphere of the samemass as





Ratio of the relaxation times of an oblate ellipsoid to a'«phere)f same mass as a function
of p (From Tao 1969).
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The degree of hydratation , 8 chosen as a hypothesis to calculate the ellipsoid
extension , p , is compared to the degree calculated from the ratio of the volume of the
model to the dry volume of the protein . The model dimensions are obtained by the
combination of the estimated extension and measured radius of gyration . The comparison
between those degrees of hydratation shows that it is clear that the method of
calculation is not applicable to those meassurements .
The conclusion of this section is , that although the birefringence data fit well with
a prolate ellipsoid with an extension of about ten , it seems difficult to find an ellipsoid
with an extension precisely fitting with the birefringence data and any observed radius
of gyration ( either from this work or as published values of Sjoberg et al. 1987 ) . This
problem will be discussed in IV 9 6 below
IV 9 4 Estimation of the dimensions of the ellipsoid by combination of the measured
rotational diffusion coefficient 6 and translational diffusion coefficient Dt
It is also possible to apply the analysis of Bernengo et al. 1981 which combines
the rotational diffusion coefficient 0, measured by electric birefringence and the
translational diffusion coefficient Dt to work out the dimensions of the ellipsoid . This
method has been described by Daune et al 1961. The translational diffusion coefficient
Dt is related to the dimensions of the equivalent ellipsoid by the relation :
Dt = ( k T t(p))/(6n rj ap2/3) (IV6 ).
The rotational diffusion coefficient is related to the dimensions by the relation :
0 = r (p) kT/ ( 8 Jtri a3p 2) (IV 7)
Where t (p ) and r (p) are two functions of p.From those two relations it can be shown
that :
(D3/0 )(27nri2/k2T2) = t3(p)r-1 (p) (IV8)
Table IV 6 , below presents the calculations of 27 n t|2/ k2T2 for various
experimental and theoretical values of Dj and 0 .
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Table IV 6










The work from Bernengo shows that the value of (D3 / 0 ) (27 IT T)2/ k2T2)
should be , for oblate ellipsoids , in the range of 1 to 1.5 approximately . In the
measurements presented over in Table IV 6, for various values of D, (D3 / 0) (27II t\2/
k^2) is significantly less than 1 .
To achieve a value of 1.5 for this product ( compatible with an oblate ellipsoid with
p equals to 10 ) either the diffusion coefficient should be 25 % higher than the measured
one or the relaxation time should be 88 % more than the observed one . It is unlikely
that experimental errors are of this size . We conclude that this is instead due to the fact
that a modelling of the shape of the molecule as an ellipsoid is not possible with this
technique . This once again will be discussed below in IV 9 6 .
IV 9 5 Principle of the determination of the dimensions of an ellipsoid from
the measure of its radius of gyration and diffusion coefficient.
As the hydrodynamic interpretation of the birefringence experiments is not easy ,
an estimation of the model parameters will now be attempted from the relations
between the radius of gyration Rg and the translational diffusion coefficient Dt . The
relations between a and b , and Dt, ( Perrin 1934) are different for prolate and oblate
ellipsoids . Those two types will be considered separately in paragraphs A and B below.
A) For a prolate ellipsoid ( a > b ) , if p is the ratio b/a, the radius of gyration (Rg ) and
the translational diffusion coefficient ( Dt ), can be both expressed as a function of a
and b.
Rg = a [ (1+ 2p2 )/5 ] *1/2 (IV 9 ).
Dt = ( k T t(p)) / (611 T| ap2/3) (IV 10 ).
Where : k is Boltzmann's constant, T the temperature ( Kelvins ) , T|: The solvent
viscosity (Poises ), t ( p ) is a function depending on the type of ellipsoid : Prolate or
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oblate . t ( p ) is expressed as follow for a prolate ellipsoid ( a > b ):
t (p) = p 2^3 (1- p2)_1 Ln [ {1+ (1- p 2 )1//2} p_1 ] (IV 11 )
From equations IV 101 & 2 we get:
a = Rg [ (1 + 2 p2 )/ 5 ]+1/2 (IV 12).
Dt.Rg 6n ti(kT)-1= [(l+2p2 )/5]1/2 t'x ( p) (IV 13).
Where t'-j^(p) is afunction of p which is fully developed in equation IV 14 below:
fx (p) = (l-p2)4Ln[ {l+(l-p2)1/2}p-1](IV14)
So from the calculation of Dt. Rg 6II q ( k T )_1 a value for the function of p :
[ (2 + p2 )/ 5 ] "*/2 t' }(p ), is found and p can be determined. This relation is plotted
in fig IV 16 . Once p is known , a is calculated from IV 12 and b is by definition the
product of p times a .From the examination of Fig IV15 it is obvious that for a prolate
ellipsoid , the determination is accurate only if p is less than say 0.2 , ( i.e. if a is at
least five times bigger than b ).
B ) Oblate
From paragraph A over :
a = Rg [ (1 + 2 p2 )/ 5 ]+1/2 (IV 12).
Dt, Rg 6 n p ( k T )_1 = [ (1 +2 p2 )/ 5 ]1/2 t(p) (IV 13 ).
Where : k is Boltzmann's constant.
T is the temperature ( 0 Kelvin ).
Tj is the solvent viscosity. ( Poises )
t ( p ) is a function depending on the type of ellipsoid : Prolate or oblate . t ( p ) is
expressed as follow for an oblate ellipsoid (b > a ):
t (p ) = p 2//3 (p2 -1)_1 Arc Tg [ (p 2 -1 J1/2 ] (IV 15 )
From equations IV12 & 13 we get:
Dt.Rg 6H p(KT)_1= [(l+2p2 )/5]1/2 t'2 ( p ) (IV 16 ).
where t '2 ( p) is developed in equation IV 17 below.
t'2 (p ) = (p2-l) 4 Arc Tg [ ( p 2-l )t/2 ] (IV17).
So from the calculation of Dt. Rg 6 IT p ( k T )-1 a value for the function of p:
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[ (2 + )/ 5 ] t 'o (p), is found and p can be determined. This relation is plotted
in fig IV 17. Once p is known : a is calculated from eq. IV 12 and b is by definition the
product of p by a .From the examination of Fig IV 16 , it is obvious that for a prolate
ellipsoid , the determination is accurate only if p is less than say 2 .
The two major problems with this determination from Rg and Dt only , are that
the accuracy of the determination is poor for oblate elipsiods and , as pointed out in
paragraph IV 9 1 , the determination of the radius of gyration by the Guinier
approximation is a source of errors . This determination is dependent on the range of Q
chosen for the approximation , thus Rg cannot be measured with an extremely high
accuracy . From results from IV 4 it is shown that the determination of Dt is more
consistent but subject to errors in the determination of the viscosity, so it can be seen that
most of the error in the experimental parameters is due to the determination of Rg.
This can be applied to the fibronectin molecule. The determination of the radius
of gyration, Rg, depends on the range of Q chosen for the Guinier approximation and it is
difficult to fix an exact value for the radius of gyration. Results from IV 4 were in a
range from 7 to 7.5 ran with a possible average of 7.3 nm. The diffusion coefficient, Dt,
n
shown little variation and can be estimated at 2.25 to 2.35 10 cgs.
Table IV 7 below shows the value for Dt. Rg 6 n T| (k T corresponding to
Rg and Dt. (rj = 0.009 c.g.s ,T = 25 0C,kT = 41.1 10"^ c.g.s.).
Table IV 7.







Dt. Rg 6 n q ( k T )-* can vary ,depending on the estimations of Dt and Rg
between 0.650 and 0.725 c.g.s. From examination of Fig IV 15 and IV 16, it can again be
concluded that the ellipsoid model for fibronectin must be an oblate ellipsoid if the
deviation from spherical shape is marked . Unfortunately the resolution is not high
enough in the measurement of Rg and Dt to allow any precise values for p to be deduced
from this data. It is then clear that the determination of the parameters of an oblate
ellipsoid for fibronectin cannot be determined from the measure of Rg and Dt alone .
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Fig IV 15:
Representation of: Dt. Rg 6 n 1)(kT )~^ = [ (1 + 2p^ )/ 5 ]*/^t (p ),




Representation of: Dt. Rg 6 II t| ( k T )~* = [ (1 + 2 )/ 5]'^^ p t ( p )
, for a oblate ellipsoid.
Dr. Rg. 6 IT r)/KT
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IV 9 7 Final remarks about the ellipsoid model.
Hydrodynamic parameters obtained from different techniques ( using the same
buffer at the same temperature ) have been compared in sections IV 9 3 ,to 5 above . This
shows that it is impossible to find an ellipsoid that shows exactly a radius of gyration
n
of 7.3 nm , a translational diffusion coefficient of 2.2 10 c.g.s., a rotational diffusion
coefficient of 208 10^ s'^and would still have a proper molecular weight and a
reasonable volume and hydratation degree. The work from Sjoberg et al. ( 1987 ) is not
exempt from those flaws . The degree of hydratation is extremely high ( 60 % ) , the
fitting with the measured diffusion coefficient is not very good ^specially considering
the fact they use a high value for the viscosity of 10 c.g.s.
Several experimental factors might cause this problem . They have been
described in sections corresponding to each technique . The main concerns are
summarized below:
A )For Dt and 0 : there is no precise knowledge of the viscosity. Both are obtained after a
complex interpretation of the raw signal.
B ) For Rg the validity of Guinier approximation depends on the shape of the particle .
The choice of the Q range for the Guinier approximation interferes with the result
(see table IV 3 over ).
The most likely explanation is that a rigid homogeneous ellipsoid does not
represent a good approximation of the shape of the fibronectin molecule . The problem
created by the possible flexibility has already been described in section IV 9 3 . But one
of the conclusions of the electric birefringene study described in section IV 9 2, was that
no internal flexibility could be detected at physiological ionic strength .
Furthermore the observed diffusion coefficient is too low to match the other
parameters . If internal flexibilty was perturbating the photon correlation signal this
would show the molecule diffusion coefficient as too fast .We can then assume that the
fact that the observed data do not match the ellipsoid model is not due to perturbations
created by molecular flexibility.
The most likely hypothesis is that an ellipsoid cannot model the fibronectin
shape satisfactorily . However with an entirely different analysis and also the help of
different techniques a conclusion similar to that of Sjoberg et al can be drawn , that is
that the fibronectin molecule can be represented as a flat structure approximately
enclosed in an oblate 10 nm diameter and approximately 1/10 extension.
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IV 10 Possible models of plasma fibronectin .
IV 10 1 The problem of electron micrograph studies.
An alternative technique to the investigations in solution is to try to "see" the
shape of the molecule by electron microscopy. We shall see now why this does not work
with fibronectin .
First, the electron micrographs obtained by various teams , reviewed in I 7 1,
show little agreement between themselves . Some teams show patch type images while
others show images that look like a more or less bent- hair pin . Those are the only
electron micrograph pictures showing fibronectin as an ordered structure (Engel et al.
1981,Odermatt et al. 1982 ,Erickson et al. 1981). They are absolutely incompatible with
any hydrodynamic data in physiological conditions. The very extended structure they
show does not fit at all with measured diffusion coefficient or radius of gyration. Other
studies show only very low resolution images (Kotelianski et al 1981,Tooney et al. 1983)
which are often irregular and cannot be of any help in modelling the structure.
Classic electron microscopy techniques do not seem appropriate to the study of the
three-dimensional properties of fragile soluble macromolecules such as fibronectin. The
treatment of the sample might create artefacts in steps such as adsorption on a grid ,
staining and dehydratation where the molecule is submitted to conditions which can
cause denaturation . Thus the pictures obtained might be far from representing the
structure in solution. Considering the large differences between hydodynamic data and
electron micrographs we can assume that the preparation of fibronectin for electron
microscopy results in a deformation of the three-dimensional structure of fibronectin.
The only way to overcome those denaturation problems would be the use of the
frozen hydrated technique:.The frozen hydrated electron microscopy technique study
specimens extremely quickly frozen in amorphous ice, therefore the samples remain in a
native ,wet stateffor a review of this technique see Stewart et al. 1986). The samples are
not undergoing any treatment likely to denature them, like staining and adsobpsion on a
grid, but are simply frozen in vitreous ice. Providing the contrast between ice and the
sample is large enougth to allow the visualisation of the sample, this clearly is the
electron microscopy technique which can most reliably be applied to fragile biological
structures. It must be pointed out that the contrast between protein molecules and water
is poor and that it is not clear whether or not it is possible to use this technique with
relatively small structures like fibronectin. A possible application that will be tested
with the new electron microscope facilities in Edinburgh University biochemistry dpt.,
will be the determination of the distances between the binding sites on the fibronectin
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molecule. By labelling ligands with heavy metals their position in a frozen hydrated
sample can be easily determined , the distance between two labels could then be assumed
as the distance between the binding sites.
As a conclusion to this electron microscopy problem , in the absence of any data
obtained with the frozen hydrated technique and considering the remarks above , the
results from electron microscopy will not be considered too seriously for the construction
of models of plasma fibronectin in solution.
IV 10 2 Possible basic models for fibronectin .
Attempts to define the overall dimensions of the molecule have been presented in
paragraph IV 9 . The conclusions were similar as those from Sjoberg et al 1987 . The
fibronectin molecule can be represented as a flat structure approximatly equivalent to
an oblate ellipsoid of revolution with a main radius of 10 nm and approximately 10
times axial ratio. This is a very interesting property because this nearly limits the
structure to a plane . Once the general shape is defined the next point is to try to find out
how the chains are constituted and how they interact together .
The evidence showing that fibronectin is made of protease resistant domains
connected by non organised structures has been presented in IV 8 2 above .We can define
the molecule as being composed of two chains made of structured domains connected by
more unstructured sections. At this stage it is not possible to define the chains more
precisely. This will be done in section IV 10 3 below.
The next point to consider is how the two chains are connected together. The
existence of fibronectin as a double disulphide bonded dimer has been known for some
time (Engvall 1978 ), but several more recent works investigated those connections
A) In 1986 it has been shown by Skorskengaard et al. et al that the C terminal ends
of the two chains should be linked by double antiparallel disulphide bonds 20 and 16
residues before the C end.
B) The region of the double disulphide bridge must be compact and not easily accesible to
the solvent because reduction of those particular bonds is very slow (Williams et al.
1983 ).
C) Results from Robinson et al ( 1984 ) show that strong non covalent interactions exist
between the two chains. This also suggests that an increase in the molecule overall
diameter at low ionic strength can take place without requiring a separation of the two
chains.
D ) A fluorescence transfer study fromWolff et al. ( 1988 )demonstrated that the N
terminal ends of both chains were close to each-other.
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Two basic models with parallel and anti-parallel chains can be proposed as in Fig
IV 17 & 18 below.
Fig IV 17;
Model A: Parallel chain configuration.
Fig IV 18 :
Model B : Anti-parallel chain configuration.
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IV 10 3 A higher resolution model.
Electric birefringence data described in this thesis shows that the molecule has a
very low electric dipole for its size. The conclusion was that the absence of a noticeable
birefringence at low concentrations should be the consequence of a symmetry within the
molecule , as suggested by the anti-parallel disulphide bonding as described in above.
This would mean that the antiparallel model model B is more likely than model A .
We can also try to integrate in this model the hydrodynamic parameters
obtained with the purified domains. The conclusion of section IV 7 was that the gelatin
binding domain was spherical . The determination of the diffusion coefficient of the 150
kD central domain was presented in section IV 6 above and shows a Dt of 3.1 10"^ c.g.s.
As discussed this means that this domain is fairly extended. A possible structure is
presented in Fig IV 19 below.
Fig IV 19:
Proposed model for the tertiary structure of plasma fibronectin in solution.
150 k D Central domain
30 k D C terminal dom
44 k D Collagen Biriumg uumouu
30 k D N terminal
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It is then possible to check that the following important features are properties
of this model:
A ) The flat structure as shown by the hydrodynamic is maintained :
a ) The presence of a large proportion of the mass of the molecule in a central
position
could explain why the radius of gyration is small when compared to the
hydrodynamic data.
P ) The shape is not a revolution ellipsoid in accordance with the results from the
analysis presented in section IV 9 above .
Y) This flat structure allows free access from both sides for the various ligands,
8 ) Accessibilty of N terminal end to allow cross-linking, by factor Villa /Williams
1982 ), is also possible .
B ) The work from Wolff et al. ( 1988 ) showed that the N-terminal ends of the two
chains had to be close to each other ,but the structure of the molecule is also
relatively compact .
C ) Strong interchain interactions may exist as the surface of contact is extensive
( Robinson etal.1984 ).
D ) The results from Homandberg et al (1986 ) which defined! how the domains
interact are in a very good agreement with this model: The 29 Kd N terminal
domain interacts with the C terminal 40 K d strong heparin binding domain,
the collagen binding domain does not bind to any other exceptWeakly to itself (this
self aggregation was checked by the scattering experiments from this work
presented in section V 6).
E) The symmetry of the model could also explain the electric birefringence data .
F ) Despite a compact structure including the interchain bonds ,the region close to
the C end must be accessible as easy proteolysis occurs with plasmin ( Petersen et al.
1982 ) .This can easily be explained despite the relativly large molecular weight of
plasmin by enzyme attack at the flat sides.
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CHAPTER V
A STUDY OF THE PLASMA FTBRQNECTTN FROM CANCER PATIENTS
V 1 BACKGROUND;
Fibronectin involvment in cancer and metastaticprocesses has been studied along
three lines , all related to early events of metastasis . Three points emerge.
A ) Synthesis of specific fibronectins by changes of the primary structure (Wagner et al.
1981, Seikiguchi et al. 1985, Matsuura et al. 1985 , Castellani et al. 1986, Borsi et al.
1987) and sugar side chains composition (Wagner et al. 1981, Nichols et al. 1986,
Castellani et al. 1986 ).
B ) Modification at the cellular receptor level by changes of receptor distribution (Chen
et al. 1986, Virtanen et al. 1987 ),and fibronectin deposition rates in the matrix
(Sherbet et al. 1982, Virtanen et al. 1987 ).
C ) Degradation of fibronectin by tumour cells (Wen -Tien et al . 1984 ,Barlatti et al.
1986, Chen et al. 1987,Tryggvason et al. 1987 , Zucker et al. 1987 ). Specific enzymes
might have been described (Stevens et al. 1985).
Surprisingly the position of fibronectins in the next stage ,anchoring of the cell
migrating in the blood stream has been much less studied . De Petro et al. 1983 showed
that transformation enhancement activity in plasma of tumour patients was linked with
fibronectin . In this chapter it will be shown that the hydrodynamic properties of
plasma fibronectin from patients with metastatic breast cancer are different from those
of plasma fibronectin from healthy people.
V 2 FIBRONECTIN PREPARATION.
The preparation steps are very important in helping to define what causes the
changes in hydrodynamic properties described below in V 3 , therefore those steps will
be descibed below.
20 ml blood samples were collected , in the ward, from patients with clinically
confirmed metastatic breast cancer . The samples were treated immediately with 20 %
sodium citrate ,25 mM EDTA, 1 volume per 4 volumes blood and transferred on ice to the
Biochemistry Department to be centrifuged at 3500 rpm for 5 minutes with a bench
centrifuge . The cell pellet was discarded, plasma samples were either frozen at - 20 C or
immediately processed by centrifugation 10,000 g for 1 h followed by chromatography on
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2cm7 x 1 cm gelatin sepharose column as described in III 1. Elution of the sample was
carried out with 4M urea 50 mM tris pH 7.4 .
In order to test the possible influence of the elution buffer on aggregation
properties one sample was eluted by: 1 M Arginine 50 mM tris pH 7.4 . Extensive dialysis
in 50 mM tris , 100 mM NaCl , pH 7.4 (dialysis buffer )was performed to remove any
traces of urea.
To rule out any possible artefactual contamination , two samples were
rechromatographed on heparin sepharose column rinsed by dialysis buffer eluted by 1 M
NaCl 50 mM Tris ImM EDTA pH 7.4 and redialysed in dialysis buffer .
PMSF 0.05 mM and EDTA 5 mM were added to all buffers used for purification .
All specimens were tested by 5 or 6 % discontinuous PAGE gels.
To test the influence of filtration , ( required for light scattering ), on the
aggregation property , one sample was centrifuged in order to pellet any material with a
sedimentation constant over 23 S . When filtering the samples care was taken to avoid
any disturbance leading to aggregation .
Those preparations steps are summarised in Fig V 1 below .
V 3 RESULTS FROM LIGHT SCATTERING
Normal plasma fibronectin was studied in section IV 2 above . The results from
cancer patients samples are presented below :
V 3 1 Samples purified by gelatin affinity only (4 Samples ):
D population l(c.g.s.) D population 2 (c.g.s.) Polydispersity %
0.29 + - 0.0710"7 0.97 +- 0.410"7 55
MolecularWeight aprox 4000 KD.Fig V 1 shows the scattering intensity as a
function of diffusion coefficient for one sample.Fig V 2 shows a Zimm plot for one of those
samples.
V 3 2 Samples repurified on heparin sepharose ( 2 Samples):
D population 1 (c.g.s.) D population 2 (c.g.s.) Polydispersity %
1.12+- 0.2 10~7 2.8 +- 0.3 10'7 38
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Fig V 1.
Preparation of fibronectin samples .
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Fig V 2:
Scattering intensity as a function of diffusion coefficient, sample purified by gelatin
affinity only.
D cm 2 /sx107
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Fig V 3 :
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V 4 THERMOLYSIN LIMITED DIGESTION.
In an attempt to explain the differences in aggregation properties between normal
plasma fibronectin and cancer patient plasma fibronectin limited thermolysin digestion
was performed as described in III 2.
It has been shown (see I 3 1,2,3 & I 4 2,3 ) that fibronectin produced by normal or
transformed cells in culture showed many differences from fibronectin from plasma . It is
also well known that cellular fibronectin is much less soluble than plasma fibronectin .
To test the possibility of the presence in plasma of cancer patients of significant amounts
of cellular fibronectin ,limited thermolysin digestion of cancer patients plasma
fibronectin was carried out under the conditions described in III.
PAGE gels and their scans are presented in Fig V 4 ,5 & 6 . They show no differences
between the control and the cancer patients plasma fibronectin samples . The material
just over 30 K, present in all cell type fibronectins as described by Seikiguchi et al.
(1985), is absent.
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This shows that fibronectin present in the plasma of metastatic cancer is similar to
normal plasma fibronectin . The observed differences in aggregation properties cannot be
explained by the presence in the plasma of metastatic patients of a large amount of
cellular or tumour type fibronectin.
Fig V 4 :
P.A.G.E
Lane 1: Undigested normal plasma fibronectin.
Lane 2:Thermolysin digest of normal plasma fibronectin.
Lanes 3 to 6 : Thermolysin disgest of cancer patient plasma fibronectin .
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Fig V 5
Scan of P.A.G.E (5 15 % )
Thermolysin fragments of normal plasma Fn.
Fig V 6
Scan of P.A.G.E. (5 15 % )
Thermolysin fragments of cancer patient plasma Fn.
-Aj YL vJ I
Vij-v'••••• ■ "'.1 '■■■■■■
96 kD 69 kD 44kD 30 kD 20 kD 14 kD
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V 5 CONCANAVALIN-A AFFINITY CHROMATOGRAPHY.
To test the possibility of a change in distribution of the carbohydrate side-chains
in fibronectin from cancer patients plasma, affinity chromatography with immobilised
concanavalin-a( con-A) was performed as follow:
1.5 ml con-Asepharose beads , equilibrated in : Tris 50 mM, NaCl 25 mM , 2 mM
Co^+/ 2 mM Mn^+ were added to the thermolysin digested samples in the same buffer .
After incubation with gentle stirring for 2 h ,samples were decanted ,the
supernatant was collected , the beads were resuspended in 1 .5 ml equilibration buffer
incubated with stirring for 30 minutes . This step was repeated three times .
Elution was realised by adding 100 microl of 1 M methyl-mannoside 40 mM EDTA
and spinning the beads at high centrifugal field to compress them as much as possible .
The supernatant was analysed by gradient page presented, with scans in Fig V 7 & 8 .
Fig V 7
96 kD 69 kD 44kD 30 kD 20 kD 14 kD
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Fig V 8:
Scan of P.A.G.E.( 5 15 %) :Concanavalin-A binding thermolysin fragments of a
cancer-patient plasma fibronectin specimen .
69 kD 44kD 30 kD 20 kD 14 kD
There is no significant difference between the scans of S.D.S.P.A.G.E. of
concanavalin-A binding thermolysin generated fragments of plasma fibrononectin from
healthy individuals amd metastatic patients . This is a proof that no large change in
the distribution of the concanavalin-A binding carbohydrate chains can be detected.
The observed difference in aggregation properties then cannot be related to a large scale
modification in the distribution of those chains .
V 6 DISCUSSION AND INTERPRETATION OF THE RESULTS:
The results from this work reveals the presence of high molecular weight
material associated with fibronectin purified from clinically confirmed metastatic
patients' plasma .
V 6 1 Are those aggregates genuine fibronectin.
The first problem is to quantify the amount of high molecular weight material in
the preparation and identify it with fibronectin .
A) Intensity of light scattering is proportional to the square of the mass of the scattering
particles and thus to sixth power of their size , so clearly to allow detection of the
higher diffusion coefficient values ( i.e. smaller sizes particles .) the large Mw
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material must represent a small number fraction of the samples . It must be noted
that filtration might have removed some larger material .
B ) The presence of a large amount of contaminants different from fibronectin would be
detected on the PAGE control gels . Assuming contaminants were present but not
detected, the preparation procedure ( as shown on fig V 9 ), was designed to remove
them : either they could be eluted by 4 M urea only and therefore would not show up
on material eluted from gelatin column by 1 M Lysine , or they would be eluted by
high ionic strength and therefore be eluted before fibronectin during the 1 M NaCl
wash of the gelatin column . The aggregates were still present on material
rechromatographed on heparin sepharose ; furthermore binding to gelatin and
heparin at physiological salt concentrations is a property of fibronectin only . Thus
the combination of the various preparation procedures rules out the presence of a
significant amount of contaminant in the samples .
C ) We must explain why the high diffusion coefficient population (i.e. the low
molecular weight population of the cancer patients fibronectin), has a translational
diffusion coefficient ( D ) value different from the one of normal plasma-Fibronectin.
This is not surprising since the diffusion coefficient of the high diffusion coefficient
population has to be extrapolated from data showing polydispersity and therefore
the precision is not high enough to allow a fine distinction to be made.
V 6 2 Nature of the laree aeeregates.
The origin of the low D population ( i.e. high molecular weight large
aggregates), has to be discussed . As shown above, identification with fibronectin seems
clear but it is more difficult to say to which form of fibronectin they belong to and
whether they can exist in vivo .
As shown in V 4 & 5 attempts to relate this aggregation property to a primary
structure modification or con-A binding sugars changes in distribution have not been
successful. As the aggregates represent a minor component in the samples it is impossible
to rule out the possibility that a modification of carbohydrate side-chains of a small
amount of fibronectin molecules or the presence of very little oncofoetal fibronectin could
be missed by the lack of sensitivity of the tests performed . But the presence in the blood
stream of fibronectin synthesised only by tumour tissues seems unlikely because tumour
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cells have been shown to degrade fibronectin in tissues (see I 13 3 above), and it would
be difficult for fibronectin produced in tissues to diffuse considering its binding
properties. Furthermore the amount produced would be very low compared to existing
plasma fibronectin . So the most logical conclusion is that those aggregates are genuine
plasma Fibronectin modified in an unknown manner within the blood stream.
The findings from this work are in accordance with the changes in biological
properties of cancer patients plasma fibronectin shown by other studies (i.e. DePetro et
al. 1983) . Perhaps it could represent a form used by the metastatic cells to anchor at
the surface of a blood capillary in their target organ .
V 6 4 The problem of copurifyingcontaminant:
Aggregation can also be due to the presence of a very small amount of co-purifing
contaminant binding to fibronectin in a non stoechiometric ratio and therefore promoting
aggregation . The chances for this hypothesis to be correct are very slim considering the
fibronectin purification technique but cannot be completely ruled out.
V 6 5 Possibility of the presence of the aggregates in vivo .
The presence of those large aggregates in vivo cannot be stated with certainty .
They clearly existed at concentrations similar to the in vivo situation so they do not
result from aggregation induced by an artificially too high concentration . On the other
hand considerable size reduction after Heparin affinity suggests that they cannot easily
dissociate after formation , thus considering the exclusion limit of the gelatin affinity
column they would be excluded from the gelatin column being directly eluted in the first
preparation step .
So the more likely hypothesis is that they form during the preparation where
the use of urea or 1 M Lysinpbuffer leads to unfolding of the protein . An alternative
possibility is that binding to gelatin during preparation triggers a conformational




EFFECTS OF HEPARIN BINDING ON THE CONFORMATION OF FIBRONECTIN.
VI I INTRODUCTION.
In this chapter ,data from light scattering and neutron small angle scattering will
show that heparin binding to fibronectin induces no macromolecular conformational
change in the molecule but triggers some aggregation . The possibility that
polymerisation could occur under those conditions will be examined.
The codistribution of fibronectin and heparan sulphate type proteoglycans in
extracellular matrix ( Hedman et al. 1982, Hayman et al. 1982), and basal lamina
(Laurie et al 1982), is well known . Heparan sulphates have also been shown to align
with stress fibres of the cytoskeleton and may represent a part of the linkage system
between extracellular matrix and cytoskeleton (Woods et al. 1984 & Singer et al 1987).
The classical technique to investigate the presence and distribution of molecules in the
matrix is immunofluorescence microscopy which obviously detects only fibrillar
insoluble fibronectin. Heparan sulphate proteoglycans are found on the cell surface and
may possibly link cytoskeleton and matrix components ( Woods et al 1984 ) . They can
also possibly act as collagen receptors ( Koda et al 1985).
Many studies with fibronectin have been carried out with Heparin as a subsitute
for heparan-sulphates which are much less easily available ( and more expensive).
Furthermore the difference between those two types of carbohydrates is only due to
the degree of sulphation jn and is not always perfectly defined .This was also what was
chosen in this study because there was no carbohydrate biochemist available and it was
impossible to run in a time consuming heparan-sulphate purification without help and
advice. Heparin interactions with fibronectin have been described in I 3 1 above .
The influence of the binding of heparin-like carbohydrates on the
three-dimensional structure of fibronectin has to date only been studied by circular
dichroism and electron spin resonance . Osterlund et al. (1985) studied the circular
dichroism spectra of fibronectin in the presence of cellular heparan sulphate and found a
change in the spectra upon heparan addition . This confirmed the results obtained by
Welsh et al( 1983) ,using the same technique with heparin . An electron spin resonance
study by Ankel et al. (1986), also reported a conformational change due to heparin
binding .
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VI 2 SAMPLES AND TECHNIQUES.
Heparin was purchased from Sigma. Plasma fibronectin was purified as described in
chapter III. Photon correlation was described in II1, molecular weight measurements by
light scattering in II2 and neutron scattering in II3 above .
VI 3 RESULTS FROM PHOTON CORRELATION SPECTROSCOPY .
VI 3 1 Experimental conditions.
The conditions were as follow:
A ) The fundamental sample time was calculated directly by the system in order to
place particles with a Stokes diameter of 20 nm in the centre of a hundred fold size
scale as described in II1 9 above.
B ) No correction was made for buffer viscosity which was assumed to be the same as
that of pure water .
C ) Each recorded measurement was the accumulation of several runs . The software
calculated the mean value of photomultiplier counts integration for each run and
rejected any run with a significant difference in integration.
D ) The "Far point " estimation of the mean scattering intensity from the correlation
function was compared to the integration of the photomultiplier counts ( see II 1 6
above ). This permitted the determination of the influence of very large aggregates
or dust out of the measuring range on the diffusion coefficientmeasurement .
E ) The "In range " index was then defined by the ratio of the far point to the total
integration of photomultiplier counts. This was performed for each run and was
typically over 99 % for crude fibronectin specimens . This showed that there was no
significant contribution due to out of range scattering material in the samples . These
good conditions for the measurement were also confirmed by the fact that the value
of the diffusion coefficient of crude fibronectin was not dependent upon the angle of
measurement as expected for a molecule that is small compared to the wavelength of
the incident light .
F ) The scattering from heparin was found to be negligible at the concentrations used in
those experiments.
G ) It is important to notice that as heparin preparations tends to be heterogenous in
molecular weight it is preferable to give heparin concentrations in mass per
volume rather than in molar concentrations .
H ) The relatively low angle of 40 degrees was chosen to measure the diffusion
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coefficient in order to ensure that the contribution of large molecular weight material
(i.e. with a size non negligible compared to the incident wavelength ),would be
detected even if this high molecular weight material was present at low
concentrations . As the scattering intensity of those large particles is strongly
dependent on the scattering angle, their contribution to the scattering fluctuations
used to determine D is more obvious at low angles, even if they represent only a minor
part of the sample .
VI 3 2 Results and interpretation.
Table VII:
Results from photon correlation spectrocopy measurements.
Buffer: Tris 50mM, NaCl 100 mM, pH 7.35, angle 40,temperature 25 0C.
Sample Heparin cone
Bovine plasma fibronectin (400mg/ml)
Same
Same
mg/ml CaC^mM D cm?/secxl0-7
0 0 2.33 +- 0.014
60 0 1.69+- 0.3
60 20 1.93+- 0.14
The diffusion coefficient decreased significantly upon the addition of heparin .
This corresponding to a 38% increase of Stokes radius for heparin concentration of 60
mg/ml. These results could be explained either by a conformational change (i.e. a large
expansion of the molecule ), or by the association of fibronectin-heparin complexes to
form large aggregates.
The large increase, upon the addition of heparin , of the standard deviation (from
less than 1 % to 17 %), should be noted . This indicates that a simple change in
conformation does not fully explain this data , but rather indicates that an aggregation
phenomenon, less easily reproducible, might have occurred.
The addition of calcium did not fully abolish the effects of heparin and the
specimens still demonstrated a Stokes radius increase of 19 % . This could be explained
only by the formation of aggregates insensitive to calcium or by an irreversible change
in the conformation of fibronectin after heparin binding . It was not possible to increase
the calcium concentration in order to try to dissociate those aggregates . Since the
structure of fibronectin is dependent on the ionic strength, the addition of a high amount
of calcium would result in an unfolding of the fibronectin molecule and therefore would
interfere with the heparin induced modification of the diffusion coefficient.
After filtration of a calcium treated sample through a 100 nm filter there was only a
minor decrease of the diffusion coefficient compared to samples before heparin treatment
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■2.26 10"^ cgs compared to 2.33 10"^ cgs . The filter pore size of lOOnm is bigger than 5
times the fibronectin molecule stokes radius approximately , corresponding to a
diffusion coefficient under around 0.4 10 cgs . Furthermore addition of calcium up to 20
mM in the absence of heparin results in a nearly similar change with a diffusion
coefficient of 2.28 10 c.g.s . Those last two facts strongly back the hypothesis that the
observed change in D is a consequence of aggregation and not of a change in the
conformation of the fibronectin molecule .
Fig VI 1 : Relation between heparin addition and D .
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A steady decrease is observed in the diffusion coefficient measured at 40 angular
degrees upon heparin addition ( see Fig. VI 1 ). Once again if a conformational change
was responsible one would expect a saturation which is not detected.
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VI 4 RESULTS FROM MEASUREMENTS OF THE ANGULAR DEPENDENCE OF
LIGHT SCATTERING.
VI 4 1 Introduction and experimental parameters.
The angular dependence of the scattering from the fibronectin solutions were
plotted by classical representation of Kc/Rq as a function of Sin^ ( 0 / 2 ) . 9 is the
scattering angle and K is an optical constant equal to: 2 n ^ (dn/dc )^ / N ,where
dn /dc represents the refractive index increment with concentration , n the refractive
index of the solvent, X is the wavelength of the incident light , c is the concentration of
the molecule studied , Rq is the excess scattering intensity of the solution relative to
toluene. The molecular weight has been shown to be the reciprocal of the normalized
intercept of the extrapolations at concentration and angle equals to zero ( see II2 above ).
Practical considerations , namely the very low fibronectin concentration and the
fact that only comparative profiles upon heparin addition were required , dictated
that only one fibronectin concentration was measured.
This method of representing the data demonstrated any polydispersity due to
the presence of particles with very different Rg and molecular weight ( Zimm 1948).
The presence of a majority of small Rg particles presenting a scattering profile with
little angular dependence , with a minority of large Rg particles ,which gives a
scattering profile showing a large increase of intensity at low angles, will show up on
this representation as a curvature of the lines of the angle dependent data. To minimise
experimental errors due to the source or to detection the various precautions described in
II 2 3&4 were followed.
The following parameters were used :
A) Rayleigh ratio for toluene 18.3 10"^ c.g.s.
B ) Laser wavelength was 514.5nm .
C ) Fibronectin extinction coefficient: 12.8 for a 1 % solution.
D ) It was not possible to measure the value of the index increment dn/dc at our
working wavelength. We used an approximate value of 0.19. Since our purpose was
only to compare the molecular weight of fibronectin in the presence and the absence
of heparin this did not represent a problem.
VI 4 2 Datafrom angular dependance of light scattering .


























































VI 4 3 Interpretation.
The representation of normalized intensity Kc/Rq as a function of angle
demonstrates a clear decrease in Kc/R0 upon heparin addition. This demonstrates that
the molecular weight is increasing. A slight curvature at low angles upon heparin
addition is also observed . This has been shown by Zimm ( 1948), to be a consequence of
polydispersity and reflects the presence of:
A) Heparin-fibronectin complexes made of only one fibronectin molecule with a small Rg
and relatively low molecular weight.
B) Complexes made by the association of many fibronectin and heparin molecules with a
large Rg and very high molecular weight.
The decrease of Kc/Rq after heparin addition is proof that an increase in average
molecular weight occurs. Thus the decrease of the diffusion coefficient is due to
aggregation and not only to a change of conformation of the fibronectin molecule.
VI 5 RESULTS FROM NEUTRON SMALL ANGLE SCATTERING.
VI 5 1 Data.
The camera for neutron scattering experiments, "D 11 " , data collection and
analysis have been described in II3 above . The distance from sample to detector was 10
m ,10 wavelength neutrons being used , Q .Rg ranges for Guinier approximations were
from 0.69 to 1.47. The Guinier representations are shown in Fig. VI3 & 4 below.
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FigVI3










Guinier plot of small angle neutron scattering.
Sample: Fibronectin with heparin 60 p g /ml .Filtered through 100 nm pore diameter
filter.
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VI 5 2 Interpretation of the small angle neutron scattering data.
Tab. VI 2 :Radius of gyration determined
Buffer: D20 Tris 50 mM NaCl 100 mM pH 7.4
Sample
Plasma fibronectin
Same + heparin filtered through lOOnm
pore diameter filter, [heparin ] = lOOmg/ml
The determination of the radius of gyration of filtered fibronectin-Heparin
complexes by neutron small angle scattering data rules out the possibility of any large
change in conformation as shown by the lack of a significant change in the radius of
gyration.
VI 6 EVIDENCE REPORTED IN THE LITERATURE OF CONFORMATIONAL
CHANGES IN FIBRONECTIN AFTER ADDITION OF HEPARIN TYPE
CARBOHYDRATES .
In contradiction with the results presented above three papers present evidence
for a change in conformation of fibronectin upon heparin addition. Two of them (Welsh
et al. 1983, Osterlund et al.1985 ), are circular dichroism studies the remaining one (
Ankel et al. 1986 ), is mainly based on electron spin resonance technique.
VI 6 1 Electron spin resonance study ■
Despite the fact that their own sedimentation studies showed no change in
sedimentation coefficient ,Ankel et al. ( 1986 ) reported a change in fibronectin
conformation in the presence of heparin at a 50 to 1 heparin / fibronectin molar ratio.
This was based on electron spin resonance (ESR ) data. This result from ESR seems
vulnerable because of the following points:
A) At 4 0 C fibronectin-heparin complexes are insoluble and form visible
precipitates . This would result ,if the spin-label-protein association was rigid , in a
dramatic change in mobility of the label. This is not observed in this work.
B) No mention is made of the temperature control system used . Temperature shifts of as
little as half a degree between or during runs could account for some of the observed
differences.
C) A microwave power of 30 mW was used although 5-10 mW seems the maximal power





permissible ( Jost et al. 1979 ) , and a high amplitude modulation was employed .
Both of these may result in spectrum distortion.
D) No proper spectrum analysis was made (ie defining peak positions and peak to peak
differences in height and position. ) .The high noise also created a uncertainty in the
determination of the position of the high field extremum in the spectra resulting in
considerable uncertainty in the measured splitting values.
E ) The estimation of the weakly immobilized label with the use of a 120kD fragments
is probably wrong because the area under the two low field peaks in Fig 3a of
reference 18 seems in a 1 to 1 ratio rather than 20 to 1 as suggestedin this work.
F ) There is no evidence that relating the protein motion to the label motion is
appropriate in this case because of the lack of evidence of rigid spin-label-protein
association. As stated in paragraph A above , there is even evidence that the two
motions are not related.
G ) Apparently no attempts were made to avoid the polydispersity problem such as
filtration or centrifugation of the specimens before the measurements.
H ) Those experiments were performed on a machine possessing only low sensitivity and
a single scan mode not suited to the detection of small variations.
Therefore we may conclude that because the association is not rigid, no deductions
on the fibronectin overall conformation are possible and that observed differences are
the result of either a very local change in conformation resulting in a greater label
freedom or a change in the polarity of the environment.
VI 6 2 Circular dichroism studies.
Two circular dichroism studies (Welsh et al. 1983, Osterlund et al.1985 ) ,show a
clear change in fibronectin CD spectrum induced by heparan-fibronectin ( Osterlund et
al.1985 ) or heparin-fibronectin ( Welsh et al. 1983), complex formation. They both
concluded that the secondary structure of fibronectin was changed upon heparan or
heparin binding. As this spectrum alteration occurs at very low heparan fibronectin
molar ratios of 1 to 100 heparan/fibronectin ( Osterlund et al.1985 ), requiring the
association of multiple fibronectin molecules on one heparan chain , the authors
suggested that this change in secondary structure might be due to polymerisation or
formation of large complexes with heparan .
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It must be noted that:
A) For both works:
a) No clear estimation of the polydispersity is possible by this technique .
P) Aggregation is known to perturb CD spectrum (see Mc Calley et al. 1972).
Y ) The effects of heparin type sugar additions on the spectra differs between the
two publications.
B ) In the work by Welsh et al. (1983):
a ) There is no convincing proof that the measured signal was due to specific changes
in Tyrosine or proline residues, hairpin bends, P-turns or y-turns.
P ) It cannot be said that fibronectin contains little or no P-sheet or a-helix.
Y) Changes observed at high pH may be due to the sensitivity of S-S bonds in those
conditions.
C) In the work of Osterlund et al. (1985 ) : As pointed out by the authors the changes
were possible even with a very low heparan/fibronectin molar ratio. We believe, as
noted by these authors , that the observed variations in the spectra are due to
polymerisation or aggregation rather to a change in secondary structure. Those results
would then confirm the findings from this work.
VI 7 CONCLUSION : CONSEQUENCES FOR FIBRONECTIN IN VIVO.
The study of Heparin-fibronectin complexes presented in this chapter show :
A) By neutron scattering of fibronectin-Heparin complexes after filtration ,that no large
change in conformation of the fibronectin molecule occurs after heparin binding.
B) By light scattering that the molecular weight of unfiltered complexes increased upon
heparin addition coupled to a decrease in diffusion coefficient.
Despite those two points the two CD studies mentioned over in VI 6 6 show
alteration of fibronectin spectra upon heparin-type carbohydrates even after a small
heparan addition. As fibronectin is known to be composed of independent domains and
that the heparin binding sites represents only a fraction of the molecule we believe that
those alterations are a consequence of aggregation.
We cannot completely rule out a possible minor change in conformation undetected
by our experimental techniques. Nevertheless if this minor change was restricted to the
heparin binding domain , C.D. studies would probably be unable to detect it as well. A
large change in conformation certainly does not occur after heparin-fibronectin complex
formation.
Addition of calcium inhibits the complex formation ( Richter et al. 1985 ).
Calcium addition does not entirely reverse the changes in diffusion coefficient with
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unfiltered material arid filtration was required to reverse entirely those changes . We
therefore believe that some of the aggregates are calcium insensitive. This could be due
either to it being impossible for calcium ions to diffuse in very dense aggregates or to
the formation of covalent fibronectin polymers by inter molecular disulphide bridge
formation.
We might therefore suggest that some in vitro polymerisation of fibronectin
could be triggered by heparin-like carbohydrate interaction with fibronectin . Formation
of non covalent complexes of multiple fibronectin molecules on one carbohydrate chain
might create the conditions required for some polymerisation of fibronectin.
Heparan sulphate proteoglycans (for review see Hook et al. 1984), are present in
the extracellular matrix as:
A) Integral membrane components ( Kjellen et al. 1980) with their protein section
imbedded in the membrane . It is believed that they can possibly create a link
between matrix and < cytoskeleton •
B ) Membane associated structures (Hedman et al. 1982 ) . Those structures are bound
through their carbohydrate or protein section to a receptor embedded in the
membrane.
Fibronectin has been shown to be associated with heparan sulphate in vivo
(Laurie et al. 1983), and in the matrix deposed by cultured cells ( Hedman et al. 1982 ).
Heparan-fibronectin aggregate formation is impossible in vitro because heparan
sulphate is immobilized as a membrane associated structure .
Association of fibronectin with heparan on the cell surface also differs from the
fibronectin association with fibronectin-receptor in the sense that more than one
fibronectin molecule can be attached to on one carbohydrate chain. This would create
clusters of fibronectin at the surface of the cells. This is impossible with fibronectin
directly linked to fibronectin-receptor where only one fibronectin molecule can be present
at a time on the receptor. Creating heparan-multi fibronectin complexes with fibronectin
molecules close to eachother could be an important step in matrix formation. It must be
noted that the heparan-fibronectin interaction is much stronger in vivo than in vitro
( Hedman et al .1982 b ).
We have shown that the fibronectin conformation is not affected upon
heparan-fibronectin complex' formation but that polymerisation of fibronectin is
possible . This suggests that a factor might help to trigger the transition of
heparan-fibronectin into a stronger association. This factor ,obviously missing in vitro.
could perhaps be responsible for fibronectin polymerisation with inclusion of
heparan-fibronectin complexes in the polymers. This would explain the stronger
heparan-fibronectin association observed with heparan-fibronectin created in vivo.
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Transformed cells, unable to create a proper extracellular matrix, synthesize
undersulphated heparan sulphate ( Pejler et al. 1987 ), unable to bind immobilized
fibronectin, but show a normal fibronectin synthesis but poor fibronectin retention ( Wen
tien et al. 1982 )J.This is no surprise as fibronectin is strongly dependent on sulphation
for heparin type carbohydrate binding ( Ogamo et al. 1985 ) . We suggest that the
creation of multi fibronectin complexes on the cell surface heparan sulphate and their
processing by an unknown mechanism into a much stronger association is a critical step
for proper matrix deposition and assembly .
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GENERAL CONCLUSION
In this thesis various physicochemical techniques have been applied to the study of the
fibronectin molecule in solution .
From the work presented in chapter IV it can be concluded that, although each of those
techniques can yield accurate results their interpretation is not easy because the amount of
information given by each method is limited . However the simultaneous application of
several complementary techniques has proved valuable. The comparison between the
measurements of the radius of gyration , the translational and rotational diffusion coefficients
has been carried out . The use of all three of those parameters was of particular interest. This
showed that the approximation of the shape of the fibronectin molecule to an ellipsoid of
revolution is not possible . This confirms that this approximation process , performed in most
physicochemical studies, should ideally not be. applied unless it has been shown that at least
three parameters depending on the shape fit the same ellipsoid .
In this specific study of the fibronectin molecule many biochemical studies were described
in the literature . This published information, as well as the measurements on isolated
fragments, allowed refinement of the the model.
Crystallographic techniques have not been succesfully applied to fibronectin yet. At
present it seems that the classical methods of crystallisation cannot , at present , allow
production of crystals from fibronectin.
The physicochemical techniques in solution can also be used for comparative studies .
Chapters V and VI shows that studies in solution can produce interesting comparative results in
pathological or physiological situations .
In chapter V , the case of the study of the diffusion coefficient of plasma fibronectin
from metastatic cancer patients , shows that light scattering could rapidly detect fine
changes that are difficult to establish with other techniques .
Chapter VI described how the investigation of the properties of the
three-dimensional 1 structure of the fibronectin molecule in the presence of heparin in vitro can
be related to the understanding of the formation of the extracellular matrix .
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Plasma fibronectin purified from the plasma of metastatic breast cancer patients has been studied by light scattering.
It clearly shows abnormal self-aggregation properties; the possible significance of these findings to the in vivo situation
is discussed.
Fibronectin; Cancer; Light scattering; (Plasma, Man)
1. INTRODUCTION
Fibronectins are a class of extracellular
glycoproteins (520 kDa) (review [1]). Their
primary structure can vary and depends on the
alternative splicing of a unique gene which can
generate at least ten different variants [2], The
molecules are composed of the concatenation of
three types of homologous sequences [3] forming
two similar, but not identical, chains linked near
the carboxy-terminus end by two interchain
disulphide bonds. One of the most striking
features of the fibronectin molecules is that they
are made of a succession of protease-resistant do¬
mains which can bind specifically to one or more
of heparin, fibrin, factor Vila, Clq, cell surface,
DNA, gelatin collagen [1],
In solution, plasma fibronectin as studied by
light scattering techniques does not show any
significant self-aggregation properties [4], but
fibronectins are present in the extracellular matrix
in an insoluble, fibrillar, form [5],
Correspondence address: L. Vuillard, Department of
Biochemistry, University of Edinburgh Medical School, Hugh
Robson Building, George Square, Edinburgh EH8 9XD,
Scotland
Receptors to fibronectin on the cell surface have
been described [6] and a transmembranous con¬
tinuity between cytoskeleton and fibronectins
through the receptor has been demonstrated [7],
The association of fibronectin with the matrix
assembly receptor has also been reported [8], The
position of fibronectin in the cell attachment pro¬
cess is therefore very important and it is probable
that fibronectins are likely to be the extracellular
matrix protein in closest contact with cells.
The involvement of fibronectin in cancer and
metastatic processes has been investigated along
three separate lines all related to early events of
metastasis leading to the detachment of cells and
their penetration into the blood stream:
(i) Synthesis of specific fibronectins by altera¬
tions of the primary structure [9] and carbohydrate
side chains composition [10],
(ii) Modification at the cellular receptor level
[11] and deposition rates of fibronectin in the
matrix [12].
(iii) Degradation of fibronectin by tumour cells
[13]. Specific enzymes have been described [14].
Surprisingly the role of fibronectins in the next
stage, that is anchoring of the cell migrating in the
blood stream, has been much less studied. De
Petro et al. [15] have shown that transformation
enhancement activity in the plasma of tumour pa-
Published by Elsevier Science Publishers B. V. (Biomedical Division)
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tients was linked with fibronectin. We report here
evidence, from a light scattering study, that plasma
fibronectin from breast metastatic cancer patients
possesses significantly different hydrodynamic
properties from normal plasma fibronectin.
2. MATERIALS AND METHODS
All affinity chromatography media were from Pharmacia
(Sweden), and all other chemicals (analytical grade) were from
BDH (England).
2.1. Protein purification
Blood samples were treated with 20% sodium citrate, 25 mM
EDTA (1 vol. per 4 vols blood) and centrifuged at 200 x g for
5 min in a bench centrifuge. The supernatant was removed and
was either frozen at — 20°C or processed immediately as
follows.
To remove any precipitates the plasma was centrifuged at
10000 x g for 1 h and then chromatographed on a 2 cm2 x
1 cm gelatin-Sepharose column as described [16]. The sample
was eluted with 4 M urea, 50 mM Tris-HCl (pH 7.4) but in
order to test its possible influence on aggregation, 1 M arginine,
50 mM Tris-HCl (pH 7.4) was also used for one sample with no
detectable difference. Exhaustive dialysis in 50 mM Tris-HCl,
100 mM NaCl, pH 7.4 (dialysis buffer), was then performed to
remove any urea traces.
To eliminate any possible artefactual contamination two
samples were rechromatographed on a heparin-Sepharose col¬
umn rinsed by dialysis buffer and then eluted by 1 M NaCl,
50 mM Tris-HCl, 1 mM EDTA (pH 7.4) and redialysed in
dialysis buffer.
PMSF (0.05 mM) was present in all buffers and EDTA
(5 mM) was added to all buffers used for purification. All
specimens were examined by 5 or 6% discontinuous PAGE gels
according to Laemmli [17].
2.2. Photon correlation spectroscopy
All work presented here was performed on a type 4700c
Malvern system (Malvern Instruments, England). The argon-
ion laser (Innova 4, USA) was used at 514.5 nm with a power
of approx. 150 mW.
For measurements on the fibronectin molecule the ex¬
perimental time was set between 5 and 15 s with no noticeable
difference between results. Each measurement involved the ac¬
cumulation of a number of runs; the software calculated the
mean value of total counts for each run and rejected any run
with a significant difference in integrated counts.
To remove any possible dust or contaminant from the 1 cm
diameter quartz cells (ALV Lasers, FRG), they and their teflon
caps were stored in pure sulphuric acid. Prior to use they were
washed 20 times with double-distilled water to remove any
traces of acid and three times further with filtered sample buffer
to ensure that the buffer composition of the sample would not
be altered by some remaining water. All buffers and all but one
sample were filtered through 200 nm pore size Nucleopore
filters (USA). These are well known for their highly constant
pore size as well as low retention of the sample because of their
design as flat surfaces as opposed to ordinary filters which have
mesh-like surfaces.
To test the influence of filtration one sample was centrifuged
and showed no difference in properties from filtered samples.
When filtering the samples care was taken to avoid any distur¬
bance leading to aggregation. We avoided the use of metal
needles which leads to metal contamination thereby triggering
fibronectin polymerisation, as well as creating high-speed flows
possibly leading to aggregation.
The first-order correlation function was calculated from the
measured second-order and related to the diffusion coefficient
D and polydispersity index (review [18]). No correction was
made for buffer viscosity which was assumed to be the same as
pure water. The analysis by the software has a specific feature
to estimate the diffusion coefficient distribution for
polydisperse solutions. The software retains in the memory the
shape of correlation functions for a large number of diffusion
coefficients. It then calculates a multiexponential curve and fits
it with the observed one. It is important to note that no assump¬
tion about the distribution of particles is made.
2.3. Molecular mass determination by light scattering
When the concentrations were high enough to produce per¬
missible signal-to-noise ratio, molecular mass estimations were
made using the classical method of Zimm [19],
3. RESULTS
Fig.l shows the diffusion coefficient/scattering
intensity profile for normal plasma fibronectin
(open squares) and for one sample of gelatin
affinity-purified fibronectin from metastatic
cancer patient plasma (black squares).
D cm2 / sx 107
Fig.l. Diffusion coefficient/scattering intensity profile of
(O—□ ) normal plasma fibronectin and (■---■) one sample of
gelatin-affinity purified fibronectin from plasma of metastatic
cancer patient.
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(1) Samples purified by gelatin affinity only (4 samples):
D population 1 D population 2
(cmVs) (cm2/s)
0.29 ± 0.07 x 10"7 0.97 ± 0.4 x 10"7 55 4000
(2) Samples repurified on heparin-Sepharose (2 samples):
D population 1 D population 2
(cm2/s) (cm2/s)
1.12 ± 0.2 x 10"7 2.80 ± 0.3 x 10"7 38
(3) Normal plasma fibronectin:
Monodisperse
distribution
D = 2.2 x 10"7
(cm2/s) 10 500
4. DISCUSSION
The most immediate result of our study is that
plasma fibronectin prepared from metastatic
cancer patients, when studied by dynamic light
scattering, presents a polydisperse distribution,
with two populations with markedly different dif¬
fusion coefficients. This contrasts with fibronectin
purified from healthy individuals which presents a
monodisperse distribution as shown in fig.l as well
as in the literature [4],
The analysis of the measured diffusion coeffi¬
cients shows that: (1) Fibronectin from metastatic
cancer patients which was purified solely on
gelatin-Sepharose comprises two populations of
material larger than normal plasma fibronectin. (2)
Heparin-repurified samples comprise one popula¬
tion of larger objects and one population of slight¬
ly smaller objects.
(i) Proof that the material scattering light is
fibronectin:
- The presence of protein contaminating the
fibronectin preparation would be detected on the
PAGE control gels.
— If contaminating material had been present, it
would have been removed by the combination of
various preparation procedures: for example, if
the contaminants were eluted by 4 M urea only and
they would not appear with material eluted from
September 1988
the gelatin column by 1 M arginine or repurified
on the immobilised-heparin column, otherwise
contaminants would have been eluted by high ionic
strength, and therefore be eluted before fibronec¬
tin during the 1 M NaCl wash of the gelatin
column.
— Furthermore, fibronectin alone binds to gelatin
at high salt concentration and heparin at
physiological salt concentration.
(ii) How much material is in an aggregated form?
The intensity of light scattering is proportional
to the square of the mass of the scattering particles
and thus to the sixth power of their size; so, clearly
to allow detection of the higher diffusion coeffi¬
cient values (i.e. those particles with smaller sizes)
the high molecular mass material must represent a
small number fraction of the total sample.
(iii) Why does the high diffusion coefficient
population of fibronectin from cancer patients
have a translational diffusion coefficient value (D)
different from that of normal plasma fibronectin?
This is not too surprising, since the diffusion
coefficients have to be calculated from a correla¬
tion function containing two decay rates, therefore
the resolution is low. It is important to note that
this is not a problem of noise but simply that the
resolution is low when the distributions of two
populations are close which means that the decays
in the correlation function are not sufficiently
dissimilar to estimate them precisely (the same
problem occurs with Scatchard plots when two
binding sites have similar dissociation constants).
In addition, this loss in resolution is a direct conse¬
quence of the polydispersity and it lowers the
quality of the diffusion coefficient measurements
but the presence of aggregation is clearly estab¬
lished. This is confirmed by the very high values of
the polydispersity index.
(iv) The important point established by our
measurements is the presence of a low D popula¬
tion (i.e. large aggregates) in plasma fibronectin
purified from metastatic cancer patients. As shown
above in point (i), identification with fibronectin is
clear but it is more difficult to determine whether
such aggregates exist in vivo:
- They clearly exist at concentrations similar to
the in vivo situation.
FEBS LETTERS
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— The exclusion limit of the gelatin affinity col¬
umn (Sepharose 4B) is smaller than that of the
heparin affinity column (Sepharose CL6b).
Despite this fact a considerable reduction in the
size of the aggregates occurs after heparin affinity
repurification. This would suggest that aggregates
cannot easily dissociate after formation.
— Because of their size they would be excluded
from the gelatin column, being directly eluted in
the first preparation step. So, the more likely
hypothesis is that they form during the preparation
where the use of urea or 1 M arginine buffer leads
to unfolding of the protein. The presence of these
large aggregates in vivo cannot be stated with cer¬
tainty.
— They are not the consequence of filtration
because one sample that had been centrifuged still
presented abnormal aggregation.
(v) We can only speculate on the origin of
fibronectin presenting this abnormal aggregation
property in vitro.
The presence in the blood stream of fibronectin
synthesised by tumour tissues seems unlikely
because tumour cells have been shown to degrade
fibronectin in tissues [13] and fibronectin pro¬
duced in tissues would have considerable difficulty
migrating considering its binding properties. Fur¬
thermore, the amount produced would be very low
compared to existing normal plasma fibronectin.
Our conclusion is that the aggregates detected are
genuine fibronectin with a different structure from
that of normal plasma fibronectin. It could be pre¬
sent in plasma from confirmed metastatic cancer
patients through modification in the blood of a
small fraction of preexisting plasma fibronectin or
could represent a form used by the metastatic cells
to anchor at the surface of a blood capillary in
their target organ.
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APPENDIX 2
Possible evidence for two heparin-binding classes of vitronectin in bovine plasma
leading to a new preparation technique for vitronectin from bovine serum.
A2 1 ABSTRACT.
Vitronectin binding to heparin depends on the treatment which vitronectin
undergoes during its preparation . In this section the possible existence the presence of
vitronectin with high and low affinity to heparin in bovine serum and plasma is shown .
This could also allow a faster non denaturing vitronectin preparation technique .
A2 2 A SHORT PRESENTATION OF VITRONECTIN.
Vitronectin is a protein identified in plasma (Hayman et al. 1983), and tissues
(Dahlback et al. 1986). It exists in two forms of Mr 65 and 75 kD ( Hayman et al. 1983 &
Akama et al. 1986). It has been shown that vitronectin is homologous with the S-protein
of the complement system ( Tomasini et al 1986 ).
Vitronectin has been sequenced through its cDNA (Susuki et al. 1986) and the
sequences responsible for various binding properties have been identified ( Suzuki et al.
1984) .Vitronectin is involved in cell attachment processes (Hayman et al. 1985) . The
binding of vitronectin to cells is mediated via a cellular receptor binding to the peptide
RGD of vitronectin ( Pytela et al. 1985) .The cellular vitronectin receptor has been
sequenced and is found to be homologous to the fibronectin cellular receptor (Suzuki et al
1986).
The functions of vitronectin in the complement system might be to act as a
regulation of the killer complex (Muller-Eberhart 1985) possibly through a trypsin
cleavage of Vitronectin ( S-Protein.) ( Bhakdi 1982) .
Vitronectin has been shown to bind to the thrombin-antithrombin III complex in
serum (111 et al. 1985).
Vitronectin can bind to heparin but not in physiological conditions ( Barnes et al
1983, Hayashi et al. 1985) . Heparin binding to vitronectin was also tested in a
functional assay . Heparin binding to vitronectin inhibits the vitronectin neutralisation
of activation of thrombin and factor Xa ( Lane et al. 1987) .In this last work, the
A2 1
dissociation constant of the vitronectin-heparin complex was found to be independent of
the Mw of heparin and equal to 10"** M . The affinity of vitronectin to heparin is
increased when vitronectin is exposed to guanidine or reduced and carboxymethylated.
Radiolateelleciheparin exhibits a dissociation constant of 4 10 -8 M with vitronectin.
A 2 3 MATERIALS.
Glass beads (type 15032, 0.15 mm diameter), and analytical grade chemicals were
from BDH (U.K.). Prior to use , glass beads were washed in pure sulphuric acid then
exaustively in water then packed in a 20cm2 by 60 cm column . Heparin sepharose was
from Pharmacia (Sweden ). Bovine blood, which was made non clotting by addition of
1/9 vol/vol ACD, was collected in a plastic container, centrifuged for 10 minutes
lO.OOOg to pellet blood cells. Plasma was then pumped and processed as described below.
A 2 4 PREPARATION OF THE SERUM SPECIMENS.
Vitronectin was prepared either from plasma or from serum. When serum was
required it was obtained from plasma by adding calcium up to 40 mM and raising pH to
aproximately 7. 8 . This material was incubated 2h at 37 C leading to formation of
a solid gel. It was then centrifuged 15 min 10, 000 g and incubated at room temperature
overnight still leading to formation of a fair amount of insoluble material
Centrifugation 15 min 10, OOOg resulted in the separation of the insoluble clot and serum .
A2 5 AFFINITY CHROMATOGRAPHY ON GLASS BEADS .
All the preparation was carried out at 4 C . The column wasequilibratedwith 50
mM Tris, 200mM NaCl, 5 mM EDTA pH 7.9 at 25 C.
150 ml of serum or plasma were loaded at a flow of lOOml/h, washed with 1.5 1
of equilibration buffer at a flow of 150ml/h . To allow a sharp transition in pH upon next
buffer the column was then rinsed with 100 ml of water . Elution was carried out by
rinsing by 200 mM NaHC03 buffer pH 9.7 at a flow of 100 ml/h . 15 ml fractions were
collected .
A2 2
A2 6 AFFINITY CHROMATOGRAPHY ON HEPARIN
The peak fractions of the previous step ( aprox. 200 ml), were dialysed twice
against lOOmM phosphate buffer pH 6 then once against 50 mM Phosphate , 100 mM
NaCl . This resulted in the formation of a precipitate which was removed by
centrifugation 5 min at 10, 000 g . The supernatant was loaded on a 2 cm^by 5 cm heparin
affinity columnequilibratedby the last dialysis buffer . It was then washed by 25 ml of
the same buffer, 10 ml of 20 mM phosphate pH 6.1 buffer . A flow of 15 ml/h was kept
for those first three steps . Elution was carried out by pumping 100 mM Tris pH 7.5 at a
flow of 8ml/h . This was sometimes followed y 50 mM Tris 1 M NaCl pH 7.5 at the same
flow .
A2 7 P.A.G.E
Polyacrylamide gel electrophoresis was carried out as described in chapter II
section 4.
A2 8 RESULTS FROM AFFINITY CHROMATOGRAPHY ON HEPARIN .
The fractions from the heparin affinity steps were analysed by P.A.G.E. in
denaturing and non denaturing conditions.
Fig A 2 1 shows the elution profile of heparin affinity .
Fig A 2 2 shows a 8 % PAGE of the heparin affinity step .
It is obvious from both the elution profile and the gels that two classes of
molecules can be released from the heparin column:
A ) The first one is released by the change in pH . It appears as two bands with Mr of 65
and 75 kD .
B ) The other class needs an increase in the ionic strength to allow elution from the
column . An important part of this fraction was represented by material with the
same characteristics on P.A.G.E as the proteins eluting only with a pH shift.
A2 3
Fig A2 I:
Vitronectin preparation : elution profile of heparin affinity chromatography step .
1.3 ml fractions.
Fig A 22:
S.D.S. P.A.G.E. of fractions from the heparin affinity chromatography step .
Lane 1: MW markers : 96, input material mg.
Lane 2 to 6 : Fractions eluted by lOOmM Tris pH 7.5
lane ? : Fraction eluted by ImM NaCl.
A2 4
A 2 9 IS THIS MATERIAL VITRONECTIN ?
At the moment the identification of this material with vitronmectin is not
absolute in the absence of specific antibodies . Nevertheless the following facts
strongly suggests identity of the pH sensitive heparin binding material with
vitronectin:
A) Same Glass binding properties .
B ) Binding to heparin at low pH .
C) Elution from the heparin column by a by shift from pH 6.1 to 7.8
D ) Same appearance on gelsas vitronectin: two bands at 65 and 75 k D .
As the pH insensitive heparin binding material has an apearance identical to
that of the pH sensitive material and is also prepared by glass affinity it is likely
that this material is vitronectin. . Absolute identification is dependent on the
antibody availability which seems difficult at the moment .
A2 10 CONCLUSION
Those results are interesting because they show that Vitronectin can show two
populations which differ in their affinity to heparin. :
A ) One can remain bound to heparin at a pH superior to 7 at near physiological ionic
strength and requires an increase of ionc trength to be realeased .
B ) The other is released from an immobilised heparin column by simply raising the pH
from 6.1 to 7.5 .
Those properties can give lead to a technique that could allow the preparation of
purified vitronectin from bovine serum in two steps . This is performed under mild
conditions as opposed to the classical methods that requires either :
A) exposure to 8 M urea which damages the molecule . (Ruoslahiti et al. 1987).
B ) Or a purification in four steps which is very time consuming . ( Barnes et al. 1983).
A2 5
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